{"text": "Management of Treatment Failure .Failure of H pylori eradication therapy is suggested when symptoms persist or recur within 14 days after the end of initial treatment .", "label": "", "metadata": {}, "score": "31.409817"}
{"text": "They also confirmed that the 7-day regimen was suboptimal in terms of treatment duration , and that a longer duration , for example , 10 days , might improve the eradication rate [ 39 ] .", "label": "", "metadata": {}, "score": "31.771166"}
{"text": "In Asia , the currently recommended first - line therapy for H. pylori infection is a PPI , AMPC , and CAM for 7 days [ 49 ] .", "label": "", "metadata": {}, "score": "33.940777"}
{"text": "A prolonged duration to 14 days of the standard clarithromycin - based triple therapy improved the eradication rate to 82.2 % but was still not good enough to attain a grade A or B report card [ 21 ] .", "label": "", "metadata": {}, "score": "34.07823"}
{"text": "In the current study , we shortened the duration of concomitant therapy from 10 days to 7 days , and still achieved high eradication rates .", "label": "", "metadata": {}, "score": "34.084827"}
{"text": "The difference between eradication rates achieved with 1 and 2 weeks of triple therapy is not statistically significant .Studies of PPI - based triple therapy for 7 days , mainly from European countries , confirm that this remains a valid duration for H. pylori treatment .", "label": "", "metadata": {}, "score": "34.497005"}
{"text": "The difference between eradication rates achieved with 1 and 2 weeks of triple therapy is not statistically significant .Studies of PPI - based triple therapy for 7 days , mainly from European countries , confirm that this remains a valid duration for H. pylori treatment .", "label": "", "metadata": {}, "score": "34.497005"}
{"text": "To prevent infection and complications , local studies should be undertaken to evaluate H. pylori eradication rates in a country .OBJECTIVES :We compared 7-day and 14-day regimens to determine the optimum duration of triple therapy for H. pylori eradication .", "label": "", "metadata": {}, "score": "38.147144"}
{"text": "The incidence of adverse events was comparable in the two groups .CONCLUSION :One - week and 2-week triple treatments for H. pylori eradication are similar in terms of efficacy , safety and patient compliance .", "label": "", "metadata": {}, "score": "41.59417"}
{"text": "7-day concomitant therapy achieved a very high eradication rate for H. pylori infection in Taiwan .Drug compliance was the only clinical factor influencing treatment efficacy .", "label": "", "metadata": {}, "score": "41.842056"}
{"text": "Discussion .The results of this meta - analysis clearly show that , for eradication of Helicobacter pylori infection , sequential therapy is superior to seven day triple therapy and similar to regimens of longer duration and those including more than two antimicrobial agents .", "label": "", "metadata": {}, "score": "42.09437"}
{"text": "Patients were asked to return at the second week to assess drug compliance and adverse effects .Repeated endoscopy with rapid urease test and histological examination or urea breath test was performed at 8 weeks after the end of anti- H. pylori therapy .", "label": "", "metadata": {}, "score": "42.513016"}
{"text": "There have been conflicting findings on the benefits of extending the length of traditional therapy .2 European guidelines indicate that triple therapy for 1 week is acceptable whereas , in the USA , 10 - 14 days of treatment is preferred .", "label": "", "metadata": {}, "score": "42.72901"}
{"text": "There have been conflicting findings on the benefits of extending the length of traditional therapy .2 European guidelines indicate that triple therapy for 1 week is acceptable whereas , in the USA , 10 - 14 days of treatment is preferred .", "label": "", "metadata": {}, "score": "42.72901"}
{"text": "Eradication of H. pylori .Table 2 lists the therapeutic outcomes of the 7-day concomitant therapy .According to the ITT analysis , H. pylori infection was eradicated in 93.7 % ( 299/319 ) of the patients receiving concomitant therapy .", "label": "", "metadata": {}, "score": "44.28481"}
{"text": "Patients were asked to return at the second week to assess drug compliance and adverse effects .Repeated endoscopy or urea breath test was performed at 8 weeks after the end of eradication therapy .", "label": "", "metadata": {}, "score": "44.629433"}
{"text": "Patients were asked to return at the end of the antibiotic treatment to assess the compliance with therapy and to estimate the incidence of side effects .", "label": "", "metadata": {}, "score": "44.7161"}
{"text": "After completing this activity , the participant should be able to : .Identify the factors associated with increased risk and transmission of H pylori infection .", "label": "", "metadata": {}, "score": "45.012726"}
{"text": "European practitioners considered 7 days of treatment sufficient to achieve a high eradication rate , in contrast to the USA , where a more consistent eradication rate was obtained by prolonging the duration of therapy to 14 days .", "label": "", "metadata": {}, "score": "45.11258"}
{"text": "European practitioners considered 7 days of treatment sufficient to achieve a high eradication rate , in contrast to the USA , where a more consistent eradication rate was obtained by prolonging the duration of therapy to 14 days .", "label": "", "metadata": {}, "score": "45.11258"}
{"text": "Rifabutin is an antituberculous agent and it is also effective for eradicating H. pylori [ 44 ] .The optimal duration of rifabutin - containing therapies is unclear , but most studies have recommended 10 - 12 days .", "label": "", "metadata": {}, "score": "46.057083"}
{"text": "Eradication assessed at least four weeks after end of treatment .Outcome assessment .The primary outcome was the efficacy of sequential therapy compared with established and new therapies in eradicating H pylori infection .", "label": "", "metadata": {}, "score": "46.143375"}
{"text": "Focareta R , Forte G , Forte F , Ciarleglio A , Grimaldi E , Ievoli F , et al .Could the 10 days sequrntial therapy be considered a first choice treatment for the eradication of Helicobacter pylori infection ?", "label": "", "metadata": {}, "score": "46.54248"}
{"text": "OBJECTIVES :We compared 7-day and 14-day regimens to determine the optimum duration of triple therapy for H. pylori eradication .Compliance and side - effects were assessed 2 weeks after the start of therapy and H. pylori eradication was assessed by stool antigen tests 4 weeks after treatment .", "label": "", "metadata": {}, "score": "46.63431"}
{"text": "It has , however , to be taken into consideration that the improved effect with sequential and concomitant therapies compared with standard therapy may also be due to the larger number of antibiotics than to the sequential administration itself [ 24 ] .", "label": "", "metadata": {}, "score": "47.09447"}
{"text": "Kalapothakos P , Liantiniotis G , Koulentis M , Koutoufaris G , Georgantas P , Rigas S. Ten days sequential treatment for Helicobacter pylori eradication in clinical practice in Greece .", "label": "", "metadata": {}, "score": "47.19473"}
{"text": "This combination product reduces the number of capsules to three taken four times per day in addition to the PPI taken twice daily .The medication may be taken with each meal and at bedtime .", "label": "", "metadata": {}, "score": "47.206722"}
{"text": "Therapy lasting 14 days eradicated 9.8 % ( 6.3 % to 11.9 % ) and 6 % ( 2.9 % to 9.3 % ) more infections than therapy lasting seven and 10 days .", "label": "", "metadata": {}, "score": "47.39353"}
{"text": "15 This confirms our finding that 7-day triple therapy is adequate for H. pylori eradication because local resistance rates are very low .No serious adverse events were documented in either treatment group .", "label": "", "metadata": {}, "score": "47.769936"}
{"text": "15 This confirms our finding that 7-day triple therapy is adequate for H. pylori eradication because local resistance rates are very low .No serious adverse events were documented in either treatment group .", "label": "", "metadata": {}, "score": "47.769936"}
{"text": "A recent review article of 15 studies ( 1723 patients ) revealed that there was a tendency towards better results by longer treatments ( 7 - 10 days versus 3 - 5 days ) [ 21 ] .", "label": "", "metadata": {}, "score": "47.994225"}
{"text": "In the head to head comparisons , sequential therapy achieved significantly better results only when compared with triple therapy lasting seven or 10 days ; we found no significant differences in other comparisons .", "label": "", "metadata": {}, "score": "48.18199"}
{"text": "But when a comparison was made with triple therapy lasting 10 days , the results were less clear - cut .Although the estimate of the effect size was better for the sequential therapy , prediction intervals were not significant , suggesting that future trials may not be able to observe a superior effect .", "label": "", "metadata": {}, "score": "48.31668"}
{"text": "No data or consensus about the duration of treatment for H. pylori in Kenya were available .We found that 1 week of treatment with esomeprazole , clarithromycin and amoxicillin achieved H. pylori eradication rates of 76.7 % and 92 % by ITT and PP analyses , respectively .", "label": "", "metadata": {}, "score": "49.69318"}
{"text": "No data or consensus about the duration of treatment for H. pylori in Kenya were available .We found that 1 week of treatment with esomeprazole , clarithromycin and amoxicillin achieved H. pylori eradication rates of 76.7 % and 92 % by ITT and PP analyses , respectively .", "label": "", "metadata": {}, "score": "49.69318"}
{"text": "310 - 319 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. A. Attumi and D. Y. Graham , \" Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks : a pilot study , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "49.724106"}
{"text": "The search for more effective eradication regimens or for new agents to treat H pylori should therefore continue .Notes .Cite this as : BMJ 2013;347:f4587 .", "label": "", "metadata": {}, "score": "49.755013"}
{"text": "There was no statistically significant difference in the side - effects between the treatment groups .The tolerability of triple therapy has been good and similar for 1- and 2-week regimens .", "label": "", "metadata": {}, "score": "49.80352"}
{"text": "There was no statistically significant difference in the side - effects between the treatment groups .The tolerability of triple therapy has been good and similar for 1- and 2-week regimens .", "label": "", "metadata": {}, "score": "49.80352"}
{"text": "Eradication rates .Our objective was to determine and compare the H. pylori eradication rates between 7- and 14-day triple therapy regimens according to the ITT and the PP analysis .", "label": "", "metadata": {}, "score": "50.390404"}
{"text": "Eradication rates .Our objective was to determine and compare the H. pylori eradication rates between 7- and 14-day triple therapy regimens according to the ITT and the PP analysis .", "label": "", "metadata": {}, "score": "50.390404"}
{"text": "In conclusion , this study shows that the efficacy and safety of 1 week of triple therapy including esomeprazole with amoxicillin and clarithromycin does not differ significantly from 2 weeks of treatment for the eradication of H. pylori .", "label": "", "metadata": {}, "score": "50.525097"}
{"text": "In conclusion , this study shows that the efficacy and safety of 1 week of triple therapy including esomeprazole with amoxicillin and clarithromycin does not differ significantly from 2 weeks of treatment for the eradication of H. pylori .", "label": "", "metadata": {}, "score": "50.525097"}
{"text": "There was no statistically significant difference in the experience of side - effects between the treatment groups .Discussion .International guidelines have allowed consensus on the best management and improved eradication rates of H. pylori .", "label": "", "metadata": {}, "score": "50.66136"}
{"text": "There was no statistically significant difference in the experience of side - effects between the treatment groups .Discussion .International guidelines have allowed consensus on the best management and improved eradication rates of H. pylori .", "label": "", "metadata": {}, "score": "50.66136"}
{"text": "Wu HY , Hsi YT , Lam JTW , Lam WM .Ten - day sequential therapy as the first - line eradication of Helicobacter pylori infection in chinese patients : a randomized - controlled trial .", "label": "", "metadata": {}, "score": "51.12414"}
{"text": "However , there is no agreement with the duration of bismuth - containing quadruple therapy now .Ten or fourteen days are often used durations in these regimens [ 24 ] .", "label": "", "metadata": {}, "score": "51.26502"}
{"text": "25 PPIs inhibit gastric - acid secretion and are most effective when taken 30 to 60 minutes prior to meals .Antibiotics : Several antibiotics with varying characteristics are used in the treatment of H pylori .", "label": "", "metadata": {}, "score": "51.339478"}
{"text": "Paoluzi OA , Visconti E , Andrei F , Tosti C , Lionetti R , Grasso E , et al .Ten and eight - day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection : a randomized controlled study on efficacy and tolerability .", "label": "", "metadata": {}, "score": "51.87577"}
{"text": "Sequential therapy is superior to seven day triple therapy and similar to regimens of longer duration or including more than two antimicrobial agents .The search for a new agent to treat H pylori is important and should continue , but until such an agent is discovered , any single therapy is unlikely to be effective all over the world .", "label": "", "metadata": {}, "score": "51.880398"}
{"text": "Supplementary table A shows a complete evaluation of risk of bias .Meta - analysis .Sequential therapy versus triple therapy lasting seven days .Twenty two studies compared sequential therapy with a triple therapy regimen lasting seven days .", "label": "", "metadata": {}, "score": "51.97943"}
{"text": "We found that the 7-day concomitant therapy produced 96.4 % treatment success by PP analysis .The eradication rate by ITT analysis was 93.7 % .", "label": "", "metadata": {}, "score": "52.111626"}
{"text": "The calculated costs for 10-day modified sequential therapy and standard therapy were $ 75.6 ( Group A ) , $ 63.8 ( Group B ) , and $ 78.8 ( Group C ) , respectively .", "label": "", "metadata": {}, "score": "52.293274"}
{"text": "Group C received 20 mg of Esomeprazole , 500 mg of Clarithromycin , and 1000 mg of Amoxicillin for standard 10-day therapy .All drugs were given twice daily . H. pylori eradication rate was checked four to eight weeks after taking the medicine by using a 13 C urea breath test .", "label": "", "metadata": {}, "score": "52.38874"}
{"text": "Links ] .Zagari RM , Bianchi - Porro G , Fiocca R , Gasbarrini G , Roda E , Bazzoli F. Comparison of 1 and 2 weeks of omeprazole , amoxicillin and clarithromycin treatment for Helicobacter pylori eradication : the HYPER Study .", "label": "", "metadata": {}, "score": "52.452415"}
{"text": "Links ] .Zagari RM , Bianchi - Porro G , Fiocca R , Gasbarrini G , Roda E , Bazzoli F. Comparison of 1 and 2 weeks of omeprazole , amoxicillin and clarithromycin treatment for Helicobacter pylori eradication : the HYPER Study .", "label": "", "metadata": {}, "score": "52.452415"}
{"text": "Several studies have previously reported that certain probiotics exhibit inhibitory activity against H. pylori in vitro and in vivo [ 58 , 59 ] .Earlier studies demonstrated that standard triple therapy plus probiotics showed better eradication rate than standard triple therapy only [ 60 - 62 ] .", "label": "", "metadata": {}, "score": "52.494896"}
{"text": "Several factors including antibiotics resistance , patient compliance , and CYP 2C19 genotypes could influence the outcome .Clinicians should use antibiotics according to local reports .", "label": "", "metadata": {}, "score": "52.53399"}
{"text": "10 day sequential therapy versus 14 day sequential therapy .Only two studies compared sequential therapy lasting 10 days with sequential therapy lasting 14 days .", "label": "", "metadata": {}, "score": "52.551125"}
{"text": "Sequential therapy requires validation in the U.S. before the ACGCG will recommend it as initial therapy .Treatment for patients with persistent H pylori infection includes quadruple therapy for 7 to 14 days or levofloxacin triple therapy for 10 days ; however , the latter also requires validation in the U.S. 10 .", "label": "", "metadata": {}, "score": "52.67134"}
{"text": "The fall in H. pylori eradication rates with standard triple therapies resulted in a search for novel therapies for H. pylori infection [ 6 ] .", "label": "", "metadata": {}, "score": "52.75657"}
{"text": "Clarithromycin resistance is thought to be the primary contributing factor .27 One meta - analysis reported a nearly 60 % reduction if clarithromycin resistance was present . 8 Quadruple therapy consists of a PPI , bismuth 525 mg four times daily , metronidazole 250 mg four times daily , and tetracycline 500 mg four times daily for 10 to 14 days .", "label": "", "metadata": {}, "score": "52.798935"}
{"text": "Study Design .In the study period , 317 H. pylori -infected patients received a 7-day pantoprazole - containing concomitant therapy ( pantoprazole 40 mg , clarithromycin 500 mg , amoxicillin 1 g and metronidazole 500 mg twice daily ) .", "label": "", "metadata": {}, "score": "53.312138"}
{"text": "Quadruple therapy with a PPI or H2RA , bismuth , metronidazole , and tetracycline for 10 to 14 days is favored in patients previously treated with a macrolide antibiotic or in those with a true penicillin allergy .", "label": "", "metadata": {}, "score": "53.400288"}
{"text": "16 - 21 , 2007 .View at Google Scholar .G. Scaccianoce , C. Hassan , A. Panarese , D. Piglionica , S. Morini , and A. Zullo , \" Helicobacter pylori eradication with either seven - day or 10-day triple therapies , and with a 10-day sequential regimen , \" Canadian Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "53.450016"}
{"text": "The possibility of a tailored therapy will be a chance in the next future to optimize the most effective eradication regimen within the various geographical areas .", "label": "", "metadata": {}, "score": "53.560665"}
{"text": "Therefore , searching for more effective first - line therapies is urgently required [ 4 , 13 ] .One recent therapeutic innovation is 10-day sequential regimen with a 5-day dual therapy ( a PPI plus amoxicillin ) , followed by a 5-day triple therapy ( a PPI plus clarithromycin and tinidazole ( or metronidazole ) )", "label": "", "metadata": {}, "score": "53.59603"}
{"text": "Hsu and colleagues [ 47 ] showed that there was a multicenter pilot study in which H. pylori -infected patients received a 14-day sequential - concomitant hybrid therapy ( esomeprazole and amoxicillin for 7 days followed by esomeprazole , amoxicillin clarithromycin , and metronidazole for 7 days ) .", "label": "", "metadata": {}, "score": "53.7005"}
{"text": "This special issue reviews the novel first - line eradication regimens with a per - protocol eradication rate exceeding 90 % .In addition , the emerging rescue therapies for the second - line and third - line therapies are also discussed .", "label": "", "metadata": {}, "score": "54.360046"}
{"text": "[Links ] .Laine L , Estrada R , Trujillo M , Fukanaga K , Neil G. Randomized comparison of differing periods of twice - a - day triple therapy for the eradication of Helicobacter pylori .", "label": "", "metadata": {}, "score": "54.429695"}
{"text": "[Links ] .Laine L , Estrada R , Trujillo M , Fukanaga K , Neil G. Randomized comparison of differing periods of twice - a - day triple therapy for the eradication of Helicobacter pylori .", "label": "", "metadata": {}, "score": "54.429695"}
{"text": "In contrast , alcohol consumption may facilitate elimination of H. pylori infection among adults .All patients who had dyspepsia and were referred for endoscopy had H. pylori -positive gastritis .", "label": "", "metadata": {}, "score": "54.49614"}
{"text": "In contrast , alcohol consumption may facilitate elimination of H. pylori infection among adults .All patients who had dyspepsia and were referred for endoscopy had H. pylori -positive gastritis .", "label": "", "metadata": {}, "score": "54.49614"}
{"text": "Sequential therapy consists of a PPI twice daily and amoxicillin 1 g twice daily for 5 days , followed by a PPI twice daily , clarithromycin 500 mg twice daily , and metronidazole twice daily for an additional 5 days .", "label": "", "metadata": {}, "score": "54.50821"}
{"text": "22 Antibiotics that were not used initially for H pylori should be used as therapy for treatment failures .After several courses of failed H pylori eradication therapy , an ulcer is considered to be refractory to therapy .", "label": "", "metadata": {}, "score": "54.749268"}
{"text": "Recently , a new therapy consisting of proton pump inhibitor , amoxicillin 1 g , levofloxacin 500 mg , and tinidazole 500 mg , all given twice daily for five days , has been shown to reach a high eradication rate .", "label": "", "metadata": {}, "score": "54.77442"}
{"text": "The data suggested that 7-day concomitant therapy achieved a high eradication rate in Taiwanese and had a great potential to replace 7-day triple therapy as a first - line anti- H. pylori therapy in Taiwan .", "label": "", "metadata": {}, "score": "55.07325"}
{"text": "Finally , two studies compared sequential therapy lasting 10 and 14 days .The second study , a randomised controlled trial conducted in Turkey and published only as an abstract , also found no significant difference .", "label": "", "metadata": {}, "score": "55.176212"}
{"text": "However , this study is the first work to investigate 7-day pantoprazole - containing concomitant therapy and the number of cases in this study was large ( . )", "label": "", "metadata": {}, "score": "55.194107"}
{"text": "In addition , the 20 % of patients with persistent H. pylori warrant repeated attempts at eradication with ever - decreasing success .A systematic review of therapy for H. pylori reported a 53 % decrease in eradication rates if clarithromycin resistance was present and if a clarithromycin - containing regimen was used [ 39 ] .", "label": "", "metadata": {}, "score": "55.23136"}
{"text": "Patients .From March 2008 to March 2012 , 319 H. pylori -infected outpatients who received a 7-day pantoprazole - containing concomitant therapy in our center were included for the retrospective analysis .", "label": "", "metadata": {}, "score": "55.317535"}
{"text": "104 - 405 , 2007 .View at Google Scholar .C. Y. Guo , Y. B. Wu , H. L. Liu , J. Y. Wu , and M. Z. Zhong , \" Clinical evaluation of four one - week triple therapy regimens in eradicating Helicobacter pylori infection , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "55.393906"}
{"text": "Eradication rates were 72 % and 97 % , respectively , in the case of metronidazole - resistant H pylori .Bismuthcontaining quadruple therapy is an alternative for initial therapy ; if not used as initial therapy , it is the preferred second - line treatment .", "label": "", "metadata": {}, "score": "55.43039"}
{"text": "H pylori eradication therapy is associated with a statistically significantly higher number of adverse events compared with antisecretory , placebo , or no treatment , according to a Cochrane Review .", "label": "", "metadata": {}, "score": "55.473293"}
{"text": "As we are not aware of local published studies to establish the rate of H. pylori eradication with the triple therapy and with different treatment periods , we decided to determine the optimum duration of triple therapy for H. pylori eradication .", "label": "", "metadata": {}, "score": "55.49465"}
{"text": "As we are not aware of local published studies to establish the rate of H. pylori eradication with the triple therapy and with different treatment periods , we decided to determine the optimum duration of triple therapy for H. pylori eradication .", "label": "", "metadata": {}, "score": "55.49465"}
{"text": "Clarithromycin resistance plays the cardinal role in failure of eradication [ 14 - 16 ] .However , prolonged duration of standard triple therapy might be a good method to overcome the challenge of resistance .", "label": "", "metadata": {}, "score": "55.615673"}
{"text": "Obvious effect was also achieved .Helicobacter pylori treatment still remains a challenge for physicians , and no current first - line therapies are able to cure the infection in all treated patients [ 2 ] .", "label": "", "metadata": {}, "score": "55.739277"}
{"text": "Scaccianoce G , Hassan C , Panarese A , Piglionica D , Morini S , Zullo A. Helicobacter pylori eradication with either 7-day or 10-day triple therapies , and with a 10-day sequential regimen .", "label": "", "metadata": {}, "score": "55.740757"}
{"text": "Safety monitoring was also conducted according to the recorded adverse events .Cost Calculations .The cost of each treatment was estimated by using retail US costs obtained from our study .", "label": "", "metadata": {}, "score": "55.840202"}
{"text": "This is particularly relevant with H. pylori eradication regimens because side - effects such as diarrhoea or taste disturbance can lead to discontinuation of therapy in some patients , with potential treatment failure .", "label": "", "metadata": {}, "score": "55.867584"}
{"text": "This is particularly relevant with H. pylori eradication regimens because side - effects such as diarrhoea or taste disturbance can lead to discontinuation of therapy in some patients , with potential treatment failure .", "label": "", "metadata": {}, "score": "55.867584"}
{"text": "Data on adverse events were available in 18 trials .Sequential therapy versus triple therapy lasting 10 days .Fourteen studies compared sequential therapy with a triple therapy regimen lasting 10 days .", "label": "", "metadata": {}, "score": "55.934628"}
{"text": "3,16,18 H pylori has since been implicated , with an estimated 15 % to 20 % of infected patients developing PUD .In Western countries , however , these rates have recently fallen owing to the downward trend of infection .", "label": "", "metadata": {}, "score": "55.944427"}
{"text": "5 Such a regimen would need to have high efficacy against clarithromycin resistant and metronidazole resistant strains of H pylori , as these strains are increasingly encountered in routine clinical practice .", "label": "", "metadata": {}, "score": "55.982647"}
{"text": "A study by Miehlke et al . showed that a high - dose PPI dual therapy with AMPC was effective as a salvage treatment for eradication of H. pylori resistant to both CAM and MNZ , with an ITT of 76 % [ 62 ] .", "label": "", "metadata": {}, "score": "56.035553"}
{"text": "Federico A , Nardone G , Gravina AG , Iovene MR , Miranda A , Compare D , et al .Efficacy of 5-day levofloxacin - containing concomitant therapy in eradication of Helicobacter pylori infection .", "label": "", "metadata": {}, "score": "56.09137"}
{"text": "View at Google Scholar .S. Y. Kim , S. W. Lee , B. S. Kwon , et al . , \" Comparative study of Helicobacter pylori eradication rates of 5-day quadruple ' Concomitant'therapy and 7-day standard triple therapy . , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "56.121758"}
{"text": "Results .Overall , 210 patients accomplished all therapy schemes , 9 case patients were excluded .The examination result indicated that the H. pylori eradication rate of each group was as follows : group A 92.5 % ( 62/67 ) , group B 86.8 % ( 59/68 ) , and group C 78.8 % ( 52/66 ) .", "label": "", "metadata": {}, "score": "56.197235"}
{"text": "If a first - line clarithromycin - based regimen was used , a second - line metronidazole - based treatment ( quadruple therapy ) may be used afterwards , and then a levofloxacin - based combination would be a third - line rescue option .", "label": "", "metadata": {}, "score": "56.31144"}
{"text": "Hsu et al .[ 33 ] presented one novel therapy - The hybrid therapy .In this therapy , the role of fourteen - day amoxicillin is to reduce the bacterial load and try to overcome the challenge of H. pylori with dual resistance ( metronidazole and clarithromycin ) .", "label": "", "metadata": {}, "score": "56.455482"}
{"text": "In patients without bleeding who undergo successful H pylori eradication therapy , remission rates are approximately 97 % in those with gastric ulcers and 98 % in those with duodenal ulcers after 12 months .", "label": "", "metadata": {}, "score": "56.558945"}
{"text": "This paper will introduce recent novel and acceptable regimens as the first - line therapies of H. pylori and the factors influencing eradication .Standard Triple Therapy .", "label": "", "metadata": {}, "score": "56.627518"}
{"text": "In addition , a reduction in the risk of gastric cancer may be associated with H pylori eradication . 11According to the Maastricht Consensus Report , it is optimal for H pylori treatment regimens to have a minimum eradication rate of 80 % .", "label": "", "metadata": {}, "score": "56.73093"}
{"text": "Clinicians must stress the importance of taking the medications as prescribed to minimise the likelihood of antibiotic resistance developing , as this is a major cause of treatment failure .", "label": "", "metadata": {}, "score": "56.781967"}
{"text": "Clinicians must stress the importance of taking the medications as prescribed to minimise the likelihood of antibiotic resistance developing , as this is a major cause of treatment failure .", "label": "", "metadata": {}, "score": "56.781967"}
{"text": "We evaluated the efficacy of this therapy regimen in our current clinical practice .The results of this study show that modified sequential therapy is superior to triple therapy for the eradication of H. pylori infection .", "label": "", "metadata": {}, "score": "56.891632"}
{"text": "This relatively expensive novel drug combination would represent an absolute increase of 17 % in the eradication rate ( with a needed to treat number of 5.88 to achieve one more successful eradication ) .", "label": "", "metadata": {}, "score": "57.01683"}
{"text": "A progressive decline in infection rates has been secondary to the improvements in sanitation as well as to the use of combination anti - HP regimens over the past decades .", "label": "", "metadata": {}, "score": "57.019413"}
{"text": "With an estimated drop - out rate of 30 % , we then needed 120 patients in total and 60 patients in each group .The type and severity of adverse events during treatment were reported by patients on diary cards , to be returned no later than 1 week after ending therapy .", "label": "", "metadata": {}, "score": "57.123795"}
{"text": "With an estimated drop - out rate of 30 % , we then needed 120 patients in total and 60 patients in each group .The type and severity of adverse events during treatment were reported by patients on diary cards , to be returned no later than 1 week after ending therapy .", "label": "", "metadata": {}, "score": "57.123795"}
{"text": "In sequential therapy , the prevalence of primary bacterial resistance to clarithromycin was 5 of 70 ( 7.1 % ) and 6 of 70 ( 8.6 % ) patients , respectively .", "label": "", "metadata": {}, "score": "57.172173"}
{"text": "One open label , randomised controlled trial is ongoing in the United States , comparing triple therapy containing clarithromycin and lasting 10 days with sequential therapy .", "label": "", "metadata": {}, "score": "57.211586"}
{"text": "Data on adverse events were available for 11 trials .Sequential therapy versus triple therapy lasting 14 days .Seven studies compared sequential therapy with a triple therapy regimen lasting 14 days .", "label": "", "metadata": {}, "score": "57.462914"}
{"text": "The effect of increasing dose is unclear .The Impact of Probiotics in Eradicating H. pylori .It is difficult to develop new effective antibiotics to eradicate H. pylori , so it is necessary to find alternative methods to improve eradication rate and compliance in first - line therapy .", "label": "", "metadata": {}, "score": "57.482544"}
{"text": "One critical point should be remembered that quinolone resistance is raised rapidly in eradication of H. pylori .Primary resistance to levofloxacin ranges between 8 % and 31 % in different countries or regions [ 41 - 43 ] .", "label": "", "metadata": {}, "score": "57.65492"}
{"text": "321 - 331 , 2008 .View at Publisher \u00b7 View at Google Scholar . D. C. Wu , P. I. Hsu , J. Y. Wu et al . , \" Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection , \" Clinical Gastroenterology and Hepatology , vol . 8 , no . 1 , pp .", "label": "", "metadata": {}, "score": "57.693634"}
{"text": "Side effects were evaluated using a structured questionnaire by personal interview .Items Observed and Examined .Illness history clinical symptom was recorded and gastroscopy was executed to clarify the disease diagnosis and status of H. pylori infection .", "label": "", "metadata": {}, "score": "57.717968"}
{"text": "This paper reviews the literature about first - line therapies for H. pylori infection in recent years .First - line therapies are facing a challenge because of increasing treatment failure due to elevated antibiotics resistance .", "label": "", "metadata": {}, "score": "57.766113"}
{"text": "However , it has also been concerned about the eradication rates with those regimens decreased due to emergence of metronidazole resistance in H. pylori over the past few years .", "label": "", "metadata": {}, "score": "57.77246"}
{"text": "The symptoms during the first day and at the end of 2 , 3 , 7 , 21 , and 35 days were monitored by scoring symptoms .", "label": "", "metadata": {}, "score": "57.840576"}
{"text": "Symptoms improvement : all the three groups could improve the symptoms such as epigastric gnawing , burning pain , and acidity since the first day .", "label": "", "metadata": {}, "score": "57.894775"}
{"text": "In recent years , there has been increasing resistance to standard antibiotic treatments for H. pylori infection [ 31 - 33 ] .This means that it is harder to get rid of H. pylori in some patients and that we need new treatment regimens .", "label": "", "metadata": {}, "score": "57.900085"}
{"text": "Some data confirm the finding of disappointing eradication rates after standard triple therapy , as widely reported in several recent studies [ 22 - 30 ] .", "label": "", "metadata": {}, "score": "57.909668"}
{"text": "The novel first - line anti- H. pylori therapies include sequential therapy [ 3 ] , concomitant quadruple therapy [ 4 ] , hybrid ( dual - concomitant ) therapy [ 5 ] , and bismuth - containing quadruple therapy .", "label": "", "metadata": {}, "score": "57.910583"}
{"text": "Some authors have demonstrated the importance of H. pylori CagA status for the efficacy of antibiotic treatment considering an infection with cytotoxic strains as a good predictive marker of successful therapy [ 11 - 13 , 66 ] .", "label": "", "metadata": {}, "score": "57.97303"}
{"text": "Because antimicrobial resistance varies geographically , studies are needed to validate sequential therapy in the U.S.In addition , sequential therapy involves the simultaneous use of metronidazole and clarithromycin for H pylori eradication .", "label": "", "metadata": {}, "score": "58.08571"}
{"text": "Introduction .Eradicating Helicobacter pylori ( H. pylori ) is the most important aspect of managing H. pylori -related gastrointestinal diseases .In the past decade , the Maastricht III Consensus Report has recommended that proton pump inhibitor- ( PPI- ) clarithromycin - amoxicillin or metronidazole treatment is the first choice for H. pylori infection [ 1 ] .", "label": "", "metadata": {}, "score": "58.177567"}
{"text": "The progressive decline in infection rates has been secondary to the improvements in sanitation as well as to the use of combination of anti - HP regimens over the past decades .", "label": "", "metadata": {}, "score": "58.239258"}
{"text": "Five of 319 patients ( 1.6 % ) failed to complete the treatment because of insufficient compliance . H. pylori was successfully eradicated in three of 5 cases ( 60 % ) .", "label": "", "metadata": {}, "score": "58.31671"}
{"text": "ROLE OF THE PHARMACIST .Efficacy , antibiotic resistance , cost , side - effect profile , allergies , and ease of administration should be taken into account when an individualized treatment regimen is being selected for a patient with H pylori .", "label": "", "metadata": {}, "score": "58.347332"}
{"text": "However , compared with triple therapy lasting 14 days , non - bismuth containing quadruple therapy , or sequential therapy in which levofloxacin was used instead of clarithromycin , no significant difference was seen ( supplementary table F ) .", "label": "", "metadata": {}, "score": "58.364784"}
{"text": "This work was supported by the National clinical specialties of China ( no .2100 - 305 ) .D. Vaira , A. Zullo , C. Hassan , G. Fiorini , and N. Vakil , \" Sequential therapy for Helicobacter pylori eradication : the time is now ! , \" Therapeutic Advances in Gastroenterology , vol .", "label": "", "metadata": {}, "score": "58.57577"}
{"text": "3 The prevalence of antimicrobial resistance in H. pylori varies regionally within and between countries .Increasing the duration of treatment or providing alternative antibiotics based on local resistance rates may improve eradication rates .", "label": "", "metadata": {}, "score": "58.58452"}
{"text": "3 The prevalence of antimicrobial resistance in H. pylori varies regionally within and between countries .Increasing the duration of treatment or providing alternative antibiotics based on local resistance rates may improve eradication rates .", "label": "", "metadata": {}, "score": "58.58452"}
{"text": "Laine et al.13 reported that ITT eradication percentages with triple therapy ( omeprazole , amoxicillin and clarithromycin ) were 86 % at 7 days , 90 % at 10 days and 92 % at 14 days in a study at a single institution .", "label": "", "metadata": {}, "score": "58.66213"}
{"text": "Laine et al.13 reported that ITT eradication percentages with triple therapy ( omeprazole , amoxicillin and clarithromycin ) were 86 % at 7 days , 90 % at 10 days and 92 % at 14 days in a study at a single institution .", "label": "", "metadata": {}, "score": "58.66213"}
{"text": "The overall eradication rate of sequential therapy in patients harbouring strains resistant to metronidazole was 86.4 % ( 78 % to 93 % ) .In patients harbouring strains resistant to metronidazole , sequential therapy achieved a significantly higher eradication rate than did triple therapy lasting seven ( difference in eradication rate 24.1 % , 7.2 % to 41.3 % ) and 10 days ( 17 % , 2.1 % to 32.7 % ) .", "label": "", "metadata": {}, "score": "58.68775"}
{"text": "The PP analysis excluded the patients with unknown H. pylori status following therapy and those with poor compliance .To determine the independent factors affecting the treatment response , 11 clinical and endoscopic parameters were analyzed by univariate analysis .", "label": "", "metadata": {}, "score": "58.778053"}
{"text": "One of our previous publications reported that quinolone therapy is effective when used to treat a susceptible infection but should be avoided when resistance is present [ 20 ] .", "label": "", "metadata": {}, "score": "58.80442"}
{"text": "The overall eradication rate of sequential therapy in patients harbouring strains resistant to both clarithromycin and metronidazole was just 37 % ( 16.2 % to 60.7 % ) .", "label": "", "metadata": {}, "score": "58.82143"}
{"text": "Eradication Confirmation .Confirmation of eradication of H pylori infection is recommended in patients who have undergone resection for early gastric cancer , in those who have had an H pylori -associated ulcer or gastric MALT lymphoma , and in patients whose symptoms persist after treatment . 8 A urea breath test or fecal antigen test may be used to confirm eradication at least 4 weeks after completion of therapy .", "label": "", "metadata": {}, "score": "58.844032"}
{"text": "Endoscopic images before and after therapy were considered another indicator of effective treatment .For the purposes of this study , the duodenal ulcer was confirmed in active or heal period by gastroscopy in seven days .", "label": "", "metadata": {}, "score": "58.91528"}
{"text": "33 , no .5 , pp .640 - 645 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. C. Wu , P. I. Hsu , J. Y. Wu et al . , \" Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection , \" Clinical Gastroenterology and Hepatology , vol . 8 , no . 1 , pp .", "label": "", "metadata": {}, "score": "58.938126"}
{"text": "In summary , the exactly mechanism of probiotics is largely unknown and further research is greatly needed .The restoration of the normal flora in the intestine might be important in patients receiving triple therapy for H. pylori eradication .", "label": "", "metadata": {}, "score": "58.93855"}
{"text": "5 , pp .280 - 284 , 2008 .View at Google Scholar \u00b7 View at Scopus . D. C. Wu , P. I. Hsu , J. Y. Wu et al . , \" Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection , \" Clinical Gastroenterology and Hepatology , vol . 8 , no . 1 , pp .", "label": "", "metadata": {}, "score": "59.16336"}
{"text": "Group C received 20 mg of Esomeprazole , 500 mg of Clarithromycin , and 1000 mg of Amoxicillin for standard 10-day therapy .All drugs were given twice daily .", "label": "", "metadata": {}, "score": "59.22508"}
{"text": "A hybrid therapy consisting of proton pump inhibitor and amoxicillin 1 g twice daily for 14 days plus clarithromycin 500 mg and tinidazole 500 mg twice daily for the last seven days gave an eradication rate of 86.6 % .", "label": "", "metadata": {}, "score": "59.336533"}
{"text": "There is a paucity of clinical evidence supporting the hypothesis that the use of quinolone leads to delays in treating tuberculosis in patients with H. pylori infection .", "label": "", "metadata": {}, "score": "59.34146"}
{"text": "27 , no .6 , pp .565 - 570 , 2011 .View at Google Scholar . H. G. Park , M. K. Jung , J. T. Jung et al . , \" Randomised clinical trial : a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in na\u00efve patients , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "59.49294"}
{"text": "10 , pp .2688 - 2691 , 2000 .View at Google Scholar .K. L. Chan , H. Zhou , D. K. K. Ng , and P. K. H. Tam , \" A prospective study of a one - week nonbismuth quadruple therapy for childhood Helicobacter pylori infection , \" Journal of Pediatric Surgery , vol .", "label": "", "metadata": {}, "score": "59.502007"}
{"text": "A biopsy also may be tested using histologic methods , which have high sensitivity and specificity but require trained personnel , and the results can vary from observer to observer .", "label": "", "metadata": {}, "score": "59.595287"}
{"text": "The resistance to metronidazole is between 30 and 40 % [ 48 , 49 ] , although it has less clinical impact .Metronidazole resistance can be partially overcome by increasing the dosage or treatment duration .", "label": "", "metadata": {}, "score": "59.62866"}
{"text": "This may improve the efficacy of clarithromycin in the second phase of treatment .The higher efficacy of the sequential regimen may be related to the larger number of antibiotics ( 3 drugs ) to which the organism is exposed with this regimen or to the use of tinidazole , which is not contained in the standard triple - drug regimen .", "label": "", "metadata": {}, "score": "59.664085"}
{"text": "205 - 213 , 2013 .View at Google Scholar . A. Zullo , L. Gatta , V. de Francesco et al . , \" High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer : a prospective controlled study , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "59.66707"}
{"text": "49 , pp .528 - 538 , 2014 .View at Google Scholar .J. Molina - Infante , B. Perez - Gallardo , M. Fernandez - Bermejo et al . , \" Clinical trial : clarithromycin vs. levofloxacin in first - line triple and sequential regimens for Helicobacter pylori eradication , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "59.690914"}
{"text": "Pre - treatment susceptibility data were also available in eight studies .6 7 31 32 36 41 44 50 Previous data suggested a high eradication rate with sequential therapy in strains resistant to clarithromycin .", "label": "", "metadata": {}, "score": "59.808266"}
{"text": "Our study confirms these reports on the low success rates of infection eradication with standard therapy .This may be mainly due to clarithromycin resistance .", "label": "", "metadata": {}, "score": "60.07431"}
{"text": "Our study suggests that modified sequential therapy may have a role as a first - line treatment for H. pylori infection in duodenal ulcer patients in China .", "label": "", "metadata": {}, "score": "60.13012"}
{"text": "6 , pp .641 - 646 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Y. Graham , S. Abudayyeh , H. M. T. El - Zimaity , J. Hoffman , R. Reddy , and A. R. Opekun , \" Sequential therapy using high - dose esomeprazole - amoxicillin followed by gatifloxacin for Helicobacter pylori infection , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "60.168068"}
{"text": "Among the subjects , five with poor compliance and six with incomplete followup were excluded from PP analysis for H. pylori eradication .All patients were included in intention - to - treat analysis .", "label": "", "metadata": {}, "score": "60.18712"}
{"text": "This study also surveyed the efficacy in the treatment of H. pylori with dual resistance .It also showed encouraging results .Tests on the efficacy of this new regimen is needed with further studies .", "label": "", "metadata": {}, "score": "60.191254"}
{"text": "The 5-day lansoprazole - containing concomitant therapy and 10-day sequential therapy had comparable eradicate rates .However , the eradication rate of 5-day concomitant therapy was lower than that of 14-day standard triple therapy .", "label": "", "metadata": {}, "score": "60.279137"}
{"text": "In the paper entitled \" 7-day nonbismuth - containing concomitant therapy achieves a high eradication rate for Helicobacter pylori in Taiwan , \" S.-S. Kao et al .", "label": "", "metadata": {}, "score": "60.286842"}
{"text": "Chung JW , Jung YK , Kim YJ , Kwon KA , Kim JH , Lee JJ , et al .Ten - day sequential versus triple therapy for H. pylori eradication : a prospective , open - label , randomized trial .", "label": "", "metadata": {}, "score": "60.35025"}
{"text": "Levofloxacin and rifamycin are listed as third - line treatments , and susceptibility testing is encouraged .The ACGCG recommends triple therapy with a PPI , clarithromycin , and amoxicillin or metronidazole for 14 days .", "label": "", "metadata": {}, "score": "60.42082"}
{"text": "Antimicrobial susceptibility testing is therefore recommended before first - line treatment for HP infection .As a consequence , the use of higher doses may be required .", "label": "", "metadata": {}, "score": "60.46058"}
{"text": "TREATMENT .Established indications for the treatment of H pylori infection include active PUD , confirmed history of PUD without prior treatment for H pylori infection , low - grade gastric MALT lymphoma , prior endoscopic resection of early gastric cancer , and uninvestigated dyspepsia .", "label": "", "metadata": {}, "score": "60.4659"}
{"text": "17 , no .35 , pp .3971 - 3975 , 2011 .View at Publisher \u00b7 View at Google Scholar . D. Y. Graham , G. M. Lew , H. M. Malaty et al . , \" Factors influencing the eradication of Helicobacter pylori with triple therapy , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "60.618073"}
{"text": "Figure 1 shows the flow of patients through the study .The other outcome was to determine the efficacy of sequential treatment against clarithromycin - resistant strains of H. pylori .", "label": "", "metadata": {}, "score": "60.654686"}
{"text": "Bacterial resistance and poor patient compliance are believed to be the primary factors in H. pylori treatment failure .The occurrence of side - effects can reduce the compliance with treatment regimens and lead to the development of bacterial resistance .", "label": "", "metadata": {}, "score": "60.65756"}
{"text": "Bacterial resistance and poor patient compliance are believed to be the primary factors in H. pylori treatment failure .The occurrence of side - effects can reduce the compliance with treatment regimens and lead to the development of bacterial resistance .", "label": "", "metadata": {}, "score": "60.65756"}
{"text": "Objective .Antimicrobial resistance has decreased eradication rates for Helicobacter pylori infection worldwide .To observe the effect of eradicating Helicobacter pylori ( H. pylori ) and the treatment of duodenal ulcer by 2 kinds of modified sequential therapy through comparing with that of 10-day standard triple therapy .", "label": "", "metadata": {}, "score": "60.708317"}
{"text": "2004;(2):CD004062 .Tong JL , Ran ZH , Shen J , et al .Meta - analysis : the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy .", "label": "", "metadata": {}, "score": "60.755604"}
{"text": "Finally , data on the response of treatments according to pre - treatment sensitivity was available in a minority of the overall patients studied , not allowing a thorough analysis of the results .", "label": "", "metadata": {}, "score": "60.762444"}
{"text": "It was significantly greater than that of standard triple therapy .Sequential therapy for Helicobacter pylori refers to the idea of adding more antibiotics to the treatment regimen but giving them in sequence rather than giving all 4 drugs together .", "label": "", "metadata": {}, "score": "60.768425"}
{"text": "In this paper , we review quinolone - containing H. pylori eradication regimens and the challenges that influence the efficacy of eradication .It is generally suggested that the use of levofloxacin should be confined to \" rescue \" therapy only , in order to avoid a further rapid increase in the resistance of H. pylori to quinolone .", "label": "", "metadata": {}, "score": "60.791534"}
{"text": "8168 - 8180 , 2013 .View at Google Scholar .J. M. Liou , C. C. Chen , C. Y. Chang , et al . , \" Efficacy of genotypic resistance - guided sequential therapy in the third - line treatment of refractory Helicobacter pylori infection : a multicentre clinical trial , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "60.837387"}
{"text": "1772 - 1778 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Kongchayanun , V. Mahachai , B. Pornthisarn , S. Amornsawadwattana , and R. K. Vilaichone , \" Efficacy of 10-day and 5-day concomitant therapy for Helicobacter pylori eradication in Thai patients with non ulcer dyspepsia , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "60.871563"}
{"text": "Table 2 : Helicobacter pylori eradication rates with sequential and standard therapy both at intention - to - treat ( ITT ) and per protocol ( PP ) analyses .", "label": "", "metadata": {}, "score": "60.887703"}
{"text": "1008 - 1011 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. M. Neville , S. Everett , H. Langworthy et al . , \" The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "60.923386"}
{"text": "One such regimen is sequential therapy , originally found to give eradication rates consistently higher than 90 % .What this study adds .The overall efficacy of sequential therapy is 84.3 % ( 95 % confidence interval 82.1 % to 86.4 % ) .", "label": "", "metadata": {}, "score": "60.933586"}
{"text": "The data show that sequential therapy achieves 90.7 % eradication rates , with a 12 % better absolute eradication rate than the standard triple therapy [ 16 ] .", "label": "", "metadata": {}, "score": "61.04576"}
{"text": "In areas with high clarithromycin resistance , regimens including bismuth - containing quadruple , sequential therapy , and concomitant should be the better choice for first - line regimens .", "label": "", "metadata": {}, "score": "61.124104"}
{"text": "A head - to - head noninferiority trial of 10-day esomeprazole - containing concomitant and 10-day esomeprazole - containing sequential therapy from our study group showed they were equivalent ( 93.0 % versus 93.1 % by per - protocol analysis ) [ 24 ] .", "label": "", "metadata": {}, "score": "61.13031"}
{"text": "In the 14-day group 12 patients were lost to follow - up ; 4 had travelled out of the city , 2 could not be reached by telephone and 6 did not see the benefit of coming back as they were asymptomatic .", "label": "", "metadata": {}, "score": "61.28223"}
{"text": "In the 14-day group 12 patients were lost to follow - up ; 4 had travelled out of the city , 2 could not be reached by telephone and 6 did not see the benefit of coming back as they were asymptomatic .", "label": "", "metadata": {}, "score": "61.28223"}
{"text": "L. Fischbach and E. L. Evans , \" Meta - analysis : the effect of antibiotic resistance status on the efficacy of triple and quadruple first - line therapies for Helicobacter pylori , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "61.400352"}
{"text": "The patients with alarm features were booked for endoscopy and follow - up in the gastroenterology clinic .Patients who did not give consent were given appropriate standard therapy .", "label": "", "metadata": {}, "score": "61.415913"}
{"text": "The patients with alarm features were booked for endoscopy and follow - up in the gastroenterology clinic .Patients who did not give consent were given appropriate standard therapy .", "label": "", "metadata": {}, "score": "61.415913"}
{"text": "But in many Asian countries , standard triple regimen is still superior to levofloxacin - based therapy as first - line regimen for H. pylori eradication .", "label": "", "metadata": {}, "score": "61.493675"}
{"text": "A total of 210 patients who were confirmed in duodenal ulcer active or heal period by gastroscopy and H. pylori positive confirmed by rapid urease test , serum anti- H. pylori antibody ( ELASE ) , or histological examination enrolled in the study .", "label": "", "metadata": {}, "score": "61.513443"}
{"text": "53 - 58 , 2011 .View at Google Scholar . Y. Gumurdulu , E. Serin , B. \u00d6zer et al . , \" Low eradication rate of Helicobacter pylori with triple 7 - 14 days and quadriple therapy in Turkey , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "61.55417"}
{"text": "To review the history , epidemiology , pathophysiology , risk factors , transmission , and complications of Helicobacter pylori infection and to discuss diagnosis , pharmacologic treatment options , and the pharmacist 's role .", "label": "", "metadata": {}, "score": "61.5663"}
{"text": "4 , pp .483 - 487 , 1999 .View at Publisher \u00b7 View at Google Scholar .B. C. Y. Wong , F. Y. Chang , S. Abid et al . , \" Triple therapy with clarithromycin , omeprazole , and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "61.609703"}
{"text": "In the paper entitled \" Helicobacter pylori eradication therapies in the era of increasing antibiotic resistance : a paradigm shift to improved efficacy , \" S. D. Georgopoulos et al . present critical issues regarding the currently available means for the management of H. pylori infection .", "label": "", "metadata": {}, "score": "61.61735"}
{"text": "The overall eradication rates and their 95 % confidence intervals were obtained by ITT and per protocol ( PP ) .ITT analysis included all patients who had taken at least one dose of study medication .", "label": "", "metadata": {}, "score": "61.64256"}
{"text": "Data on eradication according to pre - treatment antimicrobial susceptibility testing were available in eight studies , and sequential therapy was able to eradicate 72.8 % ( 61.6 % to 82.8 % ) of the strains resistant to clarithromycin .", "label": "", "metadata": {}, "score": "61.714497"}
{"text": "In the paper entitled \" The optimal first - line therapy of Helicobacter pylori infection in year 2012 , \" C.-H. Kuo et al .review the literature about first - line therapies for H. pylori infection in the recent years .", "label": "", "metadata": {}, "score": "61.728283"}
{"text": "Patients of group A received 20 mg of Esomeprazole , 500 mg of Clarithromycin for the first 5 days , followed by 20 mg of Esomeprazole , 500 mg of Clarithromycin , and 1000 mg of Amoxicillin for the remaining 5 days .", "label": "", "metadata": {}, "score": "61.78846"}
{"text": "6 , pp .565 - 570 , 2011 .View at Google Scholar .T. Kamada , K. Haruma , K. Komoto et al . , \" Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole , amoxicillin , and clarithromycin , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "61.800514"}
{"text": "Am J Gastroenterol 2009 ; 104 : 3069 -79 .Jafri NS , Hornung CA , Howden CW .Meta - analysis : sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment .", "label": "", "metadata": {}, "score": "61.811646"}
{"text": "So it is usually used in rescue therapies only .The Factors Influencing Eradication of H. pylori Infection .Resistance .Antibiotic resistance is the most serious problem in eradicating H. pylori .", "label": "", "metadata": {}, "score": "61.986717"}
{"text": "If clarithromycin resistance is less than 15 % to 20 % , triple therapy is recommended as initial treatment .In susceptible strains , the combination of a PPI , clarithromycin , and metronidazole had an eradication rate of 97 % , compared with 88 % for the combination of a PPI , clarithromycin , and amoxicillin .", "label": "", "metadata": {}, "score": "62.05165"}
{"text": "Qian J , Ye F , Zhang J , Yang YM , Tu HM , Jiang Q , et al .Levofloxacin - containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China .", "label": "", "metadata": {}, "score": "62.05393"}
{"text": "Park HG , Jung MK , Jung JT , Kwon JG , Kim EY , Seo HE , et al .Randomised clinical trial : comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients .", "label": "", "metadata": {}, "score": "62.119297"}
{"text": "35 - 44 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Miehlke , S. Krasz , W. Schneider - Brachert et al . , \" Randomized trial on 14 versus 7 days of esomeprazole , moxifloxacin , and amoxicillin for second - line or rescue treatment of Helicobacter pylori infection , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "62.13526"}
{"text": "This study has several limitations .Firstly , it was a retrospective study , although all patients were prospectively followed up by a standard protocol and the adverse events and compliance were assessed by trained assistants with study nurses with a standardized questionnaire .", "label": "", "metadata": {}, "score": "62.17754"}
{"text": "5 , pp .313 - 325 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Gatta , N. Vakil , G. Leandro , F. Di Mario , and D. Vaira , \" Sequential therapy or triple therapy for Helicobacter pylori infection : systematic review and meta - analysis of randomized controlled trials in adults and children , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "62.216812"}
{"text": "S39-S44 , 1995 .View at Google Scholar . H. Kashimura , K. Suzuki , M. Hassan et al . , \" Polaprezinc , a mucosal protective agent , in combination with lansoprazole , amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "62.33738"}
{"text": "In patients in whom H pylori infection persists and eradication is deemed appropriate , obtaining a culture and determining the sensitivity of H pylori should be considered .", "label": "", "metadata": {}, "score": "62.398354"}
{"text": "342 - 345 , 1994 .View at Google Scholar \u00b7 View at Scopus .M. Selgrad and P. Malfertheiner , \" Treatment of Helicobacter pylori , \" Current Opinion in Gastroenterology , vol .", "label": "", "metadata": {}, "score": "62.40736"}
{"text": "Routine testing of patients is not recommended because not all infected persons have active disease or complications .Testing should be reserved for patients who will require treatment in the event that the results are positive .", "label": "", "metadata": {}, "score": "62.434032"}
{"text": "16 , no . 2 , pp .139 - 145 , 2011 .View at Publisher \u00b7 View at Google Scholar .C. Hassan , V. de Francesco , A. Zullo et al . , \" Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients : improving the cost of pharmacotherapy , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "62.44219"}
{"text": "Recently updated guidelines suggest that two positive tests are needed for diagnosis of H pylori infection , except in the case of duodenal ulcer , owing to its high correlation .", "label": "", "metadata": {}, "score": "62.497925"}
{"text": "The most widely recommended treatment in international guidelines for the eradication of HP is the Standard Triple Therapy based on a proton - pump - inhibitor ( PPI ) to which two antibiotics ( CAM plus amoxicillin ( AMPC or MNZ ) are associated for 7 days [ 37 - 41 ] .", "label": "", "metadata": {}, "score": "62.499905"}
{"text": "This study suggests that the effect of intravenous high - dose pantoprazole may not be superior to non - high - dose regimen in reducing rebleeding in high - risk peptic ulcer bleeding .", "label": "", "metadata": {}, "score": "62.500114"}
{"text": "We found no statistically significant differences .Data on adverse events were available for four trials .Effect of duration of triple therapies on eradication rate .", "label": "", "metadata": {}, "score": "62.576645"}
{"text": "5 , pp .1071 - 1075 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. C. Wu , P. I. Hsu , J. Y. Wu , et al . , \" Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection , \" Clinical Gastroenterology and Hepatology , vol . 8 , pp .", "label": "", "metadata": {}, "score": "62.582737"}
{"text": "556 - 563 , 2007 .View at Google Scholar \u00b7 View at Scopus .L. Gatta , N. Vakil , G. Leandro , F. Di Mario , and D. Vaira , \" Sequential therapy or triple therapy for Helicobacter pylori infection : systematic review and meta - analysis of randomized controlled trials in adults and children , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "62.59446"}
{"text": "556 - 563 , 2007 .View at Google Scholar \u00b7 View at Scopus .L. Gatta , N. Vakil , G. Leandro , F. di Mario , and D. Vaira , \" Sequential therapy or triple therapy for Helicobacter pylori infection : systematic review and meta - analysis of randomized controlled trials in adults and children , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "62.59446"}
{"text": "A stool antigen test was repeated 6 weeks after the start of therapy to confirm eradication of H. pylori .The patients were not charged for reviews at 2 and 6 weeks and a free H. pylori stool antigen test was performed to confirm eradication .", "label": "", "metadata": {}, "score": "62.719353"}
{"text": "A stool antigen test was repeated 6 weeks after the start of therapy to confirm eradication of H. pylori .The patients were not charged for reviews at 2 and 6 weeks and a free H. pylori stool antigen test was performed to confirm eradication .", "label": "", "metadata": {}, "score": "62.719353"}
{"text": "43 - 48 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Sirimontaporn , D. Thong - Ngam , S. Tumwasorn , and V. Mahachai , \" Ten - day sequential therapy of Helicobacter pylori infection in thailand , \" The American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "62.744858"}
{"text": "Tumor - regression rates of 60 % to 90 % have been noted in patients who undergo eradication therapy .Additionally , recent studies suggest that , with H pylori eradication , 5-year recurrence rates for low - grade MALT range from 3 % to 13 % .", "label": "", "metadata": {}, "score": "62.7555"}
{"text": "In this study , we enrolled the patients with one positive test for H. pylori infection .The eradication rates may be overestimated since patients with false - positive H. pylori infection achieve successful eradication in the trial .", "label": "", "metadata": {}, "score": "62.844643"}
{"text": "12 , pp .923 - 931 , 2008 .View at Google Scholar \u00b7 View at Scopus . Y. Gumurdulu , E. Serin , B. \u00d6zer et al . , \" Low eradication rate of Helicobacter pylori with triple 7 - 14 days and quadriple therapy in Turkey , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "62.87609"}
{"text": "However , some people with H. pylori infection eventually develop inflammation of the stomach ( gastritis ) or ulcers in the stomach or upper small intestine [ 5 , 16 - 18 ] .", "label": "", "metadata": {}, "score": "63.00157"}
{"text": "Introduction .The rate of eradication obtained using a triple therapy approach has decreased substantially for the first- and second - line regimens in recent years , owing to an increasing rate of antibiotic resistance [ 1 ] .", "label": "", "metadata": {}, "score": "63.012806"}
{"text": "Data were analysed using SPSS version 15.0 .Analysis of baseline characteristics and eradication success between different treatment protocols were performed using the chi - square test .", "label": "", "metadata": {}, "score": "63.058216"}
{"text": "Data were analysed using SPSS version 15.0 .Analysis of baseline characteristics and eradication success between different treatment protocols were performed using the chi - square test .", "label": "", "metadata": {}, "score": "63.058216"}
{"text": "-test is time - consuming , and the culture rate of H. pylori is approximately 70 - 80 % [ 45 ] .The same disadvantage applies to other culture - based tests , such as the agar dilution method , the breakpoint susceptibility test , and the modified disk diffusion method .", "label": "", "metadata": {}, "score": "63.0879"}
{"text": "Group C was provided 10-day standard triple therapy .Patients of group A received 20 mg of Esomeprazole , 500 mg of Clarithromycin for the first 5 days , followed by 20 mg of Esomeprazole , 500 mg of Clarithromycin , and 1000 mg of Amoxicillin for the remaining 5 days .", "label": "", "metadata": {}, "score": "63.097107"}
{"text": "1105 - 1113 , 2007 .View at Publisher \u00b7 View at Google Scholar .T. Lind , S. V. van Zanten , P. Unge et al . , \" Eradication of Helicobacter pylori using one - week triple therapies combining omeprazole with two antimicrobials : the MACH I study , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "63.168625"}
{"text": "Sequential therapy , a new regimen administering antimicrobials in a given sequence rather than all simultaneously , has generated worldwide interest .This kind of treatment is not actually new , as it uses established drugs , all approved for eradication of H pylori .", "label": "", "metadata": {}, "score": "63.190304"}
{"text": "Initial data suggested that high eradication rates could be achieved [ 3 , 4 ] .However , this gold standard has recently become declining in cure rates to unacceptable levels ( . ) , largely as a result of emerging resistance of the organism to clarithromycin [ 5 - 9 ] .", "label": "", "metadata": {}, "score": "63.236275"}
{"text": "Several studies have demonstrated its satisfactory higher eradication rates than standard triple therapies [ 8 , 9 , 15 ] .Gatta et al . reported a rigorous systemic review that identified 13 trials evaluating 3,271 patients [ 16 ] .", "label": "", "metadata": {}, "score": "63.236534"}
{"text": "6 , pp .715 - 718 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. P. Gisbert , X. Calvet , A. O'Connor , F. M\u00e9graud , and C. A. O'Morain , \" Sequential therapy for Helicobacter pylori eradication : a critical review , \" Journal of Clinical Gastroenterology , vol .", "label": "", "metadata": {}, "score": "63.245743"}
{"text": "Ang TL , Fock KM , Ang D. A randomized controlled trial of triple therapy versus sequential therapy versus concomitant therapy as first line treatment for H. pylori Infection .", "label": "", "metadata": {}, "score": "63.31523"}
{"text": "So we need new treatment regimens .De Francesco et al .[ 9 ] discovered a new program to eradicate H. pylori sequential therapy , which can obtain a higher eradication rate , but related reports in China are still not abundant .", "label": "", "metadata": {}, "score": "63.383713"}
{"text": "4 , pp .587 - 591 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Zullo , V. Rinaldi , S. Winn et al . , \" A new highly effective shout - term therapy schedule for Helicobacter pylori eradication , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "63.400585"}
{"text": "Antibiotics may decrease the effectiveness of oral contraceptives .Allergies and the type of reaction to penicillin should also be verified .An explanation of why antibiotic and antiulcer combinations are used , when and how to take medications , what adverse effects to expect , and the importance of adherence should be provided .", "label": "", "metadata": {}, "score": "63.404232"}
{"text": "12 , pp .3069 - 3079 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Sirimontaporn , D. Thong - Ngam , S. Tumwasorn , and V. Mahachai , \" Ten - day sequential therapy of Helicobacter pylori infection in Thailand , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "63.41659"}
{"text": "However , one study stated that there was no significantly different compliance between sequential therapy and concomitant therapy [ 30 ] .Concomitant Therapy .This regimen containing four - drug regimen : a PPI ( standard dose , b.i.d . ) , clarithromycin ( 500 mg , b.i.d . ) , amoxicillin ( 1000 mg , b.i.d . ) , and metronidazole ( 500 mg , b.i.d . ) .", "label": "", "metadata": {}, "score": "63.654022"}
{"text": "6 , pp .420 - 426 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Cammarota , A. Martino , G. Pirozzi et al . , \" High efficacy of 1-week doxycycline- and amoxicillin - based quadruple regimen in a culture - guided , third - line treatment approach for Helicobacter pylori infection , \" Alimentary Pharmacology & Therapeutics , vol .", "label": "", "metadata": {}, "score": "63.667923"}
{"text": "G. Sachs , D. R. Scott , and Y. Wen , \" Gastric infection by Helicobacter pylori , \" Current Gastroenterology Reports , vol .13 , no .", "label": "", "metadata": {}, "score": "63.763348"}
{"text": "1669 - 1675 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. G. Goldman , D. A. Barrado , N. Balcarce et al . , \" Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children , \" Nutrition , vol .", "label": "", "metadata": {}, "score": "63.876972"}
{"text": "However , antibiotic resistance is one of the key factors responsible for failure of eradication of H. pylori , as well as poor compliance , high gastric acidity , a high bacterial load , and cytochrome P450 2C19 ( CYP2C19 ) polymorphism [ 2 , 6 ] .", "label": "", "metadata": {}, "score": "63.87922"}
{"text": "It is a Gram - negative bacterium found on the gastric epithelium and induces chronic inflammation of the underlying mucosa . H. pylori infection is usually contracted in the first few years of life and tends to persist indefinitely unless treated .", "label": "", "metadata": {}, "score": "64.04323"}
{"text": "J. Molina - Infante , B. Perez - Gallardo , M. Fernandez - Bermejo et al . , \" Clinical trial : clarithromycin vs. levofloxacin in first - line triple and sequential regimens for Helicobacter pylori eradication , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "64.08543"}
{"text": "11 , pp .1465 - 1470 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. H. Kuo , H. M. Hu , F. C. Kuo et al . , \" Efficacy of levofloxacin - based rescue therapy for Helicobacter pylori infection after standard triple therapy : a randomized controlled trial , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "64.12889"}
{"text": "Data on adverse events were available for four studies .Data not included in meta - analysis .Sequential therapy versus levofloxacin based sequential therapy .", "label": "", "metadata": {}, "score": "64.3171"}
{"text": "Liu SHK , Seto WK , Hung IF , Leung WK .10-day sequential versus 10-day bismuth - containing quadruple therapy as empirical first - line treatment for Helicobacter pylori : an open label randomized crossover trial .", "label": "", "metadata": {}, "score": "64.36476"}
{"text": "67 - 70 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Vaira , A. Zullo , N. Vakil et al . , \" Sequential therapy versus standard triple - drug therapy for Helicobacter pylori eradication : a randomized trial , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "64.37824"}
{"text": "The compliance rate was 98.4 % ( 314/319 ) .Multivariate analysis disclosed that poor compliance was the only independent factor influencing the efficacy of anti- H. pylori therapy with an odds ratio of 0.073 ( 95 % confidence interval , 0.011 - 0.483 ) .", "label": "", "metadata": {}, "score": "64.52029"}
{"text": "Notably , the occurrence of severe adverse events was an important cause of poor drug compliance .Smoking has been shown to reduce the effectiveness of first line triple therapy [ 31 ] .", "label": "", "metadata": {}, "score": "64.58453"}
{"text": "P. Malfertheiner , F. M\u00e9graud , C. O'Morain et al . , \" Current concepts in the management of Helicobacter pylori infection - the Maastricht 2 - 2000 Consensus Report , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "64.615616"}
{"text": "450 - 456 , 2013 .View at Google Scholar .J. Matsuzaki , H. Suzuki , T. Nishizawa et al . , \" Efficacy of sitafloxacin - based rescue therapy for Helicobacter pylori after failures of first- and second - line therapies , \" Antimicrobial Agents and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "64.717926"}
{"text": "6 , pp .463-I10 , 2003 .View at Google Scholar \u00b7 View at Scopus .L. Laine , M. B. Fennerty , M. Osato et al . , \" Esomeprazole - based Helicobacter pylori eradication therapy and the effect of antibiotic resistance : results of three US multicenter , double - blind trials , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "64.840164"}
{"text": "De Francesco V , Zullo A , Margiotta M , Marangi S , Burattini O , Berloco P , et al .Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure .", "label": "", "metadata": {}, "score": "64.87479"}
{"text": "[Links ] .Wong BC , Chang FY , Abid S , et al .Triple therapy with clarithromycin , omeprazole , and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa .", "label": "", "metadata": {}, "score": "65.01104"}
{"text": "[Links ] .Wong BC , Chang FY , Abid S , et al .Triple therapy with clarithromycin , omeprazole , and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa .", "label": "", "metadata": {}, "score": "65.01104"}
{"text": "INFECTION RISK FACTORS AND TRANSMISSION .H pylori is typically contracted during childhood .10 Lower socioeconomic status during childhood is associated with a higher risk of H pylori infection .", "label": "", "metadata": {}, "score": "65.09108"}
{"text": "One is the side effect of myelotoxicity ( 22 % ( 19 - 25 % ) ) and ocular adverse events have been reported with rifabutin - based therapy [ 45 ] .", "label": "", "metadata": {}, "score": "65.11258"}
{"text": "The possible mechanisms of probiotics in eradicating H. pylori include production of inhibitory substance , host immune modulation or competition for adhesion [ 64 , 67 , 68 ] .", "label": "", "metadata": {}, "score": "65.163666"}
{"text": "Concomitant therapy uses the same components as sequential therapy , but they are administered concomitantly [ 20 ] .It provides another novel regimen proven successful in the presence of clarithromycin resistance [ 21 ] .", "label": "", "metadata": {}, "score": "65.185394"}
{"text": "5 , pp .97 - 107 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. L. Tong , Z. H. Ran , J. Shen , C. X. Zhang , and S. D. Xiao , \" Meta - analysis : the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "65.22025"}
{"text": "Another study surveys the impact of levofloxacin on sequential therapy [ 36 ] .It demonstrated that levofloxacin - based sequential therapy had higher eradication rates than clarithromycin - based therapy ( 96 % versus 81 % by PP analysis ) .", "label": "", "metadata": {}, "score": "65.26528"}
{"text": "26 The PPIs lansoprazole ( 30 mg ) , omeprazole ( 20 mg ) , pantoprazole ( 40 mg ) , rabeprazole ( 20 mg twice daily ) , and esomeprazole ( 40 mg once daily ) are all effective for the treatment of H pylori .", "label": "", "metadata": {}, "score": "65.30649"}
{"text": "As a result , the failure rate is around 20 % for triple combination therapy ( PPI plus amoxicillin plus clarithromycin ) , which was so effective when it was first evaluated 10 years ago [ 37 , 38 ] .", "label": "", "metadata": {}, "score": "65.33037"}
{"text": "View at Google Scholar . A. S. Essa , J. R. Kramer , D. Y. Graham , and G. Treiber , \" Meta - analysis : four - drug , three - antibiotic , non - bismuth - containing \" concomitant therapy \" versus triple therapy for Helicobacter pylori eradication , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "65.487236"}
{"text": "10 , pp .1263 - 1272 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . K. \u00d6zdil , T. \u00c7alhan , A. Sahin et al . , \" Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication , \" Hepato - Gastroenterology , vol .", "label": "", "metadata": {}, "score": "65.49972"}
{"text": "New strategies to improve compliance should therefore be applied [ 30 ] .The prevalence of antimicrobial resistance might be significantly different between countries , which will greatly affect eradication rates [ 1 , 31 ] .", "label": "", "metadata": {}, "score": "65.52125"}
{"text": "The aim of this study was to assess the efficacy of sequential therapy compared with other eradication regimens , by doing a systematic review and meta - analysis of randomised controlled trials .", "label": "", "metadata": {}, "score": "65.54082"}
{"text": "It should be noted that gemifloxacin exposure is not associated with delay in tuberculosis treatment , and this has been validated in a clinical setting [ 53 ] .", "label": "", "metadata": {}, "score": "65.56534"}
{"text": "The precise mechanism for the success of the sequential therapy is not known ; however , bacteria can develop efflux channels for clarithromycin , which rapidly transfer the drug out of the bacteria cell , preventing the antibiotic from binding to the ribosome [ 45 ] .", "label": "", "metadata": {}, "score": "65.576195"}
{"text": "Gisbert JP , Pajares JM .Treatment of Helicobacter pylori infection : the past and the future .Eur J Intern Med .Greenberg ER , Anderson GL , Morgan DR , et al .", "label": "", "metadata": {}, "score": "65.58356"}
{"text": "Many clinical trials chose levofloxacin in place of clarithromycin as an alternative first - line regimen .The reported eradication rates varied from 72 % to 96 % [ 34 , 35 ] .", "label": "", "metadata": {}, "score": "65.642"}
{"text": "Overall , the compliance rate was 98.4 % .in univariate analysis .The other factors ( age , sex , alcohol drinking , coffee consumption , tea consumption , previous history of ulcer , presence of ulcer , and presence of adverse event ) did not markedly influence the eradication efficacy .", "label": "", "metadata": {}, "score": "65.73362"}
{"text": "209- 221 , 2012 .View at Publisher \u00b7 View at Google Scholar .L. Fischbach and E. L. Evans , \" Meta - analysis : the effect of antibiotic resistance status on the efficacy of triple and quadruple first - line therapies for Helicobacter pylori , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "65.811806"}
{"text": "488 - 496 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Basu , K. Rayapudi , T. Pacana , et al . , \" A randomized study comparing levofloxacin , omeprazole , nitazoxanide , and doxycycline versus triple therapy for the eradication of Helicobacter pylori , \" The American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "65.830536"}
{"text": "Malfertheiner P , Bazzoli F , Delchier JC , et al .Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium , metronidazole , and tetracycline given with omeprazole versus clarithromycin - based triple therapy : a randomised , open - label , non - inferiority , phase 3 trial .", "label": "", "metadata": {}, "score": "65.848145"}
{"text": "W. D. Chey and B. C. Y. Wong , \" American College of Gastroenterology guideline on the management of Helicobacter pylori infection , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "65.85663"}
{"text": "10 , pp .827 - 832 , 1977 .View at Google Scholar \u00b7 View at Scopus .J. M. Kang , N. Kim , D. H. Lee et al . , \" Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "65.86337"}
{"text": "The overall crude eradication rate in the Levofloxacin group was 79.05 % versus 81.4 % in the standard group ( risk ratio 0.97 ; 95 % CI ; 0.93 , 1.02 ) [ 36 ] .", "label": "", "metadata": {}, "score": "65.88226"}
{"text": "The reasons for this fall in efficacy with time are uncertain but may relate to the increasing incidence of clarithromycin - resistant strains of H. pylori , poor compliance , and rapid metabolism of proton pump inhibitor ( PPI ) [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "65.89378"}
{"text": "Strains resistant to clarithromycin .The overall eradication rate of sequential therapy in patients harbouring strains resistant to clarithromycin was 72.8 % ( 61.6 % to 82.8 % ) .", "label": "", "metadata": {}, "score": "65.91057"}
{"text": "Patients .A total of 319 patients received concomitant therapy from March 2008 to March 2012 .The subjects were all included in the ITT analysis for H. pylori eradication .", "label": "", "metadata": {}, "score": "65.93352"}
{"text": "There are several reasons causing treatment failure , the antimicrobial resistance being the most important ; other lower causes are polymorphisms of the CYP 2C19 , an increased body mass index ( BMI ) , smoking , poor compliance , and reinfections [ 8 , 27 - 29 ] .", "label": "", "metadata": {}, "score": "65.95306"}
{"text": "The factors that negatively affect successful eradication are an increase in body mass index and smoking [ 12 , 13 ] .Besides , other factors including the patient 's history of antibiotic use , the cost , and availability of the drugs would also influence the choice of regimen .", "label": "", "metadata": {}, "score": "65.9712"}
{"text": "Malaty HM .Epidemiology of Helicobacter pylori infection .Best Pract Res Clin Gastroenterol .Elitsur Y , Dementieva Y , Rewalt M , Lawrence Z. Helicobacter pylori infection rate decreases in symptomatic children : a retrospective analysis of 13 years ( 1993 - 2005 ) from a gastroenterology clinic in West Virginia .", "label": "", "metadata": {}, "score": "65.98789"}
{"text": "Oh HS , Lee DH , Seo JY , Cho YR , Kim N , Jeoung SH , et al .Ten - day sequential therapy is more effective than proton pump inhibitor - based therapy in Korea : a prospective , randomized study .", "label": "", "metadata": {}, "score": "65.98813"}
{"text": "The different phenotypes result in different degrees of PPI metabolism .CYP2C19 genotype - dependent H. pylori eradication rates were noted in many kinds of PPIs [ 51 , 53 , 54 ] .", "label": "", "metadata": {}, "score": "66.00615"}
{"text": "1530 - 1534 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Cammarota , A. Martino , G. Pirozzi et al . , \" High efficacy of 1-week doxycycline- and amoxicillin - based quadruple regimen in a culture - guided , third - line treatment approach for Helicobacter pylori infection , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "66.01127"}
{"text": "The delayed test - involving either histologic methods or the urea breath test - should occur within 4 to 8 weeks of the bleed .According to the Second Asian Pacific Consensus Guidelines , the most accurate noninvasive test is the urea breath test .", "label": "", "metadata": {}, "score": "66.01742"}
{"text": "167 - 172 , 2014 .View at Google Scholar .M. C. Peedikayil , F. I. Alsohaibani , and A. H. Alkhenizan , \" Levofloxacin - based first - line therapy versus standard first - line therapy for Helicobacter pylori eradication : meta - analysis of randomized controlled trials , \" PLoS ONE , vol .", "label": "", "metadata": {}, "score": "66.05116"}
{"text": "Park S , Chun HJ , Kim ES , Park SC , Jung ES , Lee SD , et al .The 10-day sequential therapy for Helicobacter pylori eradication in Korea : less effective than expected .", "label": "", "metadata": {}, "score": "66.06187"}
{"text": "Helidac , which is taken with each meal and at bedtime for a total of four doses of each component per day , contains two bismuth subsalicylate 262.4-mg tablets , metronidazole 250 mg , and tetracycline 500 mg .", "label": "", "metadata": {}, "score": "66.0886"}
{"text": "27 Patients should contact their health care provider should blood in the stool , vomiting , or abdominal pain occur or if symptoms persist or return after H pylori eradication therapy .", "label": "", "metadata": {}, "score": "66.191055"}
{"text": "The variable rates may result from the difference in resistances .One study demonstrated efficacy of levofloxacin - based triple therapy had higher eradication rate than clarithromycin - based triple therapy ( 83 % versus 66 % by PP analysis ) [ 35 ] .", "label": "", "metadata": {}, "score": "66.349556"}
{"text": "Smoking might cause failure of H. pylori eradication therapy .Conclusion .First - line therapies of H. pylori infection are facing a challenge because of increasing treatment failure .", "label": "", "metadata": {}, "score": "66.3956"}
{"text": "By the way , sequential therapy has not been subjected to any clinical trial in the United States , yet .A recent trial in South America , demonstrated the standard 14-day triple therapy to be more efficacious than the 10-day sequential four - drug regimen [ 60 ] .", "label": "", "metadata": {}, "score": "66.420135"}
{"text": "But all the adverse reactions of each group were relatively slight .The compliance of patients was well ( Table 3 ) .Discussion .Helicobacter pylori ( H. pylori ) is a common type of bacteria that usually infects people during childhood .", "label": "", "metadata": {}, "score": "66.44566"}
{"text": "12 , pp .1419 - 1424 , 2005 .View at Publisher \u00b7 View at Google Scholar .W. Z. Liu , S. D. Xiao , Y. Shi et al . , \" Furazolidone - containing short - term triple therapies are effective in the treatment of Helicobacter pylori infection , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "66.456406"}
{"text": "11 , pp .1529 - 1535 , 2000 .View at Publisher \u00b7 View at Google Scholar .F. Perri , M. R. Villani , V. Festa , M. Quitadamo , and A. Andriulli , \" Predictors of failure of Helicobacter pylori eradication with the standard \" Maastricht triple therapy \" , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "66.471695"}
{"text": "According to guidelines of the Maastricht III , the minimal acceptable eradication level recommended is an 80 % eradication rate ( by intention - to - treat ( ITT ) analysis ) [ 1 ] .", "label": "", "metadata": {}, "score": "66.488434"}
{"text": "1023 - 1029 , 2001 .View at Publisher \u00b7 View at Google Scholar .C. Ecclissato , M. A. M. Marchioretto , S. Mendon\u00e7a et al . , \" Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "66.49467"}
{"text": "12 , pp .1711 - 1716 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Vaira , A. Zullo , N. Vakil et al . , \" Sequential therapy versus standard triple - drug therapy for Helicobacter pylori eradication : a randomized trial , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "66.5365"}
{"text": "All patients who presented between December 2009 and May 2010 with dyspepsia and who were positive for H. pylori on stool antigen tests were enrolled .", "label": "", "metadata": {}, "score": "66.55115"}
{"text": "All patients who presented between December 2009 and May 2010 with dyspepsia and who were positive for H. pylori on stool antigen tests were enrolled .", "label": "", "metadata": {}, "score": "66.55115"}
{"text": "Exposure to quinolone is relevant to delays in diagnosing tuberculosis and the development of drug resistance .Tailored therapy to detect fluoroquinolone - resistant strains can be done by culture - based and molecular methods to provide better eradication rates .", "label": "", "metadata": {}, "score": "66.58246"}
{"text": "Recently , a triple therapy with the combination of a PPI , levofloxacin , and amoxicillin has been proposed as an alternative to the standard rescue therapy and can achieve a higher eradication rate than a bismuth - containing quadruple therapy in some regions .", "label": "", "metadata": {}, "score": "66.61107"}
{"text": "10 , pp .1587 - 1600 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. O'Morain , T. Borody , A. Farley et al . , \" Efficacy and safety of single - triple capsules of bismuth biskalcitrate , metronidazole and tetracycline , given with omeprazole , for the eradication of Helicobacter pylori : an international multicentre study , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "66.65379"}
{"text": "5 , pp .543 - 544 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Hojo , H. Miwa , A. Nagahara , and N. Sato , \" Pooled analysis on the efficacy of the second - line treatment regimens for Helicobacter pylori infection , \" Scandinavian Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "66.68612"}
{"text": "204 - 210 , 1999 .View at Google Scholar \u00b7 View at Scopus .J. P. A. O'Connor , I. Taneike , and C. O'Morain , \" Improving compliance with Helicobacter pylori eradication therapy : when and how ? \"", "label": "", "metadata": {}, "score": "66.80033"}
{"text": "Zullo A , Scaccianoce G , De Francesco V , Ruggiero V , D'Ambrosio P , Castorani L , et al .Concomitant , sequential , and hybrid therapy for H. pylori eradication : a pilot study .", "label": "", "metadata": {}, "score": "66.84663"}
{"text": "Zullo A , Gatta L , De Francesco V , Hassan C , Ricci C , Bernabucci V , et al .High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer : a prospective controlled study .", "label": "", "metadata": {}, "score": "66.86517"}
{"text": "857 - 864 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. S. Jafri , C. A. Hornung , and C. W. Howden , \" Meta - analysis : sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "66.90869"}
{"text": "Average rate of primary levofloxacin resistance to H. pylori in Europe ( 2008 - 2009 ) is around 14.1 % ( 4.0 - 28.0 % ) [ 47 ] .", "label": "", "metadata": {}, "score": "66.92377"}
{"text": "Sequential therapy versus hybrid therapy .Hybrid therapy is an evolution of sequential therapy that uses a proton pump inhibitor twice daily and amoxicillin 1 g twice daily for 14 days plus 500 mg clarithromycin and nitroimidazole derivatives , both twice daily , for the last seven days .", "label": "", "metadata": {}, "score": "67.0022"}
{"text": "22 Amoxicillin is used initially to reduce the bacterial load in the stomach to improve the efficacy of clarithromycin and metronidazole .26 In a meta - analysis of 10 randomized trials , sequential therapy achieved an eradication rate of 93.4 % versus 76.9 % for triple therapy .", "label": "", "metadata": {}, "score": "67.0474"}
{"text": "In three studies bismuth containing therapies lasted 14 days , 27 40 49 whereas in two trials they had a 10 day duration .33 56 Different bismuth formulations were used , including colloid bismuth subcitrate , bismuth pectin , and other unspecified bismuth salts .", "label": "", "metadata": {}, "score": "67.047844"}
{"text": "First - line eradication triple therapy comprises a proton pump inhibitor ( PPI ) and two of the following antibiotics : clarithromycin , metronidazole and amoxicillin .", "label": "", "metadata": {}, "score": "67.0719"}
{"text": "First - line eradication triple therapy comprises a proton pump inhibitor ( PPI ) and two of the following antibiotics : clarithromycin , metronidazole and amoxicillin .", "label": "", "metadata": {}, "score": "67.0719"}
{"text": "4 , pp .407 - 414 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Tursi , W. Elisei , G. M. Giorgetti , M. Picchio , and G. Brandimarte , \" Efficacy , tolerability , and factors affecting the efficacy of the sequential therapy in curing helicobacter pylori infection in clinical setting , \" Journal of Investigative Medicine , vol .", "label": "", "metadata": {}, "score": "67.16235"}
{"text": "The incidence of adverse effects and the compliance between two therapies are comparable .In the paper entitled \" Rescue therapy for Helicobacter pylori infection 2012 , \" J. P. Gisbert reviews current rescue therapies for H. pylori infection .", "label": "", "metadata": {}, "score": "67.26371"}
{"text": "One study in Asia compared the sequential therapy with standard triple therapy and found that the two methods did not have significantly different eradication rates ( 86 % versus 77 % by PP analysis ) [ 29 ] .", "label": "", "metadata": {}, "score": "67.27586"}
{"text": "Data on H. pylori antibiotic sensitivity profiles in Kenya are scarce , a recent study showing all H. pylori largely sensitive to clarithromycin ( 100 % ) , amoxicillin ( 100 % ) and metronidazole ( 95.4 % ) .", "label": "", "metadata": {}, "score": "67.316986"}
{"text": "Data on H. pylori antibiotic sensitivity profiles in Kenya are scarce , a recent study showing all H. pylori largely sensitive to clarithromycin ( 100 % ) , amoxicillin ( 100 % ) and metronidazole ( 95.4 % ) .", "label": "", "metadata": {}, "score": "67.316986"}
{"text": "[17 ] .Generally speaking , sequential therapy is a good but typically not an excellent regimen ( i.e. , typically achieving a grade B and not grade A result ) [ 18 ] .", "label": "", "metadata": {}, "score": "67.3614"}
{"text": "We assessed data for the primary outcome by using a random effects model , 10 to give a conservative estimate of the 95 % confidence intervals .", "label": "", "metadata": {}, "score": "67.4359"}
{"text": "109 - 118 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Treiber , S. Ammon , E. Schneider , and U. Klotz , \" Amoxicillin / metronidazole / omeprazole / clarithromycin : a new , short quadruple therapy for Helicobacter pylori eradication , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "67.45358"}
{"text": "Nausea , vomiting , abdominal pain , headache , and diarrhea are common side effects associated with treatment of H pylori .Taste disturbances may occur with metronidazole and clarithromycin .", "label": "", "metadata": {}, "score": "67.471596"}
{"text": "Seddik H , Ahid S , El AT , El Hamdi FZ , Hassar M , Abouqal R , et al .Sequential therapy versus standard triple - drug therapy for Helicobacter pylori eradication : a prospective randomized study .", "label": "", "metadata": {}, "score": "67.49639"}
{"text": "1808 - 1825 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Vaira , A. Zullo , N. Vakil et al . , \" Sequential therapy versus standard triple - drug therapy for Helicobacter pylori eradication : a randomized trial , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "67.52688"}
{"text": "Initial studies of sequential therapy suggested that its superiority over standard triple therapy might be due to improved eradication of clarithromycin resistant strains .Recently , several randomised controlled trials have compared sequential therapy with other established and new therapies .", "label": "", "metadata": {}, "score": "67.535355"}
{"text": "5 , pp .280 - 284 , 2008 .View at Google Scholar \u00b7 View at Scopus . A. S. Essa , J. R. Kramer , D. Y. Graham , and G. Treiber , \" Meta - analysis : four - drug , three - antibiotic , non - bismuth - containing \" concomitant therapy \" versus triple therapy for Helicobacter pylori eradication , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "67.56653"}
{"text": "[ 6 ] have reported that prevalence of metronidazole - resistant H. pylori strains has increased to more than 70 % in China .Two large meta - analyses [ 7 , 8 ] showed that these therapies failed to eradicate H. pylori in up to 20 % of patients .", "label": "", "metadata": {}, "score": "67.57713"}
{"text": "17 , supplement B , pp . 36B-40B , 2003 .View at Google Scholar \u00b7 View at Scopus . F. M\u00e9graud and H. Lamouliatte , \" Review article : the treatment of refractory Helicobacter pylori infection , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "67.597885"}
{"text": "Bacterial culture was successful in 178 of 210 ( 85 % ) patients .Isolated clarithromycin resistance was present in 24 of 210 ( 13.5 % ) strains .", "label": "", "metadata": {}, "score": "67.75839"}
{"text": "9 , no . 8 , Article ID e105822 , 2014 .View at Google Scholar . E. R. Greenberg , G. L. Anderson , D. R. Morgan et al . , \" 14-day triple , 5-day concomitant , and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites : a randomised trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "67.76564"}
{"text": "Alternative first - line therapies include bismuth - containing quadruple therapy , sequential therapy , concomitant therapy , and hybrid therapy .Levofloxacin - based therapy shows impressive efficacy but might be employed as rescue treatment due to rapidly raising resistance .", "label": "", "metadata": {}, "score": "67.775475"}
{"text": "The eradication rate was 80 % and 67 % , respectively in patients with isolated clarithromycin resistance who received sequential therapy compared with 31 % of patients who received standard therapy .", "label": "", "metadata": {}, "score": "67.79936"}
{"text": "Conclusions .All the three therapy schemes could alleviate symptoms of duodenal ulcer patients in China efficiently .But as far as eradicating H. pylori is concerned , the modified sequential therapy was better than standard triple therapy , especially the therapy scheme used in group A. .", "label": "", "metadata": {}, "score": "67.82742"}
{"text": "Malfertheiner P , Bazzoli F , Delchier JC , Celinski K , Giguere M , Riviere M , et al .Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium , metronidazole , and tetracycline given with omeprazole versus clarithromycin - based triple therapy : a randomised , open - label , non - inferiority , phase 3 trial .", "label": "", "metadata": {}, "score": "67.84042"}
{"text": "12 , pp .3069 - 3079 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Francavilla , E. Lionetti , and L. Cavallo , \" Sequential treatment for Helicobacter pylori eradication in children , \" Gut , vol .", "label": "", "metadata": {}, "score": "67.868256"}
{"text": "Adherence .Multiple medications , increased administration frequency , adverse effects , and cost all negatively affect adherence .22 Poor adherence is associated with antibiotic resistance and lower levels of eradication ; therefore , it is essential to stress the importance of completing the treatment exactly as prescribed .", "label": "", "metadata": {}, "score": "67.92568"}
{"text": "All participants gave written informed consent .Therapy Regimens .In each center , all patients were randomly assigned using a computer - generated list to one of the following treatments .", "label": "", "metadata": {}, "score": "67.936516"}
{"text": "BACKGROUND :Helicobacter pylori is associated with several upper gastrointestinal conditions including chronic gastritis , peptic ulcer disease , and gatric malignancy .Proton pump inhibitor - based triple therapies are considered the standard regimens for H. pylori eradication , but the optimal duration of therapy is controversial .", "label": "", "metadata": {}, "score": "67.96327"}
{"text": "613 - 624 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. S. Jafri , C. A. Hornung , and C. W. Howden , \" Meta - analysis : sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "67.97947"}
{"text": "Those variables found to be significant by univariate analysis were subsequently assessed by a stepwise logistic regression method to identify independent factors for eradication outcome .", "label": "", "metadata": {}, "score": "67.99539"}
{"text": "Table 1 : Characteristics of patients entering the intention - to - treat analysis .Effect and Symptoms Improvement Analysis .All the three groups could improve the symptoms such as epigastralgia , burning pain and acidity since the first day .", "label": "", "metadata": {}, "score": "68.03282"}
{"text": "Abstract .Background .Ten - day concomitant therapy achieves a high eradication rate in Taiwan .Whether shortening the duration of concomitant therapy can still keep a high eradication rate remains unclear .", "label": "", "metadata": {}, "score": "68.06784"}
{"text": "[Links ] .Chey WD , Wong BC .American College of Gastroenterology guideline on the management of Helicobacter pylori infection .Am J Gastroenterol 2007;102(8):1808 - 1825 .", "label": "", "metadata": {}, "score": "68.10562"}
{"text": "[Links ] .Chey WD , Wong BC .American College of Gastroenterology guideline on the management of Helicobacter pylori infection .Am J Gastroenterol 2007;102(8):1808 - 1825 .", "label": "", "metadata": {}, "score": "68.10562"}
{"text": "Alternative first - line therapies include bismuth - containing quadruple therapy , sequential therapy , concomitant quadruple therapy , and hybrid therapy .Levofloxacin - based therapies showed impressive efficacy , but they might be employed as rescue treatment except in areas with high clarithromycin resistance .", "label": "", "metadata": {}, "score": "68.15354"}
{"text": "The following recommendations are important .( 1 ) Clinicians should know the local resistance rates .( 2 )In areas with low clarithromycin resistance rates , standard triple therapy should be the primary choice , while bismuth - containing quadruple , sequential therapy and concomitant therapy could be alternative first - line therapies .", "label": "", "metadata": {}, "score": "68.15361"}
{"text": "5 , pp .1017 - 1024 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. M. Wong , Q. Gu , K. M. Chu et al . , \" Lansoprazole , levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second - line treatment of resistant Helicobacter pylori infection , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "68.22818"}
{"text": "59 - 61 , 2012 .View at Google Scholar .R. J. Saad , P. Schoenfeld , M. K. Hyungjin , and W. D. Chey , \" Levofloxacin - based triple therapy versus bismuth - based quadruple therapy for persistent Helicobacter pylori infection : a meta - analysis , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "68.25668"}
{"text": "View at Google Scholar \u00b7 View at Scopus .P. I. Hsu , K. H. Lai , C. K. Lin et al . , \" A prospective randomized trial of esomeprazole- versus pantoprazole - based triple therapy for Helicobacter pylori eradication , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "68.265915"}
{"text": "In this investigation , 13 % of the patients treated with concomitant therapy reported at least one adverse event during eradication therapy .Basically , concomitant therapy was well tolerated and had good compliance ( 98.4 % ) .", "label": "", "metadata": {}, "score": "68.29766"}
{"text": "Triple therapy , which is the current standard treatment , has low eradication rates .In conclusion , our large , prospective , controlled study shows the superiority of sequential treatment for eradicating H. pylori infection in duodenal ulcer patients compared with conventional triple therapy .", "label": "", "metadata": {}, "score": "68.31326"}
{"text": "Sequential Therapy .This novel therapy shows an impressive eradication rate above 90 % [ 25 - 28 ] .The rationale of sequential therapy includes ( 1 ) Amoxicillin would decrease the bacterial load and then the risk of selection of clarithromycin - resistant mutant and ( 2 ) Amoxicillin may disrupt the efflux pump preventing clarithromycin resistance .", "label": "", "metadata": {}, "score": "68.3181"}
{"text": "540 - 546 , 2011 .View at Google Scholar .C. Chiesa , L. Pacifico , C. Anania , E. Poggiogalle , F. Chiarelli , and J. F. Osborn , \" Helicobacter pylori therapy in children : overview and challenges , \" International Journal of Immunopathology and Pharmacology , vol .", "label": "", "metadata": {}, "score": "68.34386"}
{"text": "In this study , smoking is one of clinical factors influencing treatment outcome by univariate analysis .The reason for this is possibly due to low prevalence rate of smoking .", "label": "", "metadata": {}, "score": "68.44886"}
{"text": "17 , no .35 , pp .3971 - 3975 , 2011 .View at Publisher \u00b7 View at Google Scholar . D. Y. Graham and S. Akiko , \" New concepts of resistance in the treatment of Helicobacter pylori infections , \" Nature Clinical Practice Gastroenterology & Hepatology , vol .", "label": "", "metadata": {}, "score": "68.47533"}
{"text": "Luther J , Higgins PD , Schoenfeld PS , Moayyedi P , Vakil N , Chey WD .Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection : systematic review and meta - analysis of efficacy and tolerability .", "label": "", "metadata": {}, "score": "68.53984"}
{"text": "Jafri NS , Hornung CA , Howden CW .Meta - analysis : sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment .", "label": "", "metadata": {}, "score": "68.542076"}
{"text": "Am J Gastroenterol 2007;102(5):951 - 956 .[Links ] .Megraud F. Update on therapeutic options for Helicobacter pylori - related diseases .Curr Infect Dis Rep 2005;7(2):115 - 1120 .", "label": "", "metadata": {}, "score": "68.544556"}
{"text": "Am J Gastroenterol 2007;102(5):951 - 956 .[Links ] .Megraud F. Update on therapeutic options for Helicobacter pylori - related diseases .Curr Infect Dis Rep 2005;7(2):115 - 1120 .", "label": "", "metadata": {}, "score": "68.544556"}
{"text": "1462 - 1470 , 2003 .View at Google Scholar \u00b7 View at Scopus . A. S. Raghunath , A. P. S. Hungin , D. Wooff , and S. Childs , \" Systematic review : the effect of Helicobacter pylori and its eradication on gastro - oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "68.58234"}
{"text": "Egger M , Juni P , Bartlett C , Holenstein F , Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews ?", "label": "", "metadata": {}, "score": "68.59012"}
{"text": "However , it has been reported that the sensitivity of culture is less than 60 % .Additionally , in vitro antimicrobial sensitivity does not necessarily lead to eradication in vivo and vice versa .", "label": "", "metadata": {}, "score": "68.5983"}
{"text": "Eradication rate of sequential therapy according to antimicrobial resistance .Eight studies provided data on eradication according to pre - treatment antimicrobial susceptibility testing .6 7 31 32 36 41 44 50 Two studies were at low risk of bias .", "label": "", "metadata": {}, "score": "68.60272"}
{"text": "1808 - 1825 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Laine , M. B. Fennerty , M. Osato et al . , \" Esomeprazole - based Helicobacter pylori eradication therapy and the effect of antibiotic resistance : results of three US multicenter , double - blind trials , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "68.625404"}
{"text": "This variation in the results could be due to factors such as bacterial virulence , environmental factors and widespread use of antibiotics .Increasing antimicrobial resistance has resulted in falling eradication rates with standard therapies .", "label": "", "metadata": {}, "score": "68.640045"}
{"text": "This variation in the results could be due to factors such as bacterial virulence , environmental factors and widespread use of antibiotics .Increasing antimicrobial resistance has resulted in falling eradication rates with standard therapies .", "label": "", "metadata": {}, "score": "68.640045"}
{"text": "56 - 65 , 2012 .View at Publisher \u00b7 View at Google Scholar . A. O'Connor , J. P. Gisbert , D. McNamara , and C. O'Morain , \" Treatment of Helicobacter pylori infection 2011 , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "68.69961"}
{"text": "One study compared the efficacy of a 10-day bismuth - containing quadruple therapy and a 7-day triple therapy .Their data revealed that the bismuth - quadruple therapies had a higher eradication rate than the triple therapy ( 93 % versus 70 % by PP analysis ) [ 23 ] .", "label": "", "metadata": {}, "score": "68.83883"}
{"text": "Lahbabi M , Alaoui S , El Rhazi K , El Abkari M , Nejjari C , Amarti A , et al .Sequential therapy versus standard triple - drug therapy for Helicobacter pylori infection : result of the HPFEZ randomised study .", "label": "", "metadata": {}, "score": "68.912636"}
{"text": "In the studies using levofloxacin 1000 mg daily , 240 patients were randomised to standard sequential therapy and 240 to the levofloxacin based sequential therapy .", "label": "", "metadata": {}, "score": "68.943375"}
{"text": "In the paper entitled \" Impact of Lactobacillus reuteri supplementation on anti - Helicobacter pylori levofloxacin - based second - line therapy , \" V. Ojetti et al . assessed the efficacy of L. reuteri supplementation in H. pylori eradication and in preventing gastrointestinal side effects during a second - line levofloxacin triple therapy .", "label": "", "metadata": {}, "score": "69.036"}
{"text": "11 , pp .1333 - 1343 , 2003 .View at Publisher \u00b7 View at Google Scholar .B. J. McMahon , T. W. Hennessy , J. M. Bensler et al . , \" The relationship among previous antimicrobial use , antimicrobial resistance , and treatment outcomes for Helicobacter pylori infections , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "69.0436"}
{"text": "Guidelines .Two primary treatment guidelines are used in the U.S. : the Maastricht Consensus Report ( MCR ) and the American College of Gastroenterology Clinical Guideline ( ACGCG ) on H pylori infection .", "label": "", "metadata": {}, "score": "69.06384"}
{"text": "[52 ] critically evaluated the evidence existing on the role of non - bismuth quadruple therapy ( PPI - clarithromycin - amoxicillin - nitroimidazole ) [ 53 - 55 ] in the treatment of HP infection .", "label": "", "metadata": {}, "score": "69.06726"}
{"text": "Ma CX , Peng GL , Zhao YK , Zhang XY , Zhan LY .Treatment outcomes of functional dyspepsia patients with Helicobacter pylori infection : a comparison between sequential treatment regimen and conventional triple therapy .", "label": "", "metadata": {}, "score": "69.07869"}
{"text": "12 , pp .3069 - 3079 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. H. Choi , D. I. Park , S. J. Oh et al . , \" Effectiveness of 10 day - sequential therapy for Helicobacter pylori eradication in Korea , \" The Korean Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "69.13276"}
{"text": "View at Publisher \u00b7 View at Google Scholar .M. Deltenre , C. Jonas , M. van Gossum , M. Buset , J. Otero , and E. de Koster , \" Omeprazole - based antimicrobial therapies : results in 198 Helicobacter pylori -positive patients , \" European Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "69.16284"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Zullo , L. Gatta , V. de Francesco et al . , \" High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer : a prospective controlled study , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "69.18241"}
{"text": "18 Genetics , changes in acid secretion and gastric hormones , and the pattern of the induced gastritis are among the factors involved in H pylori -induced PUD .", "label": "", "metadata": {}, "score": "69.2041"}
{"text": "6 , pp .2630 - 2640 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Myllyluoma , L. Veijola , T. Ahlroos et al . , \" Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo - controlled , double - blind randomized pilot study , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "69.22179"}
{"text": "5 , pp .845 - 850 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .V. de Francesco , A. Zullo , M. Margiotta et al . , \" Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "69.24545"}
{"text": "[Links ] .de Boer WA , Thys JC , Borody TJ , Graham DY , O'Morain C , Tytgat GN .Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens .", "label": "", "metadata": {}, "score": "69.400604"}
{"text": "[Links ] .de Boer WA , Thys JC , Borody TJ , Graham DY , O'Morain C , Tytgat GN .Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens .", "label": "", "metadata": {}, "score": "69.400604"}
{"text": "The odds ratios were 0.073 ( 95 % confidence interval ( CI ) , 0.011 - 0.483 ) .Table 5 : Multivariate analysis for clinical factors related to eradication efficacy of H. pylori .", "label": "", "metadata": {}, "score": "69.44417"}
{"text": "18B-20B , 2003 .View at Google Scholar \u00b7 View at Scopus .C. W. Howden and R. H. Hunt , \" Guidelines for the management of Helicobacter pylori infection , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "69.44474"}
{"text": "Therefore , the modified sequential therapy is an economical alternative to standard triple therapy .Statistical Analysis .The sample size was a priori calculated based on available data in the literature [ 14 ] .", "label": "", "metadata": {}, "score": "69.444855"}
{"text": "This study compared two kinds of modified sequential therapy and a kind of conventional triple therapy to explore the difference in eradication of H. pylori and treatment of duodenal ulcer and such improvement of symptoms .", "label": "", "metadata": {}, "score": "69.484566"}
{"text": "2010;15(suppl 1):1 - 6 .Chey WD , Wong BC , Practice Parameters Committee of the American College of Gastroenterology .American College of Gastroenterology guideline on the management of Helicobacter pylori infection .", "label": "", "metadata": {}, "score": "69.48752"}
{"text": "One study revealed that levofloxacin - based sequential therapy and levofloxacin based triple therapy were significantly superior to standard triple therapy plus probiotic ( PP / ITT analysis : 95.5/95.5 % , 89.1/86.3 % , and 77.1/72.4 % , resp . )", "label": "", "metadata": {}, "score": "69.49898"}
{"text": "9790 , pp .507 - 514 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Miehlke , C. Kirsch , W. Schneider - Brachert et al . , \" A prospective , randomized study of quadruple therapy and high - dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin , \" Helicobacter , vol . 8 , no .", "label": "", "metadata": {}, "score": "69.61196"}
{"text": "421 - 427 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. C. Cheng , W. L. Chang , W. Y. Chen , H. B. Yang , J. J. Wu , and B. S. Sheu , \" Levofloxacin - containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "69.67155"}
{"text": "One American study in 2011 surveyed the efficacy of 14-day triple therapy .The eradication rates of 14-day standard therapy , concomitant therapy , and sequential therapy were 82.2 % ( 401 of 488 ) , 73.6 % ( 360 of 489 ) , and 76.5 % ( 372 of 486 ) , respectively .", "label": "", "metadata": {}, "score": "69.67676"}
{"text": "Possible adverse effects of the regimen were headache , nausea , vomiting , diarrhoea , loss of appetite , taste disturbance , abdominal pain and rash .", "label": "", "metadata": {}, "score": "69.71092"}
{"text": "Possible adverse effects of the regimen were headache , nausea , vomiting , diarrhoea , loss of appetite , taste disturbance , abdominal pain and rash .", "label": "", "metadata": {}, "score": "69.71092"}
{"text": "12 , pp .3393 - 3398 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. J. F. Laheij , L. G. M. van Rossum , J. B. M. J. Jansen , H. Straatman , and A. L. M. Verbeek , \" Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta - analysis , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "69.73825"}
{"text": "Exposure to quinolones is relevant to delays in the diagnosis of tuberculosis and the development of drug resistance .Tailored therapy to detect quinolone - resistant strains could offer better eradication rates .", "label": "", "metadata": {}, "score": "69.772255"}
{"text": "Therefore , this study represents the real world scenario for H. pylori detection and eradication .In conclusion , 7-day concomitant therapy achieved a very high eradication rate for H. pylori infection in Taiwan .", "label": "", "metadata": {}, "score": "69.83024"}
{"text": "De Francesco V , Zullo A , Hassan C , Della VN , Pietrini L , et al .The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme : a prospective , randomised study .", "label": "", "metadata": {}, "score": "69.87508"}
{"text": "McNicholl AG , Marin AC , Molina - Infante J , Castro M , Barrio J , Ducons J , et al .Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice .", "label": "", "metadata": {}, "score": "69.89254"}
{"text": "Drug allergy to penicillin is also an important factor influencing regimen chosen .In H. pylori infected patients allergic to penicillin , the previously recommended first - line treatment with omeprazole - clarithromycin - metronidazole has low efficacy for curing the infection .", "label": "", "metadata": {}, "score": "69.93439"}
{"text": "857 - 864 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. R. Greenberg , G. L. Anderson , D. R. Morgan et al . , \" 14-day triple , 5-day concomitant , and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites : a randomised trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "69.96353"}
{"text": "12 , pp .1419 - 1424 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Seddik , S. Ahid , T. El Adioui et al . , \" Sequential therapy versus standard triple - drug therapy for Helicobacter pylori eradication : a prospective randomized study , \" European Journal of Clinical Pharmacology , vol .", "label": "", "metadata": {}, "score": "69.96563"}
{"text": "737 - 741 , 2004 .View at Google Scholar \u00b7 View at Scopus . E. Lionetti , V. L. Miniello , S. P. Castellaneta et al . , \" Lactobacillus reuteri therapy to reduce side - effects during anti-", "label": "", "metadata": {}, "score": "69.96842"}
{"text": "12 , pp .923 - 931 , 2008 .View at Google Scholar \u00b7 View at Scopus .V. de Francesco , M. Margiotta , A. Zullo et al . , \" Clarithromycin - resistant genotypes and eradication of Helicobacter pylori , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "70.055534"}
{"text": "For many years , a recommended alternative approach ( Maastricht III Consensus and Guidelines of American College of Gastroenterology ) has been the addition of PPIs to the old regimen comprising a bismuth salt , tetracycline , and MNZ [ 48 ] .", "label": "", "metadata": {}, "score": "70.08263"}
{"text": "Conclusions .The use of quinolones such as levofloxacin should be confined to \" rescue \" therapy only , in order to avoid a further rapid increase in H. pylori resistance to quinolone .", "label": "", "metadata": {}, "score": "70.10033"}
{"text": "690 - 700 , 2001 .View at Google Scholar \u00b7 View at Scopus .J. P. Gisbert and A. G. McNicholl , \" Maintenance of Helicobacter pilori eradication rates with triple therapy over 12 years in a Spanish Hospital , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "70.10838"}
{"text": "2 3 The prevalence of resistance to clarithromycin and metronidazole has increased substantially in recent years , and a corresponding decrease has occurred in the eradication rate for H pylori infection , 4 which has declined to unacceptable levels in most Western countries .", "label": "", "metadata": {}, "score": "70.11345"}
{"text": "Concomitant therapy is less complex than sequential therapy .One randomized control trial compared the efficacy of sequential therapy and concomitant therapy and found that these two therapies showed similar eradication rates ( 93.1 % versus 93.0 % by PP analysis ) and compliance [ 30 ] .", "label": "", "metadata": {}, "score": "70.136505"}
{"text": "The 1994 National Institutes of Health Consensus Statement advises that acid - suppressive therapy be given in combination with antimicrobial treatment in patients testing positive for H pylori because of the acceleration in healing seen with simultaneous administration of these medications .", "label": "", "metadata": {}, "score": "70.192314"}
{"text": "5 , pp .747 - 749 , 2004 .View at Google Scholar \u00b7 View at Scopus .R. J. F. Laheij , L. G. M. van Rossum , J. B. M. J. Jansen , H. Straatman , and A. L. M. Verbeek , \" Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta - analysis , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "70.25685"}
{"text": "Objective To do a systematic review and meta - analysis of studies comparing sequential therapy for eradication of Helicobacter pylori with pre - existing and new therapies , thus providing a glimpse of eradication success worldwide .", "label": "", "metadata": {}, "score": "70.260025"}
{"text": "However , 22 ( 18.3 % ) were lost to follow - up .The only patient who had less than 90 % compliance was in the EAC 14 group .", "label": "", "metadata": {}, "score": "70.302185"}
{"text": "However , 22 ( 18.3 % ) were lost to follow - up .The only patient who had less than 90 % compliance was in the EAC 14 group .", "label": "", "metadata": {}, "score": "70.302185"}
{"text": "Investigators in different parts of the world have made several attempts to find new regimens as a more effective alternative to traditional triple therapies .One of these is sequential therapy .", "label": "", "metadata": {}, "score": "70.340935"}
{"text": "Liou JM , Chen CC , Chen MJ , Chen CC , Chang CY , Fang YJ , et al .Sequential versus triple therapy for the first - line treatment of Helicobacter pylori : a multicentre , open - label , randomized trial .", "label": "", "metadata": {}, "score": "70.37567"}
{"text": "17 , no .35 , pp .3971 - 3975 , 2011 .View at Google Scholar .R. M. Genta and D. Y. Graham , \" Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori : a topographic study of H. pylori density and distribution , \" Gastrointestinal Endoscopy , vol .", "label": "", "metadata": {}, "score": "70.419136"}
{"text": "4 , pp .409 - 414 , 2010 .View at Google Scholar \u00b7 View at Scopus . E. R. Greenberg , G. L. Anderson , D. R. Morgan et al . , \" 14-day triple , 5-day concomitant , and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites : a randomised trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "70.42042"}
{"text": "17 , pp .374 - 381 , 2012 .View at Google Scholar .M. Tanaka , E. Isogai , H. Isogai et al . , \" Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "70.4214"}
{"text": "556 - 563 , 2007 .View at Google Scholar \u00b7 View at Scopus .N. S. Jafri , C. A. Hornung , and C. W. Howden , \" Meta - analysis : sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "70.44827"}
{"text": "Testing Methods .Tests for H pylori fall into one of two categories : invasive and noninvasive .Invasive : Invasive tests include endoscopy , the rapid urease test , histologic methods , and culture .", "label": "", "metadata": {}, "score": "70.48298"}
{"text": "Probiotics .Probiotics are live microbial organisms that may partially restore microecology in the intestine .Probiotics have been shown to reduce the risk of adverse effects associated with H pylori treatment .", "label": "", "metadata": {}, "score": "70.53552"}
{"text": "5 , pp .1071 - 1075 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. H. Choi , D. I. Park , S. J. Oh et al . , \" Effectiveness of 10 day - sequential therapy for Helicobacter pylori eradication in Korea , \" The Korean Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "70.54643"}
{"text": "Another concern is the efficacy of sequential therapy for dual resistance ( clarithromycin and metronidazole resistance ) .Unfortunately , there is still no large study to confirm this point .", "label": "", "metadata": {}, "score": "70.556274"}
{"text": "S190-S192 , 2000 .View at Google Scholar \u00b7 View at Scopus .J. M. Lee , N. P. Breslin , D. K. Hyde , M. J. Buckley , and C. A. O'Morain , \" Treatment options for Helicobacter pylori infection when proton pump inhibitor - based triple therapy fails in clinical practice , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "70.56659"}
{"text": "41 - 53 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. J. F. Laheij , L. G. M. Van Rossum , J. B. M. J. Jansen , H. Straatman , and A. L. M. Verbeek , \" Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta - analysis , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "70.57096"}
{"text": "A MEDLINE search to May 2011 by using the keywords \" sequential therapy \" and \" Helicobacter pylori \" yielded 168 citations .Recently UygunA and colleagues [ 46 ] perform a study to compare the eradication success of a 14-day sequential regimen with proton - pump - inhibitor - based triple treatment .", "label": "", "metadata": {}, "score": "70.59396"}
{"text": "10 , pp .1077 - 1084 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. P. Gisbert and F. De La Morena , \" Systematic review and meta - analysis : levofloxacin - based rescue regimens after Helicobacter pylori treatment failure , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "70.65425"}
{"text": "Bismuth - Containing Quadruple Therapy .The Maastricht III Consensus Report [ 1 ] and the Second Asia - Pacific Consensus Guidelines for H. pylori Infection [ 20 ] both recommended bismuth - containing quadruple therapy as an alternative first - line regimen for H. pylori infection .", "label": "", "metadata": {}, "score": "70.76982"}
{"text": "Furuta T , Graham DY .Pharmacologic aspects of eradication therapy for Helicobacter pylori infection .Gastroenterol Clin North Am .Gisbert JP , Calvet X , O'Connor A , et al .", "label": "", "metadata": {}, "score": "70.7699"}
{"text": "J Clin Gastroenterol .2010;44:313 - 325 . O'Connor A , Gisbert JP , McNamara D , O'Morain C. Treatment of Helicobacter pylori infection 2010 .Helicobacter .", "label": "", "metadata": {}, "score": "70.83201"}
{"text": "177 - 240 , 1994 .View at Google Scholar .S. K. Lam and N. J. Talley , \" Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "70.84887"}
{"text": "16 The urea breath test has demonstrated 94 % sensitivity and 95 % specificity ; the stool antigen test is less sensitive and specific .24 Endoscopy is an alternative means of confirming eradication .", "label": "", "metadata": {}, "score": "70.85541"}
{"text": "and a power of 0.85 [ 15 ] . H. pylori eradication rate was the main analytic target .Total eradication rate and its 95 % confidence interval of each scheme were calculated and analyzed by ITT ( intention to treat analysis ) and PP ( per - protocol analysis ) , respectively .", "label": "", "metadata": {}, "score": "70.8564"}
{"text": "83 - 97 , 2011 .View at Google Scholar .M. Selgrad , J. Bornschein , T. Rokkas , and P. Malfertheiner , \" Clinical aspects of gastric cancer and Helicobacter pylori -screening , prevention , and treatment , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "70.894684"}
{"text": "The eradication rates were 80 % in the quadruple therapy group versus 55 % in the standard therapy group [ 23 ] .Besides , the bismuth - containing quadruple therapy provides superior eradication with similar safety and tolerability to standard therapy .", "label": "", "metadata": {}, "score": "70.95424"}
{"text": "However , the prevalence of primary resistance to levofloxacin found by the authors in this study was quite low ( 7.9 % ) compared with that reported by a recent multicentre survey in southern Europe ( 13.1 % ) .", "label": "", "metadata": {}, "score": "70.955414"}
{"text": "160 - 161 , 2012 .View at Google Scholar .K. Murakami , T. Fujioka , T. Okimoto , R. Sato , M. Kodama , and M. Nasu , \" Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy , \" International Journal of Antimicrobial Agents , vol .", "label": "", "metadata": {}, "score": "70.977646"}
{"text": "1808 - 1825 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Miura and R. Hokari , \" Seeking an optimal eradication therapy for Helicobacter pylori infection , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "71.04808"}
{"text": "The influence of age on the efficacy of concomitant treatment is unclear ; the only study that has evaluated concomitant therapy in children showed favorable results ( 94 % of eradications in 33 children ) [ 37 ] .", "label": "", "metadata": {}, "score": "71.12368"}
{"text": "According to recent studies , such eradication rates have plummeted to even 25%-60 % [ 8 - 10 ] .The many causes of fall in efficacy are varied including antibiotic resistance , poor compliance , high gastric acidity , high bacterial load , and the cytochrome P450 2C19 ( CYP2C19 ) polymorphism [ 10 ] .", "label": "", "metadata": {}, "score": "71.17707"}
{"text": "To be noticed as a limitation in the application of this regimen is the fluoroquinolone levofloxacin included in the treatment , which appears to rapidly generate resistance , with a peculiar increase recently demonstrated among Asian populations [ 9 ] .", "label": "", "metadata": {}, "score": "71.181145"}
{"text": "74 National monitoring studies such as one started ( but later discontinued ) in the United States may help clinicians to choose the appropriate therapy .", "label": "", "metadata": {}, "score": "71.19507"}
{"text": "Regional monitoring of resistance rates should help to guide treatment , and new agents for treatment need to be developed .Introduction .Helicobacter pylori infection causes peptic ulcers , gastric mucosa associated lymphoid tissue lymphoma , and gastric cancer .", "label": "", "metadata": {}, "score": "71.21138"}
{"text": "Links ] .Gerrits MM , van Vliet AH , Kuipers EJ , Kusters JG .Helicobacter pylori and antimicrobial resistance : molecular mechanisms and clinical implications .", "label": "", "metadata": {}, "score": "71.28313"}
{"text": "Links ] .Gerrits MM , van Vliet AH , Kuipers EJ , Kusters JG .Helicobacter pylori and antimicrobial resistance : molecular mechanisms and clinical implications .", "label": "", "metadata": {}, "score": "71.28313"}
{"text": "789 - 795 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Ierardi , F. Giorgio , G. Losurdo , A. D. Leo , and M. Principi , \" As the increase in antibiotic resistances could change the treatment of helicobacter pylori infection : it will be a matter of geography ? \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "71.30052"}
{"text": "The main reasons for this phenomenon are point mutations of H. pylori DNA or inappropriate frequent antibiotic use [ 43 , 44 ] .Tailored therapy to detect quinolone - resistant strains could offer better eradication with quinolone - containing H. pylori regimens .", "label": "", "metadata": {}, "score": "71.301315"}
{"text": "This meta - analysis showed a trend preferring sequential therapy to triple therapy .Sequential therapies also demonstrated better eradication rates than standard triple therapy for clarithromycin - resistant strains ( 89 % versus 29 % by PP analysis ) [ 25 ] .", "label": "", "metadata": {}, "score": "71.3105"}
{"text": "6 , pp .917 - 920 , 2011 .View at Publisher \u00b7 View at Google Scholar Quinolone - Containing Therapies in the Eradication of Helicobacter pylori .", "label": "", "metadata": {}, "score": "71.3492"}
{"text": "109 , pp .1148 - 1152 , 2011 .View at Publisher \u00b7 View at Google Scholar . E. Lionetti , F. Indrio , L. Pavone , G. Borrelli , L. Cavallo , and R. Francavilla , \" Role of probiotics in pediatric patients with Helicobacter pylori infection : a comprehensive review of the literature , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "71.4489"}
{"text": "Abstract .Background .Though Helicobacter pylori ( HP ) infections have progressively declined throughout most of the industrialized countries , a gradual increase in failure of HP eradication treatments is observed .", "label": "", "metadata": {}, "score": "71.453125"}
{"text": "11 , pp .2387 - 2392 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. J. F. Laheij , L. G. M. Van Rossum , J. B. M. J. Jansen , H. Straatman , and A. L. M. Verbeek , \" Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta - analysis , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "71.51536"}
{"text": "498 - 503 , 2012 .View at Google Scholar .P. I. Hsu , K. H. Lai , H. H. Tseng et al . , \" Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia , \" Journal of Clinical Gastroenterology , vol .", "label": "", "metadata": {}, "score": "71.52602"}
{"text": "6 , pp .1029 - 1031 , 2000 .View at Google Scholar \u00b7 View at Scopus .J. P. Gisbert and X. Calvet , \" Review article : rifabutin in the treatment of refractory Helicobacter pylori infection , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "71.53264"}
{"text": "2011 , no .34 , pp .604 - 617 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. Wenzhen , L. Yumin , G. Quanlin et al . , \" Is antimicrobial susceptibility testing necessary before first - line treatment for Helicobacter pylori infection ?", "label": "", "metadata": {}, "score": "71.60172"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Vaira , A. Zullo , N. Vakil et al . , \" Sequential therapy versus standard triple - drug therapy for Helicobacter pylori eradication : a randomized trial , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "71.65963"}
{"text": "22 Patients with PUD should eliminate or reduce stress , cigarette smoking , alcohol , NSAIDs , and additional medications associated with dyspepsia , as well as avoid foods and beverages that contribute to dyspepsia or ulcer symptoms .", "label": "", "metadata": {}, "score": "71.67334"}
{"text": "This was a prospective randomised investigator - blind comparative trial of 7- and 14-day triple therapy for H. pylori eradication conducted at the Aga Khan University Hospital , Nairobi .", "label": "", "metadata": {}, "score": "71.69437"}
{"text": "This was a prospective randomised investigator - blind comparative trial of 7- and 14-day triple therapy for H. pylori eradication conducted at the Aga Khan University Hospital , Nairobi .", "label": "", "metadata": {}, "score": "71.69437"}
{"text": "1140 - 1144 , 2012 .View at Google Scholar \u00b7 View at Scopus .N. Wueppenhorst , H. Stueger , M. Kist , and E. Glocker , \" High secondary resistance to quinolones in German Helicobacter pylori clinical isolates , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "71.73691"}
{"text": "The commonly used dosage of levofloxacin was 500 mg daily in many studies in Asia [ 37 ] .Studies demonstrated that increasing the dosage of levofloxacin can not overcome levofloxacin resistance [ 38 , 39 ] .", "label": "", "metadata": {}, "score": "71.73959"}
{"text": "A selection of relevant English - language clinical trials , systematic reviews , and meta - analyses within the time period 2010 - 2012 was performed .", "label": "", "metadata": {}, "score": "71.763504"}
{"text": "11 , pp .1970 - 1975 , 2011 .View at Google Scholar .S. Baba , Y. Oishi , Y. Watanabe , et al . , \" Gastric wash - based molecular testing for antibiotic resistance in Helicobacter pylori , \" Digestion , vol .", "label": "", "metadata": {}, "score": "71.77444"}
{"text": "Clarithromycin resistance is the most important issue .The cause of high H. pylori clarithromycin resistance rates was mainly resulted from the long - term use of clarithromycin for respiratory tract infections [ 16 ] .", "label": "", "metadata": {}, "score": "71.79635"}
{"text": "299 - 304 , 2011 .View at Google Scholar \u00b7 View at Scopus . A. O'Connor , J. P. Gisbert , D. McNamara , and C. O'Morain , \" Treatment of Helicobacter pylori infection 2011 , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "71.86645"}
{"text": "In : DiPiro JT , Talbert RL , Yee GC , et al , eds .Pharmacotherapy : A Pathophysiologic Approach .8th ed .New York , NY : McGraw - Hill Medical ; 2011 .", "label": "", "metadata": {}, "score": "71.884186"}
{"text": "Indeed , during the last few years , different studies have found that the success rate following such regimens is disappointingly low , with values less than 45 - 60 % in some countries [ 4 ] .", "label": "", "metadata": {}, "score": "71.92385"}
{"text": "3 , no .5 , pp .445 - 451 , 1994 .View at Google Scholar \u00b7 View at Scopus . H. Suzuki , F. Franceschi , T. Nishizawa , and A. Gasbarrini , \" Extragastric manifestations of Helicobacter pylori infection , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "72.05701"}
{"text": "Aminian K , Farsad F , Ghanbari A , Fakhreih S , Hasheminasab SM .A randomized trial comparing four Helicobacter pylori eradication regimens : standard triple therapy , ciprofloxacin based triple therapy , quadruple and sequential therapy .", "label": "", "metadata": {}, "score": "72.09912"}
{"text": "[Links ] .Suzuki T , Matsuo K , Ito H , Sawaki A , Hirose K , Wakai K , et al .Smoking increases the treatment failure for Helicobacter pylori eradication .", "label": "", "metadata": {}, "score": "72.131256"}
{"text": "[Links ] .Suzuki T , Matsuo K , Ito H , Sawaki A , Hirose K , Wakai K , et al .Smoking increases the treatment failure for Helicobacter pylori eradication .", "label": "", "metadata": {}, "score": "72.131256"}
{"text": "Resistance to levofloxacin has increased rapidly in recent years and the worldwide resistance rate is around 16.2 % ( 95 % CI 14.4 - 18 % ) .", "label": "", "metadata": {}, "score": "72.374504"}
{"text": "Cost is a major consideration in many countries .The cost of the sequential regimen is similar to that of the standard regimen in China , which makes it an attractive and reasonable alternative to triple therapy [ 48 - 50 ] .", "label": "", "metadata": {}, "score": "72.63603"}
{"text": "To assess the eradication rate of 7-day pantoprazole - containing concomitant therapy in Taiwan and to investigate factors influencing the eradication outcome .Methods .", "label": "", "metadata": {}, "score": "72.728546"}
{"text": "CLINICAL MANIFESTATIONS .H pylori infection has been implicated in the development of gastritis , gastric and duodenal ulceration , and gastric cancer .Gastritis .", "label": "", "metadata": {}, "score": "72.817795"}
{"text": "167 - 180 , 2002 .View at Publisher \u00b7 View at Google Scholar .J. Q. Huang and R. H. Hunt , \" The evolving epidemiology of Helicobacter pylori infection and gastric cancer , \" Canadian Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "72.8892"}
{"text": "1221 - 1228 , 2000 .View at Google Scholar \u00b7 View at Scopus .N. J. Peng , K. H. Lai , R. S. Liu et al . , \" Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by 13 C urea breath test , \" Digestive Diseases and Sciences , vol .", "label": "", "metadata": {}, "score": "72.90729"}
{"text": "5 , pp .306 - 309 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Padol , Y. Yuan , M. Thabane , I. T. Padol , and R. H. Hunt , \" The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first - line PPI therapies : a meta - analysis , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "72.95456"}
{"text": "Here we review fluoroquinolone - based H. pylori eradication regimens and discuss the challenges we are faced with owing to the emerging resistance to antibiotics that can influence the efficacy of eradication , particular the public health issue of tuberculosis .", "label": "", "metadata": {}, "score": "72.98038"}
{"text": "5 , pp .352 - 360 , 2008 .View at Google Scholar . D. Y. Graham , \" The changing epidemiology of GERD : geography and Helicobacter pylori , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "73.00841"}
{"text": "View at Google Scholar .T. S. Wu , H. M. Hu , F. C. Kuo , and C. H. Kuo , \" Eradication of Helicobacter pylori infection , \" Kaohsiung Journal of Medical Sciences , vol .", "label": "", "metadata": {}, "score": "73.070244"}
{"text": "To critically review evidence on the efficacy of the therapeutic availabilities for HP eradication , as yet .Methods .A selection of Clinical Trials , Systematic Reviews and Meta - analyses within the time period 2010 - 2012 , was performed through a Medline search .", "label": "", "metadata": {}, "score": "73.08827"}
{"text": "9790 , pp .507 - 514 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. M. Fock , P. Katelaris , K. Sugano et al . , \" Second Asia - Pacific consensus guidelines for Helicobacter pylori infection , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "73.08967"}
{"text": "4 , pp .299 - 305 , 2011 .View at Google Scholar . H. Szajewska , A. Horvath , and A. Piwowarczyk , \" Meta - analysis : the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "73.12659"}
{"text": "Rifabutin inhibits DNA - dependent RNA polymerase and initiation of transcription , preventing protein synthesis .Drug Regimens to Eradicate H pylori .No single drug achieves the optimal eradication rate on its own , and most treatment regimens include two antibiotics in addition to a PPI ( TABLES 1 and 2 ) .", "label": "", "metadata": {}, "score": "73.1297"}
{"text": "Fluoroquinolones , especially levofloxacin , are used in the eradication of Helicobacter pylori worldwide .Many consensus guidelines recommend that the second - line rescue therapy for H. pylori eradication consists of a proton pump inhibitor , a quinolone , and amoxicillin as an option .", "label": "", "metadata": {}, "score": "73.1619"}
{"text": "Levofloxacin could be used as an alternative agent for clarithromycin in either a standard triple , quadruple , or sequential regimens .The use of levofloxacin in first - line therapy has also been surveyed .", "label": "", "metadata": {}, "score": "73.23689"}
{"text": "Strains resistant to levofloxacin .Only one study tested primary resistance to levofloxacin .32 No significant difference in eradication rate was found between the sequential therapy and the \" modified \" sequential therapy ( in which levofloxacin was used instead of clarithromycin ) , but the number of patients studied was extremely low ( supplementary table I ) .", "label": "", "metadata": {}, "score": "73.237785"}
{"text": "Meta - analysis : the effect of antibiotic resistance status on the efficacy of triple and quadruple first - line therapies for Helicobacter pylori .Aliment Pharmacol Ther 2007;26(3):343 - 357 .", "label": "", "metadata": {}, "score": "73.31372"}
{"text": "Meta - analysis : the effect of antibiotic resistance status on the efficacy of triple and quadruple first - line therapies for Helicobacter pylori .Aliment Pharmacol Ther 2007;26(3):343 - 357 .", "label": "", "metadata": {}, "score": "73.31372"}
{"text": "53 - 59 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .V. Rinaldi , A. Zullo , V. de Francesco et al . , \" Helicobacter pylori eradication with proton pump inhibitor - based triple therapies and re - treatment with ranitidine bismuth citrate - based triple therapy , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "73.42526"}
{"text": "View at Publisher \u00b7 View at Google Scholar .S. P. Xiao , M. Gu , and G. X. Zhang , \" Is levofloxacin - based triple therapy an alternative for first - line eradication of Helicobacter pylori ?", "label": "", "metadata": {}, "score": "73.45514"}
{"text": "54 - 58 , 1998 .View at Google Scholar \u00b7 View at Scopus .M. Okada , K. Oki , T. Shirotani et al . , \" A new quadruple therapy for the eradication of Helicobacter pylori .", "label": "", "metadata": {}, "score": "73.45983"}
{"text": "106 , no .11 , pp .1976 - 1977 , 2011 .View at Google Scholar .F. Parente , C. Cucino , and G. Bianchi Porro , \" Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts , \" Digestive and Liver Disease , vol .", "label": "", "metadata": {}, "score": "73.58172"}
{"text": "In addition , these regimens should minimize antimicrobial resistance .Pharmacologic Agents .Antisecretory Drugs : H2RAs are associated with lower eradication rates , and therefore they should not be substituted for PPIs .", "label": "", "metadata": {}, "score": "73.6882"}
{"text": "12 , pp .923 - 931 , 2008 .View at Google Scholar \u00b7 View at Scopus .L. Boyanova and I. Mitov , \" Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents , \" Expert Review of Anti - Infective Therapy , vol . 8 , no . 1 , pp .", "label": "", "metadata": {}, "score": "73.71219"}
{"text": "5 61 62 The eradication rate is uniformly less than the 80 % target set at the beginning and well below what should be expected for treatment of an infectious disease .", "label": "", "metadata": {}, "score": "73.75598"}
{"text": "Questionnaire .A complete medical history and demographic data were obtained from each patient , including age , sex , medical history , history of smoking , alcohol , coffee , and tea consumption .", "label": "", "metadata": {}, "score": "73.76561"}
{"text": "1 Alternative antibiotics based on local resistance rates may improve eradication rates .The widespread and indiscriminate use of antibiotics in developing countries has resulted in a higher prevalence of resistance than in industrialised countries .", "label": "", "metadata": {}, "score": "73.77876"}
{"text": "1 Alternative antibiotics based on local resistance rates may improve eradication rates .The widespread and indiscriminate use of antibiotics in developing countries has resulted in a higher prevalence of resistance than in industrialised countries .", "label": "", "metadata": {}, "score": "73.77876"}
{"text": "Conflict of Interests .The authors declare that there is no conflict of interest regarding the production of this paper .W. D. Chey and B. C. Y. Wong , \" American College of Gastroenterology guideline on the management of Helicobacter pylori infection , \" The American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "73.83699"}
{"text": "Adverse Reaction .Both treatments were well tolerated and no patient was withdrawn from the study .The most frequent adverse reaction related to the treatment was gastroenteric reaction .", "label": "", "metadata": {}, "score": "73.84839"}
{"text": "2010;25:S99-S110 .McColl KE .Helicobacter pylori infection .N Engl J Med .Ford AC , Axon AT .Epidemiology of Helicobacter pylori infection and public health implications .", "label": "", "metadata": {}, "score": "73.87412"}
{"text": "Links ] .Megraud F. H. pylori antibiotic resistance : prevalence , importance , and advances in testing .Gut 2004;53(9):1374 - 1384 .[Links ] .", "label": "", "metadata": {}, "score": "73.87755"}
{"text": "Links ] .Megraud F. H. pylori antibiotic resistance : prevalence , importance , and advances in testing .Gut 2004;53(9):1374 - 1384 .[Links ] .", "label": "", "metadata": {}, "score": "73.87755"}
{"text": "H pylori infection has been shown to cause peptic ulcer disease , gastric mucosa associated lymphoid tissue lymphoma , and gastric cancer .59 Eradication therapy has been shown to improve outcomes in peptic ulcer disease as well as mucosa associated lymphoid tissue lymphoma , by reducing recurrence .", "label": "", "metadata": {}, "score": "73.88872"}
{"text": "Calvet X , Lehours P , Lario S , Megraud F. Diagnosis of Helicobacter pylori infection .Helicobacter .2010;15(suppl 1):7 - 13 .Berardi RR , Fugit RV .", "label": "", "metadata": {}, "score": "73.91632"}
{"text": "138 - 144 , 1996 .View at Google Scholar \u00b7 View at Scopus .G. Sisson , A. Goodwin , A. Raudonikiene et al . , \" Enzymes associated with reductive activation and action of nitazoxanide , nitrofurans , and metronidazole in Helicobacter pylori , \" Antimicrobial Agents and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "73.94592"}
{"text": "Materials and Methods .General Data of Patients .This was a comparative , parallel , open - label , multicenter , randomized study .It was carried out between January 2007 and July 2009 .", "label": "", "metadata": {}, "score": "73.96651"}
{"text": "Duck WM , Sobel J , Pruckler JM , Song Q , Swerdlow D , Friedman C , et al .Antimicrobial resistance incidence and risk factors among Helicobacter pylori - infected persons , United States .", "label": "", "metadata": {}, "score": "73.97365"}
{"text": "Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development .The information presented in this activity is not meant to serve as a guideline for patient management .", "label": "", "metadata": {}, "score": "73.98331"}
{"text": "Cases of Nitroimidazole resistance as well as dual resistance ( to both CAM and MNZ ) are described [ 33 ] .For these latter patients , concomitant therapy may be more suitable than sequential therapy .", "label": "", "metadata": {}, "score": "74.000916"}
{"text": "The eradication rate for quadruple therapy was 93 % , compared with 68 % for triple therapy .Quadruple therapy should be considered as first - line therapy in areas with high clarithromycin resistance .", "label": "", "metadata": {}, "score": "74.07715"}
{"text": "To predict the risk of gastric cancer development and diagnose atrophic gastritis , new serologic testing for a combination of pepsinogen I and II and gastrin and HP antibodies has yielded satisfactory results over the last decades .", "label": "", "metadata": {}, "score": "74.08684"}
{"text": "54 - 60 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. H. Hunt , S. D. Xiao , F. Megraud et al . , \" World gastroenterology organisation global guideline : Helicobacter pylori in developing countries , \" Journal of Clinical Gastroenterology , vol .", "label": "", "metadata": {}, "score": "74.09301"}
{"text": "10 , pp .1587 - 1600 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. K. Chuah , W. C. Tai , P. I. Hsu , et al . , \" The efficacy of second - line anti-", "label": "", "metadata": {}, "score": "74.10855"}
{"text": "View at Google Scholar . E. Gen\u00e9 , X. Calvet , R. Azagra , and J. P. Gisbert , \" Triple vs. Quadruple therapy for treating Helicobacter pylori infection : an updated meta - analysis , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "74.147964"}
{"text": "40 No trial was at low risk of bias .Data on adverse events were available for four studies .Sequential therapy versus non - bismuth quadruple therapy .", "label": "", "metadata": {}, "score": "74.20001"}
{"text": "So the quinolone - based triple therapy is not generally recommended as first - line therapy .The regimen could be considered in those areas with clarithromycin resistance greater than 15%-20 % and quinolone resistance less than 10 % [ 34 ] .", "label": "", "metadata": {}, "score": "74.47078"}
{"text": "View at Google Scholar \u00b7 View at Scopus .R. A. Devasia , A. Blackman , T. Gebretsadik et al . , \" Fluoroquinolone resistance in Mycobacterium tuberculosis : the effect of duration and timing of fluoroquinolone exposure , \" The American Journal of Respiratory and Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "74.54674"}
{"text": "The 11 articles included in this met - analysis showed no significant difference between patients with HP eradicated and those with persistent infection .The authors therefore concluded that HP eradication does not worsen the clinical outcomes of GERD .", "label": "", "metadata": {}, "score": "74.5494"}
{"text": "789 - 795 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. M. Best , D. J. M. Haldane , G. S. Bezanson , and S. J. Veldhuyzen van Zanten , \" Helicobacter pylori : primary susceptibility to clarithromycin in vitro in Nova Scotia , \" Canadian Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "74.58055"}
{"text": "Nakajima S , Nishiyama Y , Yamaoka M , et al .Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years .", "label": "", "metadata": {}, "score": "74.589294"}
{"text": "S10-S18 , 1997 .View at Google Scholar .W. M. Duck , J. Sobel , J. M. Pruckler et al . , \" Antimicrobial resistance incidence risk and factors among Helicobacter pylori -infected persons , United States , \" Emerging Infectious Diseases , vol .", "label": "", "metadata": {}, "score": "74.63971"}
{"text": "Malfertheiner P , Megraud F , O'Morain C , Bell D , Bianchi PG , Deltenre M , et al .Current European concepts in the management of Helicobacter pylori infection - the Maastricht consensus report .", "label": "", "metadata": {}, "score": "74.71123"}
{"text": "10 , pp .4512 - 4518 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Liou , C. Y. Chang , W. H. Sheng et al . , \" Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin - based therapies , \" Antimicrobial Agents and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "74.73331"}
{"text": "View at Google Scholar \u00b7 View at Scopus .J. L. Tong , Z. H. Ran , J. Shen , and S. D. Xiao , \" Sequential therapy vs. Standard triple therapies for Helicobacter pylori infection : a meta - analysis , \" Journal of Clinical Pharmacy and Therapeutics , vol .", "label": "", "metadata": {}, "score": "74.75081"}
{"text": "The novel therapy is well tolerated .Drug compliance is an important clinical factor influencing its treatment efficacy .In the paper entitled \" Comparison between single - dose esomeprazole- and pantoprazole - based triple therapy on the effectiveness for Helicobacter pylori eradication in Taiwanese population , \" H.-Y. Shih et al .", "label": "", "metadata": {}, "score": "74.84845"}
{"text": "Besides RUT positive , all participants must be positive in anti-Hp antibody , H. pylori dying , and histological examination .In d1 , 2 , 3 , 7 , 21 , and 35 , the symptoms of patients such as epigastralgia , burning pain , and acidity were evaluated ; the adverse reaction and the compliance of the patients were also assessed .", "label": "", "metadata": {}, "score": "74.87909"}
{"text": "6 , pp .564 - 573 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. D. Chey and B. C. Y. Wong , \" American College of Gastroenterology guideline on the management of Helicobacter pylori infection , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "74.90794"}
{"text": "Malfertheiner P , Megraud F , O'Morain C , Bazzoli F , El - Omar E , Graham D , et al .Current concepts in the management of Helicobacter pylori infection : the Maastricht III Consensus Report .", "label": "", "metadata": {}, "score": "74.92064"}
{"text": "Malfertheiner P , Megraud F , O'Morain C , Bazzoli F , El - Omar E , Graham D , et al .Current concepts in the management of Helicobacter pylori infection : the Maastricht III Consensus Report .", "label": "", "metadata": {}, "score": "74.92064"}
{"text": "CAM resistance may reduce the efficacy of non - bismuth quadruple therapy , although the eradication rate remains much higher than in standard triple therapy .", "label": "", "metadata": {}, "score": "74.95357"}
{"text": "Basso D , Plebani M , Kusters JG .Pathogenesis of Helicobacter pylori infection .Helicobacter .2010;15(suppl 1):14 - 20 .Kuwahara H , Miyamoto Y , Akaike T , et al .", "label": "", "metadata": {}, "score": "74.990234"}
{"text": "Results .During December 2009 and May 2010 , 146 patients with H. pylori- positive dyspepsia were identified .Of these , 26 were excluded : 21 did not meet inclusion criteria and 5 did not give consent .", "label": "", "metadata": {}, "score": "74.99625"}
{"text": "Results .During December 2009 and May 2010 , 146 patients with H. pylori- positive dyspepsia were identified .Of these , 26 were excluded : 21 did not meet inclusion criteria and 5 did not give consent .", "label": "", "metadata": {}, "score": "74.99625"}
{"text": "Singh M , Way LG , Logasamy N , Chettiar R , Na CS , Menon J. Helicobacter pylori eradication in East Malaysia : sequentail vs standard 7 day triple therapy - a prospective randomized trial .", "label": "", "metadata": {}, "score": "75.03354"}
{"text": "Therefore , levofloxacin - based therapy was no longer recommended as a first - line regimen .Rescue Second - Line Quinolone - Containing Therapy .", "label": "", "metadata": {}, "score": "75.03474"}
{"text": "1808 - 1825 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. M. Fock , P. Katelaris , K. Sugano et al . , \" Second Asia - Pacific Consensus Guidelines for Helicobacter pylori infection , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "75.05766"}
{"text": "Pharmacy Postgraduate Healthcare Education , LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education .UAN : 0430 - 0000 - 11 - 035-H01-P Credits : 2.0 hours ( 0.20 ceu ) Type of Activity : Knowledge .", "label": "", "metadata": {}, "score": "75.137794"}
{"text": "Only five patients discontinued treatment as a result of adverse events during eradication therapy .Multivariate analysis revealed that drug compliance was the only independent clinical factor influencing treatment efficacy .", "label": "", "metadata": {}, "score": "75.24774"}
{"text": "493 - 496 , 1992 .View at Google Scholar \u00b7 View at Scopus .V. de Francesco , F. Giorgio , C. Hassan et al . , \" Worldwide H. pylori antibiotic resistance : a systematic review , \" Journal of Gastrointestinal and Liver Diseases , vol .", "label": "", "metadata": {}, "score": "75.29796"}
{"text": "In the 46 randomised controlled trials , 5666 patients were randomised to receive sequential treatment , and the overall eradication rate , pooled with a random model , was 84.3 % ( 82.1 % to 86.4 % ) .", "label": "", "metadata": {}, "score": "75.31941"}
{"text": "Moher D , Pham B , Jones A , Cook DJ , Jadad AR , Moher M , et al .Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta - analyses ?", "label": "", "metadata": {}, "score": "75.36258"}
{"text": "Compliance of patients was checked by counting unused medication at the completion of treatment .Poor compliance was defined as taking less than 80 % of the total medication .", "label": "", "metadata": {}, "score": "75.37115"}
{"text": "European Study Group on Antibiotic Susceptibility of Helicobacter pylori .Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori .Eur J Clin Microbiol Infect Dis 1992 ; 11 : 777 -81 .", "label": "", "metadata": {}, "score": "75.38522"}
{"text": "The main current effort should be to maintain the eradication rate of HP above 85 % and to prevent any increase in antimicrobial resistance in the general population .", "label": "", "metadata": {}, "score": "75.4079"}
{"text": "Nevertheless , more studies are necessary to delineate the cause - effect relationship for any of these issues [ 5 ] .Helicobacter pylori infects approximately 50 % of the adult population [ 1 , 6 ] : only 20 % of HP - infected people are symptomatic whereas 80 % of them are symptom - free .", "label": "", "metadata": {}, "score": "75.488304"}
{"text": "1467 - 1475 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .V. De Francesco , F. Giorgio , C. Hassan et al . , \" Worldwide H. pylori antibiotic resistance : a systematic review , \" Journal of Gastrointestinal and Liver Diseases , vol .", "label": "", "metadata": {}, "score": "75.50825"}
{"text": "Because of the heterogeneity , we did subgroup analyses according to country of origin , risk of bias , proton pump inhibitor used , duration of non - bismuth containing quadruple therapy , type of publication , and use of tinidazole in the sequential therapy ( supplementary table E ) .", "label": "", "metadata": {}, "score": "75.53255"}
{"text": "Antimicrobial resistance is not important for the other groups of antibiotics ( amoxicillin , tetracycline ) because of the low prevalence .However , it is not practical to perform culturing before first - line therapy .", "label": "", "metadata": {}, "score": "75.539444"}
{"text": "27 Levofloxacin may play a role in initial treatment and is an option for second - line therapy .27 Eradication rates range from 72 % to 96 % ; however , resistance to levofloxacin is increasing , especially in countries with a high consumption of fluoroquinolones .", "label": "", "metadata": {}, "score": "75.645096"}
{"text": "6 , pp .1039 - 1040 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . K. L. Goh and P. Navaratnam , \" High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin , levofloxacin , and other antibiotics in Malaysia , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "75.67769"}
{"text": "Gender , smoking habit , alcohol consumption and prior endoscopy had no influence on eradication rates , but our study was not powered for this conclusion .", "label": "", "metadata": {}, "score": "75.79832"}
{"text": "Gender , smoking habit , alcohol consumption and prior endoscopy had no influence on eradication rates , but our study was not powered for this conclusion .", "label": "", "metadata": {}, "score": "75.79832"}
{"text": "World Gastroenterology Organisation .World Gastroenterology Organisation Global Guideline : Helicobacter pylori in developing countries .J Clin Gastroenterol .Mourad - Baars P , Hussey S , Jones NL .", "label": "", "metadata": {}, "score": "75.83617"}
{"text": "Patients never treated before for Helicobacter pylori infection .Patients without significant comorbidity ( for example , renal failure , hepatic failure , cancer ) .", "label": "", "metadata": {}, "score": "75.8631"}
{"text": "83 - 97 , 2011 .View at Google Scholar . D. Cullen , G. Hawkey , D. Greenwood , et al . , \" Helicobacter pylori and gastroesophageal reflux disease : a Community - Based Study , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "75.86319"}
{"text": "Compliance and tolerability .Compliance was analysed in 98 patients , after exclusion of the 22 patients lost to follow - up .Compliance was good in 97 ( 98.98 % ) of the participants .", "label": "", "metadata": {}, "score": "75.9214"}
{"text": "Compliance and tolerability .Compliance was analysed in 98 patients , after exclusion of the 22 patients lost to follow - up .Compliance was good in 97 ( 98.98 % ) of the participants .", "label": "", "metadata": {}, "score": "75.9214"}
{"text": "Gastroenterology 2011 ; 140 ( suppl 1 ) : S148 .Franceschi F , Campanale M , Finizio R , Barbaro F , Tortora A , Gigante G , et al .", "label": "", "metadata": {}, "score": "75.95996"}
{"text": "Human - to - human contact has been reported to be responsible for transmission of H pylori , with a high incidence within families .9 The foremost means of transmission are believed to be the gastro - oral route ( vomit ) and the fecal - oral route .", "label": "", "metadata": {}, "score": "76.027084"}
{"text": "79 - 87 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Szajewska , A. Horvath , and A. Piwowarczyk , \" Meta - analysis : the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "76.09314"}
{"text": "84 The applicability of the results should also be viewed with caution , as information regarding the efficacy of the sequential therapy in several Western countries is lacking .", "label": "", "metadata": {}, "score": "76.15006"}
{"text": "127 - 134 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Koletzko , N. L. Jones , K. J. Goodman et al . , \" Evidence - based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children , \" Journal of Pediatric Gastroenterology and Nutrition , vol .", "label": "", "metadata": {}, "score": "76.168625"}
{"text": "1069 - 1079 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Zou , J. Dong , and X. Yu , \" Meta - analysis : lactobacillus containing quadruple therapy versus standard triple first - line therapy for Helicobacter pylori eradication , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "76.26082"}
{"text": "Gastroenterology 2012 ; 142 : S487 .Fakheri H , Taghvaei T , Hosseini V , Bari Z. A comparison between sequential therapy and a modified bismuth - based quadruple therapy for Helicobacter pylori eradication in Iran : a randomized clinical trial .", "label": "", "metadata": {}, "score": "76.27275"}
{"text": "857 - 864 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Kuwayama , K. Asaka , T. Sugiyama , et al . , \" Rabeprazole - based eradication therapy for Helicobacter pylori : a large - scale study in Japan , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "76.32927"}
{"text": "View at Google Scholar \u00b7 View at Scopus .W. D. Chey and B. C. Y. Wong , \" American College of Gastroenterology guideline on the management of Helicobacter pylori infection , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "76.41291"}
{"text": "The Maastricht IV Consensus Report recommended a selection of antibiotics for third - line regimens , depending on bacterial culture results and antimicrobial sensitivity tests [ 5 ] .", "label": "", "metadata": {}, "score": "76.42802"}
{"text": "10 , pp .1077 - 1084 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Romano , A. Cuomo , A. G. Gravina et al . , \" Empirical levofloxacin - containing versus clarithromycin - containing sequential therapy for Helicobacter pylori eradication : a randomised trial , \" Gut , vol .", "label": "", "metadata": {}, "score": "76.64048"}
{"text": "556 - 563 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Liou , C. C. Chen , M. J. Chen , et al . , \" Sequential versus triple therapy for the first - line treatment of Helicobacter pylori : a multicentre , open - label , randomized trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "76.69505"}
{"text": "155 - 168 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. P. Gisbert , A. P\u00e9rez - Aisa , M. Castro - Fern\u00e1ndez et al . , \" Helicobacter pylori first - line treatment and rescue option containing levofloxacin in patients allergic to penicillin , \" Digestive and Liver Disease , vol .", "label": "", "metadata": {}, "score": "76.696594"}
{"text": "4 , pp .497 - 501 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Furuta , Y. Sagehashi , N. Shirai et al . , \" Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection , \" Clinical Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "76.8627"}
{"text": "Another meta - analysis , using a fixed effect model , showed that non - bismuth based quadruple therapy was superior to the triple therapy .", "label": "", "metadata": {}, "score": "76.9337"}
{"text": "In a recent trial by Basu et al .[ 65 ] a new regimen with high eradication rate was proposed : a novel drug combination was tested within a clinical trial and compared with a standard triple therapy ( amoxicillin , CAM , and lansoprazole ) .", "label": "", "metadata": {}, "score": "76.98759"}
{"text": "NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease .Helicobacter pylori in peptic ulcer disease .JAMA .1994;272:65 - 69 .Yamaoka Y. Mechanisms of disease : Helicobacter pylori virulence factors .", "label": "", "metadata": {}, "score": "77.05068"}
{"text": "Lancet .Gisbert JP , Khorrami S , Carballo F , et al . H. pylori eradication therapy vs. antisecretory non - eradication therapy ( with or without long - term maintenance antisecretory therapy ) for the prevention of recurrent bleeding from peptic ulcer .", "label": "", "metadata": {}, "score": "77.07228"}
{"text": "1069 - 1079 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Francavilla , E. Lionetti , S. P. Castellaneta et al . , \" Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy : a pilot study , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "77.14392"}
{"text": "Schulz KF , Chalmers I , Hayes RJ , Altman DG .Empirical evidence of bias : dimensions of methodological quality associated with estimates of treatment effects in controlled trials .", "label": "", "metadata": {}, "score": "77.15474"}
{"text": "7,11A cohort effect related to the lower socioeconomic status of children in previous decades is surmised to be the reason behind the increased prevalence in older age groups .", "label": "", "metadata": {}, "score": "77.17026"}
{"text": "Poor compliance was reported in one patient in the EAC 14 group .The incidence of adverse events was comparable in the two groups .CONCLUSION :", "label": "", "metadata": {}, "score": "77.19781"}
{"text": "View at Publisher \u00b7 View at Google Scholar . A. Ford and P. Moayyedi , \" How can the current strategies for Helicobacter pylori eradication therapy be improved ? \"", "label": "", "metadata": {}, "score": "77.22815"}
{"text": "PATHOPHYSIOLOGY .Once H pylori enters the body , several mechanisms allow it to evade attack by the immune system , including genetic diversity and bacterial mimicry .", "label": "", "metadata": {}, "score": "77.26844"}
{"text": "Quadruple therapy ( PPI + CAM + AMPC and/or MNZ \u00b1 Bismuth ) and sequential therapy ( PPI + AMPC for 5 days , then PPI + CAM + MNZ for other 5 days ) are efficacious alternatives to standard triple therapy for both adults and children .", "label": "", "metadata": {}, "score": "77.32676"}
{"text": "507 - 514 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. I. Hsu , K. H. Lai , E. J. Chien et al . , \" Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori -associated gastritis , \" Anticancer Research , vol .", "label": "", "metadata": {}, "score": "77.50523"}
{"text": "The eradication rates according to intention - to - treat and per - protocol analyses were 93.7 % ( 299/319 ) and 96.4 % ( 297/308 ) , respectively .", "label": "", "metadata": {}, "score": "77.517815"}
{"text": "A meta - analysis published in 2009 presented the pooled eradication rate of concomitant therapy studies between 1998 to 2002 as 89.7 % on ITT and 92.9 % on PP analysis [ 20 ] .", "label": "", "metadata": {}, "score": "77.582855"}
{"text": "27 Vaginal candidiasis may result during or after treatment .While PPIs may alter the bioavailability of orally administered medications because of an increase in intragastric pH and some PPIs inhibit the hepatic CYP2C19 pathway , an FDA database review found limited drug interactions with PPIs .", "label": "", "metadata": {}, "score": "77.60019"}
{"text": "1287 - 1291 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. C. Yang , H. L. Wang , H. D. Chern et al . , \" Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole - amoxicillin dual therapy for Helicobacter pylori eradication , \" Pharmacotherapy , vol .", "label": "", "metadata": {}, "score": "77.60599"}
{"text": "Gut 2013 ; 62 : 34 -42 .Vaira D , Zullo A , Vakil N , Gatta L , Ricci C , Perna F , et al Sequential therapy versus standard triple - drug therapy for Helicobacter pylori eradication : a randomized trial .", "label": "", "metadata": {}, "score": "77.63075"}
{"text": "Infect Immun .Malfertheiner P , Chan FK , McColl KE .Peptic ulcer disease .Lancet .Tan VP , Wong BC .Helicobacter pylori and gastritis : untangling a complex relationship 27 years on .", "label": "", "metadata": {}, "score": "77.66011"}
{"text": "The results were even unacceptable in Latin American ( 76.5 % ) and Thailand ( 57.1 ) [ 21 , 30 ] .It is more convenient than sequential therapy because of the shorter duration of treatment and less complex drug administration .", "label": "", "metadata": {}, "score": "77.708084"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .F. W. Tsay , H. H. Tseng , P. I. Hsu et al . , \" Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "77.89001"}
{"text": "As with any systematic review and meta - analysis , the results rely on the quality and reporting of the trials .Most of the studies included had problems with concealment of allocation and blinding , which are important safeguards against bias in randomised controlled trials .", "label": "", "metadata": {}, "score": "77.985176"}
{"text": "3156 - 3161 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. S. Sheu , J. J. Wu , C. Y. Lo et al . , \" Impact of supplement with Lactobacillus - and Bifidobacterium - containing yogurt on triple therapy for Helicobacter pylori eradication , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "77.994484"}
{"text": "4 , pp .287 - 290 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Helicobacter pylori Eradication Therapy : Current Availabilities .", "label": "", "metadata": {}, "score": "78.03432"}
{"text": "However , when we compared sequential therapy with non - bismuth containing quadruple therapy or sequential therapy in which levofloxacin was used instead of clarithromycin , we found no significant difference ( supplementary table G ) .", "label": "", "metadata": {}, "score": "78.06406"}
{"text": "153 - 160 , 2002 .View at Google Scholar \u00b7 View at Scopus .G. Guariso , D. Basso , C. F. Bortoluzzi et al . , \" GastroPanel : evaluation of the usefulness in the diagnosis of gastro - duodenal mucosal alterations in children , \" Clinica Chimica Acta , vol .", "label": "", "metadata": {}, "score": "78.06503"}
{"text": "Serum anti-Hp antibody was also probed ( ELASE ) .The patients who were intensive positive in RUT ( show red in five minutes ) could be considered qualified .", "label": "", "metadata": {}, "score": "78.07634"}
{"text": "A meta - analysis was performed in 2009 .It compares concomitant ( 293 subjects , duration 3 to 5 days ) and triple therapy ( 283 subjects , duration 5 to 10 days ) and four other studies evaluating concomitant therapy ( 478 subjects , duration 3 to 7 days ) .", "label": "", "metadata": {}, "score": "78.09673"}
{"text": "Lansoprazole , amoxicillin , and clarithromycin are available as a daily administration card under the name Prevpac .In patients allergic to penicillin , metronidazole may be substituted for amoxicillin .", "label": "", "metadata": {}, "score": "78.10945"}
{"text": "[Links ] .Kimang'a AN , Revathi G , Kariuki S , Sayed S , Devani S. Helicobacter pylori : prevalence and antibiotic susceptibility among Kenyans .", "label": "", "metadata": {}, "score": "78.14315"}
{"text": "[Links ] .Kimang'a AN , Revathi G , Kariuki S , Sayed S , Devani S. Helicobacter pylori : prevalence and antibiotic susceptibility among Kenyans .", "label": "", "metadata": {}, "score": "78.14315"}
{"text": "More often , acute gastritis progresses to chronic active gastritis .From here , patients may develop antrum - predominant gastritis or multifocal atrophic gastritis .", "label": "", "metadata": {}, "score": "78.254074"}
{"text": "Culture has high specificity , but its sensitivity is variable .Noninvasive : The urea breath test , the stool antigen test , and serologic testing are noninvasive methods of diagnosing H pylori .", "label": "", "metadata": {}, "score": "78.42715"}
{"text": "rRNA PCR .The data indicate that isolating H. pylori from drinking water , tap and reverse osmosis water samples , by the culture method and consequent identification by biochemical tests and PCR represent a clear signal for the presence of this dangerous pathogen in the consumable water .", "label": "", "metadata": {}, "score": "78.43946"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. S. Essa , J. R. Kramer , D. Y. Graham , and G. Treiber , \" Meta - analysis : four - drug , three - antibiotic , non - bismuth - containing \" concomitant therapy \" versus triple therapy for Helicobacter pylori eradication , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "78.492516"}
{"text": "The triple treatment including a proton pump inhibitor , clarithromycin , and amoxicillin or metronidazole to treat H pylori infection , proposed at the first Maastricht conference , 60 has become universal since all the consensus conferences and guidelines around the world recommended it .", "label": "", "metadata": {}, "score": "78.58959"}
{"text": "546 - 551 , 2013 .View at Google Scholar . H. Fakheri , T. Taghvaei , V. Hosseini , and Z. Bari , \" A comparison between sequential therapy and a modified bismuth - based quadruple therapy for Helicobacter pylori eradication in iran : a randomized clinical trial , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "78.62404"}
{"text": "One may need to choose a more potent quinolone in order to prevent the development of quinolone resistance during anti- H. pylori therapy .One recent study from Taiwan showed that gemifloxacin was superior to levofloxacin in antimicrobial activity against H. pylori isolates and even overcame some levofloxacin resistance [ 52 ] .", "label": "", "metadata": {}, "score": "78.63107"}
{"text": "Results .An increasing rise in HP resistance rates for antimicrobial agents is currently observed .Further causes of HP treatment failure include polymorphisms of the CYP 2C19 , an increased body mass index ( BMI ) , smoking , poor compliance and re - infections .", "label": "", "metadata": {}, "score": "78.69077"}
{"text": "Clinicians should use antibiotics according to local reports .Table 1 : Recommended first - line therapies for Helicobacter pylori infection .Acknowledgments .The authors are thankful for the supports from Excellence for Cancer Research Center Grant DOH100-TD - C-111 - 002 , Department of Health , Executive Yuan , Taiwan , Kaohsiung Medical University Hospital ( KMUH100 - 0I01 , KMUH100 - 0R02 , KMUH100 - 0R04 ) , and Changhua Christian Hospital - Kaohsiung Medical University ( 100-CCH - KMU-005 ) .", "label": "", "metadata": {}, "score": "78.720825"}
{"text": "61 - 65 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Broutet , A. Marais , H. Lamouliatte et al . , \" cagA status and eradication treatment outcome of anti-", "label": "", "metadata": {}, "score": "78.808304"}
{"text": "6 , pp .317 - 322 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Yu , W. Weihong , and H. Fulian , \" Consensus on treatment of Helicobacter pylori infection in China , \" Chinese Journal of Medical Guide , vol .", "label": "", "metadata": {}, "score": "78.808975"}
{"text": "The disadvantages are that each mutation connected to variable antibiotic resistance needs to be determined , and that the cost may be high .The Impact of Quinolone Exposure on Tuberculosis .", "label": "", "metadata": {}, "score": "78.83296"}
{"text": "Results 46 randomised controlled trials were reviewed and analysed .5666 patients were randomised to sequential therapy and 7866 to other ( established and new ) treatments .", "label": "", "metadata": {}, "score": "78.85845"}
{"text": "Helicobacter .2010;15(suppl 1):53 - 59 .Tummala S , Keates S , Kelly CP .Update on the immunologic basis of Helicobacter pylori gastritis .", "label": "", "metadata": {}, "score": "78.92549"}
{"text": "We also used a random effects model to pool data for safety , 10 and expressed them as relative risk for adverse events .We required at least three comparable study groups for every comparison for randomised controlled trials to be included in the meta - analysis .", "label": "", "metadata": {}, "score": "78.92942"}
{"text": "Clin Gastroenterol Hepatol 2010 ; 8 : 36 -41 .Romano M , Cuomo A , Gravina AG , Miranda A , Iovene MR , Tiso A , et al .", "label": "", "metadata": {}, "score": "78.998055"}
{"text": "Aliment Pharmacol Ther 2011 ; 34 : 1098 -105 .Gatta L , Vaira D , Vakil N , Ricci C , Fiorini G , Castelli V , et al .", "label": "", "metadata": {}, "score": "79.002884"}
{"text": "Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics , \" Antimicrobial Agents and Chemotherapy , vol .45 , no .", "label": "", "metadata": {}, "score": "79.05322"}
{"text": "In a meta - analysis , bismuth based quadruple therapy failed to show an improvement in eradication rate compared with the triple therapy .The eradication rate , according to the intention to treat analysis , was 80 % ( 95 % confidence interval 73.9 % to 84.9 % ) for quadruple therapy compared with only 55 % ( 48.6 % to 62.1 % ) for the triple therapy .", "label": "", "metadata": {}, "score": "79.13986"}
{"text": "Current guidelines recommend eradication therapy in patients with PUD .Gastric Cancer .More prevalent in men than in women , gastric cancer is the second most common cause of cancer - related deaths in men , with a 5-year survival rate of 20 % .", "label": "", "metadata": {}, "score": "79.37176"}
{"text": "27 The effect of probiotics on eradication rates and adverse events was examined in a meta - analysis by Tong and colleagues .33 The eradication rate for triple therapy plus probiotics was 83.6 % , compared with 74.8 % for triple therapy without probiotics .", "label": "", "metadata": {}, "score": "79.4459"}
{"text": "Aliment Pharmacol Ther 2010 ; 31 : 1077 -84 .Wu DC , Hsu PI , Wu JY , Opekun AR , Kuo CH , Wu IC , e al .", "label": "", "metadata": {}, "score": "79.45783"}
{"text": "Helicobacter pylori : Drug Resistance .Since resistance rates for antimicrobial agents rise with their indiscriminate use , clarithromycin ( CAM ) resistance may be due to the widespread use of this agent for upper respiratory tract infections [ 19 , 20 ] .", "label": "", "metadata": {}, "score": "79.52487"}
{"text": "All of the 319 patients were included in the adverse event analysis .In total , 13.2 % ( 42/319 ) of the patients reported at least one adverse event during eradication therapy .", "label": "", "metadata": {}, "score": "79.589676"}
{"text": "While H pylori is a risk factor , evidence is insufficient to suggest that the eradication of H pylori prevents gastric cancer .Gastric Mucosa - Associated Lymphoid Tissue ( MALT ) Lymphoma .", "label": "", "metadata": {}, "score": "79.58994"}
{"text": "6 , pp .1088 - 1094 , 2004 .View at Google Scholar \u00b7 View at Scopus .S. Koletzko , F. Richy , P. Bontems et al . , \" Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe , \" Gut , vol .", "label": "", "metadata": {}, "score": "79.59795"}
{"text": "22 Eradication heals the ulcer , relieving the patient 's symptoms .A Cochrane Review found that eradication of H pylori reduces gastric and duodenal ulcer recurrence .", "label": "", "metadata": {}, "score": "79.61993"}
{"text": "RESEARCH .Helicobacter pylori eradication : a randomised comparative trial of 7-day versus 14-day triple therapy .Ahmed Sokwala I ; Mahesh V Shah II ; Smita Devani III ; Gerald Yonga IV .", "label": "", "metadata": {}, "score": "79.67534"}
{"text": "Therefore , several attempts have been made to substitute for ineffective cultures .The presence of a gyrA mutation is predictive of treatment failure with triple therapy for quinolones such as levofloxacin [ 45 ] .", "label": "", "metadata": {}, "score": "79.678345"}
{"text": "523 - 528 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. H. Hung , B. S. Sheu , W. L. Chang , H. M. Wu , C. C. Liu , and J. J. Wu , \" Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "79.75687"}
{"text": "Drug compliance was the only clinical factor influencing treatment efficacy .Authors ' Contribution .S.-S. Kao and W.-C. Chen contributed equally to the work .", "label": "", "metadata": {}, "score": "79.84419"}
{"text": "109 - 118 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Georgopoulos , V. Papastergiou , E. Xirouchakis et al . , \" Evaluation of a four - drug , three - antibiotic , vonbismuth - containing \" concomitant \" therapy as first - line Helicobacter pylori eradication regimen in Greece , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "79.94701"}
{"text": "The sequential therapy was largely experimented in Italy where an increase in the eradication rate by at least 10 % was observed , compared with standard regimens , independently on clarithromycin resistance [ 56 , 57 ] .", "label": "", "metadata": {}, "score": "79.96986"}
{"text": "The high eradication rate ( 94.5 % ) was also reported in Europe , such as Greece [ 30 ] .However in Latin America , Greenberg et al .", "label": "", "metadata": {}, "score": "80.171646"}
{"text": "10 , pp .984 - 988 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. Y. Wang , S. N. Li , C. S. Liu et al . , \" Effects of ingesting Lactobacillus- and Bifidobacterium - containing yogurt in subjects with colonized Helicobacter pylori , \" American Journal of Clinical Nutrition , vol .", "label": "", "metadata": {}, "score": "80.27252"}
{"text": "The mode of action of levofloxacin is based on the inhibition of bacterial DNA topoisomerase II [ 8 ] .The advantage of levofloxacin - containing triple therapy is that there is an in vivo synergistic effect with respect to quinolone antimicrobial agents and proton - pump inhibitors ( PPIs ) when strains of H. pylori are targeted [ 9 ] .", "label": "", "metadata": {}, "score": "80.27472"}
{"text": "Serologic testing uses immunoglobulin G antibodies to H pylori to detect infection .Because antibodies exist for months after H pylori eradication , serologic testing is not recommended for confirmation of eradication .", "label": "", "metadata": {}, "score": "80.340706"}
{"text": "Given the described geographical variability , the development of better treatments for HP infection should take into consideration the distribution of antibiotic resistance among affected populations in different geographical areas ; however , these data are still lacking outside the USA .", "label": "", "metadata": {}, "score": "80.381195"}
{"text": "Gemifloxacin , a newer quinolone with poor activity against M. tuberculosis compared to levofloxacin and moxifloxacin , may be a promising alternative to overcome this problem .", "label": "", "metadata": {}, "score": "80.44588"}
{"text": "Helicobacter pylori was first isolated by Warren and Marshall in 1982 .It is a Gram - negative bacterium found on the gastric epithelium and induces chronic inflammation of the underlying mucosa . H. pylori infection is usually contracted in the first few years of life and tends to persist indefinitely unless treated .", "label": "", "metadata": {}, "score": "80.50499"}
{"text": "Multifocal atrophic gastritis can lead to gastric ulcers and lymphomas .Peptic Ulcer Disease .Originally , stress and diet were considered to be the causative factors for peptic ulcer disease ( PUD ) .", "label": "", "metadata": {}, "score": "80.514885"}
{"text": "However , in areas where bismuth is not available , a levofloxacin - containing triple therapy is recommended .Gisbert and De La Morena reported that a levofloxacin - containing therapy was borderline significant ( 81 % ) compared to bismuth - based quadruple therapy ( 70 % ) [ 39 ] .", "label": "", "metadata": {}, "score": "80.66098"}
{"text": "26 Metronidazole induces DNA double - strand breaks and results in cell death .Increasing the dosage and duration of metronidazole can partially overcome drug resistance .", "label": "", "metadata": {}, "score": "80.72894"}
{"text": "A triple therapy , comprising proton pump inhibitor , clarithromycin , and amoxycillin or metronidazole , is among the most used first - line treatments in primary medical care in several countries including Canada , the United States , and Europe [ 14 , 15 , 19 - 21 ] .", "label": "", "metadata": {}, "score": "80.74444"}
{"text": "The high virulence exhibited by H pylori results in an increased ability to adhere to the mucosa , as well as a greater ability to manufacture potentially toxic enzymes .", "label": "", "metadata": {}, "score": "80.8229"}
{"text": "Because of the heterogeneity , we did subgroup analyses according to country of origin , use of tinidazole ( instead of metronidazole ) in the sequential therapy , risk of bias , type of publication , and proton pump inhibitor used ( supplementary table C ) .", "label": "", "metadata": {}, "score": "81.06055"}
{"text": "24 , no .10 , pp .1461 - 1468 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Lesbros - Pantoflickova , I. Corthesy - Theulaz , L. Blum , et al . , \" Helicobacter pylori and probiotics , \" Journal of Nutrition , vol .", "label": "", "metadata": {}, "score": "81.16954"}
{"text": "These regimens showed better and acceptable eradication outcomes [ 75 ] .So it is reasonable to choose quadruple therapy or levofloxacin - based triple therapy for patients allergic to penicillin .", "label": "", "metadata": {}, "score": "81.2424"}
{"text": "4 , pp .365 - 370 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. C. Tai , T. H. Hu , C. H. Lee , H. H. Chen , C. C. Huang , and S. K. Chuah , \" Ano - perianal tuberculosis : 15 years of clinical experiences in Southern Taiwan , \" Colorectal Disease , vol .", "label": "", "metadata": {}, "score": "81.314026"}
{"text": "Javid G , Zargar SA , Bhat K , Khan BA , Yatoo GN , Gulzar GM , et al .Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India : a randomized comparative trial .", "label": "", "metadata": {}, "score": "81.573395"}
{"text": "Data were analysed according to ITT and PP criteria .The ITT analysis included all patients randomised to a treatment group , whereas in the PP analysis patients lost during follow - up or showing low compliance were excluded .", "label": "", "metadata": {}, "score": "81.61748"}
{"text": "Data were analysed according to ITT and PP criteria .The ITT analysis included all patients randomised to a treatment group , whereas in the PP analysis patients lost during follow - up or showing low compliance were excluded .", "label": "", "metadata": {}, "score": "81.61748"}
{"text": "In this study , we retrospectively assess the eradication rate of 7-day nonbismuth containing concomitant therapy in Taiwan and investigated the host factors influencing the eradication outcome .", "label": "", "metadata": {}, "score": "81.62766"}
{"text": "29 32 47 Overall , 355 patients were randomised to sequential therapy and 356 patients were randomised to the modified sequential therapy .One study compared sequential therapy with a modified sequential therapy using levofloxacin at dosages of 500 mg daily and 1000 mg daily .", "label": "", "metadata": {}, "score": "81.9128"}
{"text": "12 , pp .2330 - 2338 , 1998 .View at Publisher \u00b7 View at Google Scholar .P. Sipponen , \" Chronic Gastritis in former times and now , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "81.91847"}
{"text": "The different significance of adverse reaction incidence rate of each scheme was analyzed by Fisher exact probability test .Results .General Data .There were total 210 patients enrolled in the study , 201 patients accomplished actually ( 95.7 % ) , and 9 patients were lost ( 4.3 % ) .", "label": "", "metadata": {}, "score": "82.04834"}
{"text": "As the outcome ( that is , eradication ) was almost always assessed by objective means , we did not consider blinding to be crucial .", "label": "", "metadata": {}, "score": "82.05775"}
{"text": "230 - 243 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Alakkari , A. Zullo , and H. J. O'Connor , \" Helicobacter pylori and nonmalignant diseases , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "82.060684"}
{"text": "The rapid urease test permits the detection of H pylori in a biopsy .The biopsied tissue is placed into a dye that changes color , if positive , based on increased pH. The pH increases when the urease is converted to urea by the H pylori .", "label": "", "metadata": {}, "score": "82.10459"}
{"text": "Helicobacter pylori infection and nonmalignant diseases .Helicobacter .2010;15(suppl 1):29 - 33 .Konturek PC , Konturek SJ , Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis .", "label": "", "metadata": {}, "score": "82.13706"}
{"text": "Randomised controlled trials examining the eradication rate of sequential therapy compared with other treatments were eligible for inclusion ( box ) .We imposed no language restrictions .", "label": "", "metadata": {}, "score": "82.19647"}
{"text": "The cut - off value of urea breath test was set at 4.8 % of \u03b4 13 CO 2 [ 27 ] .Statistical Analysis .", "label": "", "metadata": {}, "score": "82.26954"}
{"text": "A prevention of gastric cancer can be obtained by eradication of HP , the success of which depends on the degree of preneoplastic changes ( gastric atrophy and intestinal metaplasia ) at the time of eradication .", "label": "", "metadata": {}, "score": "82.29231"}
{"text": "1643 - 1645 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Schabereiter - Gurtner , A. M. Hirschl , B. Dragosics et al . , \" Novel real - time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens , \" Journal of Clinical Microbiology , vol .", "label": "", "metadata": {}, "score": "82.2938"}
{"text": "Ltd ) , clarithromycin ( 250 mg / tab , 030501 , Hangzhou Chinese - American East China Pharmaceutical Co.Ltd ) , and Amoxicillin ( 500 mg / tab , 011003 , Pharmaceutical factory ) .", "label": "", "metadata": {}, "score": "82.538895"}
{"text": "It is known that bacteria can develop efflux channels for CAM , which rapidly transfer the drug out of the bacterial cell , preventing the binding of the antibiotic to the ribosome [ 22 ] .", "label": "", "metadata": {}, "score": "82.5977"}
{"text": "10 We calculated proportions , their differences , and 95 % confidence intervals by using the method recommended by Newcombe and Altman .We calculated the number needed to treat and 95 % confidence intervals from the reciprocal of the risk difference of the meta - analysis .", "label": "", "metadata": {}, "score": "82.60627"}
{"text": "In 2005 , the Nobel Prize in Medicine was awarded to Warren and Marshall for their discovery .The frequency of H pylori infection is decreasing worldwide .", "label": "", "metadata": {}, "score": "82.74639"}
{"text": "An efficacy of ranitidine bismuth - based triple therapies has also been demonstrated as retreatments [ 51 ] .Non - bismuth quadruple therapy ( PPI - CAM - AMPC - nitroimidazole ) also represents a safe alternative to triple therapy and should be taken into consideration when the efficacy of triple therapy results in being unacceptably low [ 33 ] .", "label": "", "metadata": {}, "score": "82.75776"}
{"text": "113 - 117 , 2006 .View at Google Scholar \u00b7 View at Scopus .G. Nardone , \" Risk factors for cancer development in Helicobacter pylori gastritis , \" Digestive and Liver Disease , vol .", "label": "", "metadata": {}, "score": "82.87988"}
{"text": "compared the primary and secondary resistance of Helicobacter pylori strains isolated between 2006 - 2008 and 2009 - 2011 to clarithromycin and levofloxacin in Southern Poland .", "label": "", "metadata": {}, "score": "82.955215"}
{"text": "They recommend to test children having first - degree relatives with gastric cancer as well as children showing refractory iron - deficiency anemia with previous negative tests for other causes .", "label": "", "metadata": {}, "score": "83.01965"}
{"text": "Search strategy and study selection .This meta - analysis was developed according to the PRISMA ( preferred reporting items for systematic reviews and meta - analyses ) statement guidelines .", "label": "", "metadata": {}, "score": "83.058426"}
{"text": "-axis represents the change rate of symptom score in DU patients .( The lines represent the trend rather than a continuous variable ) . H. pylori Eradication Rate .", "label": "", "metadata": {}, "score": "83.09331"}
{"text": "This discrepancy could be explained in part by different types of H. pylori virulence factors , especially CagA , VacA , OipA , and DupA. In the paper entitled \" Recent insights into antibiotic resistance in Helicobacter pylori eradication , \" W. Wu et al . present the antibiotic resistance rates in different continental areas and the impact of antibiotic resistances on the eradication of H. pylori .", "label": "", "metadata": {}, "score": "83.09334"}
{"text": "Triple treatments including a proton pump inhibitor , clarithromycin , and amoxicillin or metronidazole have lost efficacy , which is now uniformly less than the 80 % target set initially .", "label": "", "metadata": {}, "score": "83.164474"}
{"text": "The methods for preventing the selection of resistance include using a combination of antibiotics , increasing compliance , and increasing the length of treatment .The Polymorphism of CYP2C19 .", "label": "", "metadata": {}, "score": "83.19864"}
{"text": "241- 245 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. Murakami , T. Furuta , T. Ando et al . , \" Multi - center randomized controlled study to establish the standard third - line regimen for Helicobacter pylori eradication in Japan , \" Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "83.25264"}
{"text": "By the way , rates of both ulcer complications and mortality still remain high nowadays .The prevalence of HP - associated ulcers is decreasing , whereas a role of nonsteroidal anti - inflammatory drugs ( NSAID ) is becoming predominant .", "label": "", "metadata": {}, "score": "83.302414"}
{"text": "These studies highlighted the important issue that quinolone exposure is relevant to delays in diagnosing tuberculosis and the development of drug resistance .This is particularly important for doctors to bear in mind , especially among certain subsets of patients , such as those infected with human immunodeficiency virus ( HIV ) , or in a country burdened with a high prevalence of tuberculosis such as Taiwan [ 51 ] .", "label": "", "metadata": {}, "score": "83.38848"}
{"text": "33 - 37 .M. Rathbone and B. Rathbone , \" Helicobacter pylori and gastric cancer , \" Recent Results in Cancer Research , vol .", "label": "", "metadata": {}, "score": "83.468056"}
{"text": "40 - 45 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Yoshida , H. Ono , A. Kuchiba , N. Saeki , and H. Sakamoto , \" Genome - wide germline analyses on cancer susceptibility and GeMDBJ database : gastric cancer as an example , \" Cancer Science , vol .", "label": "", "metadata": {}, "score": "83.48639"}
{"text": "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans , \" Infection with Helicobacter pylori , \" IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , vol .", "label": "", "metadata": {}, "score": "83.49115"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. C. Y. Cheng , S. K. Lam , and G. B. Ong , \" Maximum acid output to graded doses of pentagastrin and its relation to parietal cell mass in Chinese patients with duodenal ulcer , \" Gut , vol .", "label": "", "metadata": {}, "score": "83.53318"}
{"text": "Only 25 patients were from South Africa , where eradication rates were 86 % ( 19/22 ) ( 95 % CI 65.1 - 97.1 % ) by PP analysis and 76 % ( 19/25 ) ( 95 % CI 54.9 - 90.6 % ) by ITT analysis .", "label": "", "metadata": {}, "score": "83.82396"}
{"text": "Only 25 patients were from South Africa , where eradication rates were 86 % ( 19/22 ) ( 95 % CI 65.1 - 97.1 % ) by PP analysis and 76 % ( 19/25 ) ( 95 % CI 54.9 - 90.6 % ) by ITT analysis .", "label": "", "metadata": {}, "score": "83.82396"}
{"text": "View at Google Scholar . S. Georgopoulos , V. Papastergiou , E. Xirouchakis et al . , \" Evaluation of a four - drug , three - antibiotic , nonbismuth - containing ' concomitant'therapy as firstline Helicobacter pylori eradication regimen in Greece , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "83.98357"}
{"text": "Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter pylori Eradication in Duodenal Ulcer Patients in China : A Multicenter Clinical Comparative Study .Received 27 July 2011 ; Revised 25 October 2011 ; Accepted 25 October 2011 .", "label": "", "metadata": {}, "score": "84.00333"}
{"text": "In the presence of alcohol , the inhibition of ALDH results in elevated blood acetaldehyde levels and a disulfiram reaction .25 Fluoroquinolones induce cell death by disrupting gyrase , an enzyme needed for DNA replication ; however , the overuse of fluoroquinolones has led to an increase in resistance rates , reaching 20 % in some areas .", "label": "", "metadata": {}, "score": "84.015465"}
{"text": "Prevalence is 12.9 % in the United States and may be as high as 24 % in some European countries [ 40 - 42 ] .", "label": "", "metadata": {}, "score": "84.02536"}
{"text": "65 - 69 , 2011 .View at Google Scholar .J. B. Watson , S. F. Moss , and H. Will , \" Pylori stagger under the weight of this LOAD ?", "label": "", "metadata": {}, "score": "84.027405"}
{"text": "343 - 357 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. O'Connor , I. Taneike , A. Nami et al . , \" Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland , \" European Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "84.04128"}
{"text": "For the strains resistant to both clarithromycin and metronidazole , only sequential therapy in which levofloxacin was used instead of clarithromycin was able to significantly overcome the resistance to both antimicrobials .", "label": "", "metadata": {}, "score": "84.047745"}
{"text": "The publication is also useful to pharmacy technicians , students , other health professionals and individuals interested in health management .Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education , LLC , accredited by the Accreditation Council for Pharmacy Education ( ACPE ) as a provider of continuing pharmacy education .", "label": "", "metadata": {}, "score": "84.094574"}
{"text": "Gastroenterology 2013 ; 144 ( suppl 1 ) : S333 .Sardarian H , Fakheri H , Hosseini V , Taghvaei T , Maleki I , Mokhtare M. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran : a prospective randomized trial .", "label": "", "metadata": {}, "score": "84.165794"}
{"text": "Health Technol Assess 2003 ; 7 : 1 -76 .Balk EM , Bonis PA , Moskowitz H , Schmid CH , Ioannidis JP , Wang C , et al .", "label": "", "metadata": {}, "score": "84.34862"}
{"text": "In patients with duodenal ulcers , the duodenal mucosa is damaged by excess acid production .Excess acid is released in response to abnormal gastrin release , which is caused by gastric mucosal inflammation induced by H pylori .", "label": "", "metadata": {}, "score": "84.40878"}
{"text": "For example , there was zero resistance to levofloxacin in Malaysia but 8.2 % resistance in Japan [ 10 , 11 ] .An increased use of quinolones in various different countries is probably responsible for this rise in quinolone resistance across different classes of bacteria , including H. pylori .", "label": "", "metadata": {}, "score": "84.68182"}
{"text": "We assessed funnel plots for evidence of asymmetry and possible publication bias or other small study effects , by using the Egger 's linear regression and regarding a two sided P value of 0.10 or less as significant .", "label": "", "metadata": {}, "score": "84.85846"}
{"text": "Over recent decades , HP infections have progressively declined throughout most of the industrialized countries .HP still represents , by the way , a clinical issue among those people who were infected as children at a time when HP was endemic or among immigrants coming from endemic countries [ 14 , 15 ] .", "label": "", "metadata": {}, "score": "84.99656"}
{"text": "Subgroup analyses are entirely observational in their nature and have the limitations of any observational investigation , including possible bias through confounding by other study level characteristics .", "label": "", "metadata": {}, "score": "85.038345"}
{"text": "2011;26(suppl 1 ) : 42 - 45 .CDC .Helicobacter pylori : fact sheet for health care providers .Accessed August 28 , 2011 .", "label": "", "metadata": {}, "score": "85.08085"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. R. Greenberg , G. L. Anderson , D. R. Morgan et al . , \" 14-day triple , 5-day concomitant , and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites : a randomised trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "85.18097"}
{"text": "Symptoms improvement evaluation : disappearance rate of chief symptoms was the rate of chief symptoms disappearing entirely ; alleviation rate was the rate of symptoms improvement including obvious effect , effect , and progress .", "label": "", "metadata": {}, "score": "85.22191"}
{"text": "Occasionally , authors may express opinions that represent their own viewpoint .Conclusions drawn by participants should be derived from objective analysis of scientific data .", "label": "", "metadata": {}, "score": "85.631676"}
{"text": "HP positive peptic ulcer disease ( PUD ) is recommended for treatment .However , for children with HP infection without PUD , treatment should be considered by the clinician evaluating the potential advantages and the risk factors of a developed chronic infection with bad consequences .", "label": "", "metadata": {}, "score": "85.8399"}
{"text": "Liberati A , Altman DG , Tetzlaff J , Mulrow C , Gotzsche PC , Ioannidis JP , et al .The PRISMA statement for reporting systematic reviews and meta - analyses of studies that evaluate healthcare interventions : explanation and elaboration .", "label": "", "metadata": {}, "score": "85.87387"}
{"text": "34 We decided to pool eradication data separately for each country .As recently shown , 76 a significant dispersion can be seen across the countries , highlighted by the values of I 2 .", "label": "", "metadata": {}, "score": "86.09901"}
{"text": "343 - 357 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Perez Aldana , M. Kato , S. Nakagawa et al . , \" The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance , \" Helicobacter , vol .", "label": "", "metadata": {}, "score": "86.109344"}
{"text": "The chronic inflammation caused by the infection may lead to atrophic inflammatory changes in the stomach , resulting in cyclo - oxygenase-2 expression and increased prostaglandin .", "label": "", "metadata": {}, "score": "86.2267"}
{"text": "Staggering the treatment with multiple antibiotics does not increase side effects but still eradicates almost all H. pylori isolates , the exceptions being doubly resistant isolates .", "label": "", "metadata": {}, "score": "86.55643"}
{"text": "405 - 416 , 2010 .View at Google Scholar \u00b7 View at Scopus .N. Mu\u00f1oz , \" Is Helicobacter pylori a cause of gastric cancer ?", "label": "", "metadata": {}, "score": "86.5847"}
{"text": "View at Publisher \u00b7 View at Google Scholar .J. S. Kim , B. W. Kim , J. H. Ham , et al . , \" Sequential therapy for Helicobacter pylori infection in Korea : systematic review and meta - analysis , \" Gut Liver , vol .", "label": "", "metadata": {}, "score": "87.042175"}
{"text": "Tetracycline is associated with photosensitivity and may cause tooth discoloration in children .Bismuth is associated with darkening of the stool and of the tongue .", "label": "", "metadata": {}, "score": "87.41599"}
{"text": "Only 7 patients ( 5.8 % ) were smokers and 43 ( 35.8 % ) had a history of alcohol consumption .The difference in distribution of participants between the EAC 7 and EAC 14 groups was not significant for either smoking or alcohol consumption , with p -values of 0.24 and 0.85 respectively .", "label": "", "metadata": {}, "score": "87.76469"}
{"text": "Only 7 patients ( 5.8 % ) were smokers and 43 ( 35.8 % ) had a history of alcohol consumption .The difference in distribution of participants between the EAC 7 and EAC 14 groups was not significant for either smoking or alcohol consumption , with p -values of 0.24 and 0.85 respectively .", "label": "", "metadata": {}, "score": "87.76469"}
{"text": "Studies in Thailand , Spain , and Taiwan demonstrated the efficacy of sequential therapy ; however , studies from Panama , France , and Korea failed to show a significant difference between standard triple therapy and sequential therapy .", "label": "", "metadata": {}, "score": "87.80211"}
{"text": "8,9 The prevalence of infection in the United States is estimated to be 30 % to 40 % .10 Generally , rates of infection are higher in developing countries ; however , there is variation within countries .", "label": "", "metadata": {}, "score": "87.93747"}
{"text": "Evaluation of risk of bias .We assessed risk of bias as described in the Cochrane handbook , 9 by evaluating the random sequence generation , concealment of allocation , blinding of participants and personnel , blinding of outcome assessment , incomplete outcome data , selective reporting , and other sources of bias .", "label": "", "metadata": {}, "score": "87.980606"}
{"text": "By the way , other studies evaluating the same relation actually produced inconsistent results [ 75 ] .A systematic review by Qian et al .", "label": "", "metadata": {}, "score": "88.14543"}
{"text": "This type of gastritis is typically associated with duodenal ulcer disease presenting with minimal to no gastric atrophy .Lymphomas are a rare complication of antrum - predominant gastritis .", "label": "", "metadata": {}, "score": "88.29077"}
{"text": "[Links ] .Murray LJ , Lane AJ , Harvey IM , Donovan JL , Nair P , Harvey RF .Inverse relationship between alcohol consumption and active Helicobacter pylori infection : the Bristol Helicobacter project .", "label": "", "metadata": {}, "score": "88.32976"}
{"text": "[Links ] .Murray LJ , Lane AJ , Harvey IM , Donovan JL , Nair P , Harvey RF .Inverse relationship between alcohol consumption and active Helicobacter pylori infection : the Bristol Helicobacter project .", "label": "", "metadata": {}, "score": "88.32976"}
{"text": "4 , pp .298 - 300 , 1997 .View at Google Scholar \u00b7 View at Scopus .J. Cabrita , M. Oleastro , R. Matos et al . , \" Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area , Portugal ( 1990 - 1999 ) , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "88.608406"}
{"text": "Its pathogenesis is multifactorial and involves bacterial , host , and environmental factors that interplay in the histological progression to neoplasia .HP has been recognized as a major factor in the early stages of cancer development , so its screening and eradication are mandatory for cancer prevention .", "label": "", "metadata": {}, "score": "88.95947"}
{"text": "On a global scale , resistance was detected in 2014 cases ( 17.2 % , 95 % CI 16.5 - 17.9 % ) .The resistance rates were obviously different among the following areas : Europe ( 11.1 % ) , Asia ( 18.9 % ) , and America ( 29.3 % ) [ 18 ] .", "label": "", "metadata": {}, "score": "89.019684"}
{"text": "The nonbismuth quadruple therapy and the sequential regimens resulted in being similar in terms of efficacy and safety .Several randomised controlled trials and meta - analyses have demonstrated that non - bismuth quadruple therapy is more effective and equally well tolerated as standard triple therapy .", "label": "", "metadata": {}, "score": "89.69307"}
{"text": "812S-818S , 2007 .View at Google Scholar .K. Miki , Y. Urita , F. Ishikawa et al . , \" Effect of bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans , \" Journal of Dairy Science , vol .", "label": "", "metadata": {}, "score": "89.730064"}
{"text": "Helicobacter pylori ( H. pylori ) infection is a global human pathogen and plays a cardinal role in the development of peptic ulcer disease , gastric adenocarcinoma , and mucosa - associated tissue lymphoma [ 1 ] .", "label": "", "metadata": {}, "score": "89.920654"}
{"text": "Gastritis induced by H pylori results from the secretion of cytokines , which leads to inflammation .Further adding to the evidence that H pylori is responsible for the development of gastritis is the fact that gastritis is resolved through eradication of H pylori .", "label": "", "metadata": {}, "score": "89.9629"}
{"text": "4 , pp .409 - 414 , 2010 .View at Google Scholar \u00b7 View at Scopus . S. K. Chuah , F. W. Tsay , P. I. Hsu , and D. C. Wu , \" A new look at anti-", "label": "", "metadata": {}, "score": "90.10485"}
{"text": "Chi - square test with or without Yates correction for continuity and Fisher 's exact test were used when appropriate to compare the treatment outcome and host factors using the SPSS program ( version 10.1 , Chicago , IL , USA ) .", "label": "", "metadata": {}, "score": "90.18209"}
{"text": "Helicobacter pylori ( H. pylori , Hp ) plays a crucial role in the pathogenesis of chronic gastritis , peptic ulcer disease ( gastric ulcer , duodenal ulcer ) , gastric - mucosa - associated lymphoid tissue ( MALT ) lymphoma , and gastric adenocarcinoma . H. pylori is a major cause of illness and death worldwide [ 1 ] .", "label": "", "metadata": {}, "score": "90.21464"}
{"text": "Conclusions .In the next future , the perspective of a tailored therapy could optimize eradication regimens within the different countries .Introduction .Helicobacter pylori ( HP ) is an ubiquitous gram - negative bacterium .", "label": "", "metadata": {}, "score": "90.43768"}
{"text": "8 Studies of rifabutin - based treatment have achieved an eradication rate of 79 % for third - line therapy .27 However , rifabutin is associated with resistance to Mycobacterium tuberculosis . 8 Furazolidone , a nitrofuran derivative , has antibacterial efficacy against gram - negative bacteria .", "label": "", "metadata": {}, "score": "90.68366"}
{"text": "Over the past two decades , HP has represented a pivotal role in nonmalignant diseases of the upper gastrointestinal tract , as peptic ulcer disease ( PUD ) , functional dyspepsia ( FD ) , and gastroesophageal reflux disease ( GERD ) [ 70 ] .", "label": "", "metadata": {}, "score": "90.728676"}
{"text": "22 Amoxicillin inhibits the synthesis of the bacterial cell wall and has a low resistance rate .Clarithromycin , a macrolide and strong inhibitor of CYP3A4 , binds to the ribosome and inhibits protein synthesis .", "label": "", "metadata": {}, "score": "90.79604"}
{"text": "Department of Medicine , Aga Khan University Hospital , Nairobi , Kenya .BACKGROUND :Helicobacter pylori is associated with several upper gastrointestinal conditions including chronic gastritis , peptic ulcer disease , and gatric malignancy .", "label": "", "metadata": {}, "score": "90.84128"}
{"text": "On ITT analysis EAC 7 eradication rates were 76.7 % ( 95 % confidence interval ( CI ) 66 - 87.4 % ) whereas for EAC 14 the eradication rates were 73.3 % ( 95 % CI 62.1 - 84.5 % ) .", "label": "", "metadata": {}, "score": "90.861115"}
{"text": "On ITT analysis EAC 7 eradication rates were 76.7 % ( 95 % confidence interval ( CI ) 66 - 87.4 % ) whereas for EAC 14 the eradication rates were 73.3 % ( 95 % CI 62.1 - 84.5 % ) .", "label": "", "metadata": {}, "score": "90.861115"}
{"text": "We found a slightly statistically significant effect in favour of sequential therapy in trials conducted in China , Italy , Korea , and Morocco .One of these studies compared sequential therapy with both proton pump inhibitor - amoxicillin - clarithromycin and proton pump inhibitor - amoxicillin - metronidazole .", "label": "", "metadata": {}, "score": "90.86368"}
{"text": "733 - 744 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Rathbone and B. Rathbone , \" Helicobacter pylori and gastric cancer , \" Recent Results in Cancer Research , vol .", "label": "", "metadata": {}, "score": "90.94931"}
{"text": "As exploratory analyses , they may explain some of the observed variability between trials .We used the Cochran Q statistic to compare the relative risks between studies in the analyses .", "label": "", "metadata": {}, "score": "90.998085"}
{"text": "In previous studies , Saccharomyces boulardii and Lactobacillus supp . are the most common probiotics used in clinical trials .Several meta - analysis studies showed that standard triple therapy accompanied with the Saccharomyces boulardii or Lactobacillus supp .", "label": "", "metadata": {}, "score": "91.13039"}
{"text": "The most frequent symptoms were nausea ( 26 patients ; 8.2 % ) and headache ( 11 patients ; 3.4 % ) .Less - frequent symptoms were abdominal pain ( 3 patients ; 0.9 % ) , abdominal constipation ( 2 patients ; 0.6 % ) , and diarrhea ( 2 patients ; 0.6 % ) .", "label": "", "metadata": {}, "score": "91.33786"}
{"text": "LG is the guarantor .Funding :None .Ethical approval : Not needed .Data sharing : No additional data available .Megraud F , Coenen S , Versporten A , Kist M , Lopez - Brea M , Hirschl AM , et al .", "label": "", "metadata": {}, "score": "91.50182"}
{"text": "This highly sensitive and specific test measures the amount of carbon dioxide produced by the conversion of 13 C - urea by H pylori .The stool antigen test uses polyclonal or monoclonal antibodies to detect H pylori antigens ; of these tests , enzyme - linked immunosorbent assay has the highest accuracy .", "label": "", "metadata": {}, "score": "91.84955"}
{"text": "Data sources Medline , Embase , and Cochrane Central Register of Controlled Trials up to May 2013 ; abstract books of major European , American , and Asian gastroenterological meetings .", "label": "", "metadata": {}, "score": "91.87608"}
{"text": "With the help of Barry Marshall , Warren successfully colonized the bacteria , which were first thought to belong to the Campylobacter genus because of their shape and properties .", "label": "", "metadata": {}, "score": "91.90293"}
{"text": "Identify patients who warrant testing and treatment for H pylori infection .Differentiate between the available treatments for H pylori infection .First detected in gastric biopsies by John Warren in 1979 , Helicobacter pylori was noted to rest on the gastric epithelial cells beneath the mucous gel .", "label": "", "metadata": {}, "score": "91.93708"}
{"text": "Patients are divided into three phenotypes : extensive ( EM ) , intermediate ( IM ) , and poor ( PM ) metabolizers .Ethnic differences in the frequencies of CYP2C19 gene polymorphism are well known .", "label": "", "metadata": {}, "score": "91.9904"}
{"text": "This paper is conceived to critically review evidence on the efficacy of the therapeutic availabilities for HP eradication , available as yet .A Medline search was performed indicating as keywords \" Helicobacter , \" \" Eradication Regimens , \" \" Eradication Rate , \" \" Epidemiology , \" \" Drug Resistance .", "label": "", "metadata": {}, "score": "92.18156"}
{"text": "REFERENCES .Hajdu SI .Nobel laureate pathologists .Ann Clin Lab Sci .Warren JR , Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis .", "label": "", "metadata": {}, "score": "93.19109"}
{"text": "Data extraction .Two investigators ( LG and NV ) assessed articles independently , using pre - designed data extraction forms .Disagreement between investigators was resolved by discussion with the other two investigators ( DV and CS ) .", "label": "", "metadata": {}, "score": "93.59456"}
{"text": "[Links ] Clinical Considerations for the Treatment of H pylori Infection .FACULTY : . G. Blair Sarbacker , PharmD Assistant Professor , Pharmacy Practice University of the Incarnate Word Feik School of Pharmacy San Antonio , Texas .", "label": "", "metadata": {}, "score": "93.73341"}
{"text": "PubMed , Cochrane Library , Trip Database , and Ovid Medicine were used as referral databases .Jadad Scale ( score 0 to 5 ) was used as a predetermined strategy of inclusion for clinical trials .", "label": "", "metadata": {}, "score": "93.77231"}
{"text": "Latin - American National Gastroenterological Societies affiliated with the Inter - American Association of Gastroenterology ( AIGE ) , \" The American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "94.159836"}
{"text": "[Links ] .de Bortoli N , Leonardi G , Ciancia E , Merlo A , Bellini M , Costa F , et al .", "label": "", "metadata": {}, "score": "94.38706"}
{"text": "[Links ] .de Bortoli N , Leonardi G , Ciancia E , Merlo A , Bellini M , Costa F , et al .", "label": "", "metadata": {}, "score": "94.38706"}
{"text": "Gut 2010 ; 59 : 1465 -70 .Greenberg ER , Anderson GL , Morgan DR , Torres J , Chey WD , Bravo LE , et al .", "label": "", "metadata": {}, "score": "94.59233"}
{"text": "1562 - 1566 , 2013 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Almeida , J. M. Rom\u00e3ozinho , M. M. Donato , et al . , \" Helicobacter pylori antimicrobial resistance rates in the central region of Portugal , \" Clinical Microbiology and Infection , 2014 .", "label": "", "metadata": {}, "score": "94.787125"}
{"text": "4 , pp .489 - 496 , 1999 .View at Publisher \u00b7 View at Google Scholar .12 , no .4 , pp .", "label": "", "metadata": {}, "score": "95.01154"}
{"text": "As HP - related PUD is the cause of symptoms in only a minority of patients with dyspepsia , recommendations on HP testing and subsequent eradication in all patients with dyspeptic symptoms vary greatly [ 71 ] .", "label": "", "metadata": {}, "score": "95.03726"}
{"text": "Journal of Digestive Diseases , vol .11 , no .4 , pp .244 - 248 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "95.316025"}
{"text": "FACULTY DISCLOSURE STATEMENTS : .Drs .Sarbacker and Montfort have no actual or potential conflicts of interest in relation to this activity .Postgraduate Healthcare Education , LLC does not view the existence of relationships as an implication of bias or that the value of the material is decreased .", "label": "", "metadata": {}, "score": "95.38587"}
{"text": "Ping - I Hsu Nan - Jing Peng .References .S. K. Chuah , F. W. Tsay , P. I. Hsu , and D. C. Wu , \" A new look at anti-", "label": "", "metadata": {}, "score": "95.46715"}
{"text": "77 78 In contrast , blinding seeks to prevent performance and detection bias by protecting the sequence after assignment .77 79 Empirical studies show that the effects of experimental interventions measured as odds ratios are exaggerated on average by 21 % if allocation concealment is unclear or inadequate and by 18 % if trials are not reported as \" double blind .", "label": "", "metadata": {}, "score": "95.77281"}
{"text": "e114 - 120 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Indicators .Related links .Share .SAMJ , S. Afr . med .", "label": "", "metadata": {}, "score": "96.10738"}
{"text": "We also calculated the I 2 statistic .13 Its value ranges from 0 % to 100 % , with 0 % representing no observed heterogeneity and larger values indicating increasing heterogeneity .", "label": "", "metadata": {}, "score": "96.22154"}
{"text": "The pathophysiology of FD is actually multifactorial .Several randomized controlled trials performed in western countries and in Asia have given opposite results about the role of HP infection in causing FD , with no evidence for the former countries whereas a success of eradication has been obtained in some east Asian populations [ 70 ] .", "label": "", "metadata": {}, "score": "96.37929"}
{"text": "Ahmed Sokwala I ; Mahesh V Shah II ; Smita Devani III ; Gerald Yonga IV .I MD , MMed .Department of Medicine , Aga Khan University Hospital , Nairobi , Kenya II MB ChB , MMed .", "label": "", "metadata": {}, "score": "96.73924"}
{"text": "Cochrane Database Syst Rev .2006;(2):CD003840 .Malfertheiner P , Megraud F , O'Morain C , et al .Current concepts in the management of Helicobacter pylori infection : the Maastricht III Consensus Report .", "label": "", "metadata": {}, "score": "96.93679"}
{"text": "Molina - Infante J , Perez - Gallardo B , Fernandez - Bermejo M , Hernandez - Alonso M , Vinagre G , Duenas C , et al .", "label": "", "metadata": {}, "score": "97.93808"}
{"text": "Conclusions .Many different factors play a role in the development of HP infection , including geography , ethnicity , age , and socioeconomic elements .", "label": "", "metadata": {}, "score": "97.96017"}
{"text": "[Links ] Indicadores .Links relacionados .Compartilhar .SAMJ , S. Afr . med .j. vol.102 no.6 Cape Town Jun. 2012 .RESEARCH .", "label": "", "metadata": {}, "score": "98.09199"}
{"text": "Managing HP Infection in Children : The 2011 ESPGHAN and NASPGHAN Guidelines .In 2011 the European and North American Societies of Pediatric Gastroenterology Hepatology and Nutrition ( ESPGHAN and NASPGHAN ) emitted evidence - based guidelines for managing HP in children [ 69 ] .", "label": "", "metadata": {}, "score": "98.963"}
{"text": "H pylori sustains survival in the host by disrupting epithelial - cell inflammatory signaling , which in turn modifies mucosal immune response .13 Not only does H pylori have genes that allow for adaptation to varying gastric conditions , but the high amount of urease it produces permits colonization in the stomach .", "label": "", "metadata": {}, "score": "98.9888"}
{"text": "Score criteria : score 0 for no symptoms ; score 1 for slight , symptoms could be remarked ; score 2 for medium , had chief complaint of symptoms but did not affect daily life ; score 3 for severe , had symptoms and affected daily life .", "label": "", "metadata": {}, "score": "99.80249"}
{"text": "HP infection would be protective towards gastroesophageal disease ( GERD ) .By the way , HP is associated with esophageal squamous cell carcinoma , and long - term PPI treatments in patients with persistent HP infection may cause gastric atrophy , which is a precancerous lesion [ 72 , 73 ] .", "label": "", "metadata": {}, "score": "100.2327"}
{"text": "Once HP has colonised the stomach , an immune response begins ; as a result , normal acid secretion and gastric architecture are modified .Consequences are gastritis , peptic ulcer disease , functional dyspepsia , and cancer .", "label": "", "metadata": {}, "score": "100.42003"}
{"text": "Foreign language papers were translated where necessary .We used bibliographies of all relevant studies identified to do a recursive search .In addition , we contacted authors to obtain unpublished data from their studies , whenever we deemed it necessary .", "label": "", "metadata": {}, "score": "100.560074"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .Working Party of the European Helicobacter pylori Study Group , \" Technical annex : tests used to assess Helicobacter pylori infection , \" Gut , vol .", "label": "", "metadata": {}, "score": "100.947395"}
{"text": "The search strategy we used identified 610 citations , of which we excluded 545 after examining the title and abstract .We retrieved and evaluated 65 articles in more detail .", "label": "", "metadata": {}, "score": "100.99156"}
{"text": "During the 1990s evidence emerged of its etiologic role in stomach cancers in adults .HP was classified in 1994 among the group I carcinogens by the International Agency for Research on Cancer [ 4 ] .", "label": "", "metadata": {}, "score": "101.16538"}
{"text": "Contributors : LG , CS , NV , and DV conceived the study .LG , CS , and DV collected the data .LG and CS analysed and interpreted the data and drafted the manuscript .", "label": "", "metadata": {}, "score": "101.82799"}
{"text": "69 70 However , the number of studies was small and most of them were done in Italy .Since then , several randomised controlled trials have been carried out in different parts of the world comparing sequential therapy with traditional and novel treatments , providing a glimpse into current eradication rates with new and old treatments .", "label": "", "metadata": {}, "score": "103.03274"}
{"text": "All rights reserved .Reproduction in whole or in part without permission is prohibited . H. pylori Eradication Therapy . 1 Division of Gastroenterology , Department of Internal Medicine , Kaohsiung Veterans General Hospital and National Yang - Ming University , Kaohsiung , Taiwan 2 Department of Nuclear Medicine , Kaohsiung Veterans General Hospital and National Yang - Ming University , 386 Ta - Chung 1st", "label": "", "metadata": {}, "score": "103.43063"}
{"text": "The authors have no conflicts of interest to declare .Acknowledgments .The study was approved by both Institutional Review Broad and Ethics Committee of Kaohsiung Veterans General Hospital , Taiwan ( VGHKS12-CT6 - 06 ) .", "label": "", "metadata": {}, "score": "103.58627"}
{"text": "5 , pp .668 - 671 , 2004 .View at Google Scholar \u00b7 View at Scopus .12 , no .4 , pp .", "label": "", "metadata": {}, "score": "104.55148"}
{"text": "5 , pp .668 - 671 , 2004 .View at Google Scholar \u00b7 View at Scopus .12 , no .4 , pp .", "label": "", "metadata": {}, "score": "104.55148"}
{"text": "9790 , pp .507 - 514 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .98 , no . 3 , pp .", "label": "", "metadata": {}, "score": "105.392265"}
{"text": "Conflict of Interests .The authors have no competing interests to report .This paper represents original research that has not been published nor submitted for publication elsewhere .", "label": "", "metadata": {}, "score": "106.026535"}
{"text": "49 - 53 , 2012 .View at Publisher \u00b7 View at Google Scholar .16 , no . 2 , pp .139 - 145 , 2011 .", "label": "", "metadata": {}, "score": "106.29654"}
{"text": "The rapid urease test , histology , and urea breath test were performed according to our previous studies [ 13 ] .A biopsy specimen was taken from the lesser curvature site of the antrum for rapid urease test .", "label": "", "metadata": {}, "score": "106.30678"}
{"text": "857 - 864 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .15 , no .5 , pp .", "label": "", "metadata": {}, "score": "107.1478"}
{"text": "415 - 420 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .98 , no . 3 , pp .", "label": "", "metadata": {}, "score": "107.26962"}
{"text": "1123 - 1127 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .24 , no . 7 , pp .", "label": "", "metadata": {}, "score": "107.37932"}
{"text": "2116 - 2123 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 13 , no . 8 , pp .", "label": "", "metadata": {}, "score": "107.70872"}
{"text": "109 - 118 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .16 , no . 2 , pp .", "label": "", "metadata": {}, "score": "107.772896"}
{"text": "49 , no .12 , pp .1103 - 1109 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "107.866844"}
{"text": "12 , pp .3393 - 3398 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .15 , no .", "label": "", "metadata": {}, "score": "107.92133"}
{"text": "JAMA 2002 ; 287 : 2973 -82 .Received 29 February 2012 ; Accepted 17 April 2012 .Academic Editor : Ping - I Hsu .", "label": "", "metadata": {}, "score": "107.93544"}
{"text": "49 , no .10 , pp .3638 - 3643 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "107.93921"}
{"text": "Lancet 2011 ; 378 : 507 -14 .Kim YS , Kim SJ , Yoon JH , Suk KT , Kim JB , Kim DJ , et al .", "label": "", "metadata": {}, "score": "108.29088"}
{"text": "16 19 24 27 29 32 33 34 38 39 48 49 50 57 58 Three studies could not be included in the meta - analysis because our criteria required at least three comparable study groups for every comparison .", "label": "", "metadata": {}, "score": "108.31743"}
{"text": "Yep - Gamarra V , Rodriguez - Ulloa C , Diaz - Velez C , Aldave - Herrera A , Donet JA , Rodas JI , et al .", "label": "", "metadata": {}, "score": "108.45535"}
{"text": "1123 - 1129 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .15 , no . 1 , pp .", "label": "", "metadata": {}, "score": "108.55768"}
{"text": "39 , no .4 , pp .1319 - 1322 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "108.681305"}
{"text": "4 , pp .359 - 363 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 64 , no .", "label": "", "metadata": {}, "score": "108.84544"}
{"text": "163 - 168 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .158 , no . 8 , pp .", "label": "", "metadata": {}, "score": "109.545654"}
{"text": "10 , pp .1128 - 1135 , 2013 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .62 , no .", "label": "", "metadata": {}, "score": "109.70051"}
{"text": "Department of Medicine , Aga Khan University Hospital , Nairobi , Kenya IV MB ChB , MMed , Dip Cardiol , MBA , FESC , FACC .", "label": "", "metadata": {}, "score": "109.95519"}
{"text": "93 , no .11 , pp .2097 - 2101 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "110.47238"}
{"text": "2 , no .5 , pp .273 - 279 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "110.85618"}
{"text": "48 , no .4 , pp .261 - 264 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "111.617004"}
{"text": "47 , no . 1 , pp .53 - 58 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "112.315796"}
{"text": "The analysis by country shows that in Colombia , Mexico , and Nicaragua , no significant difference existed between treatments tested .Limitations of study .", "label": "", "metadata": {}, "score": "112.51839"}
{"text": "31 34 41 55 57 58 In four trials , non - bismuth quadruple therapy lasted 10 days , 31 41 55 57 and in the remaining two it lasted five days , 34 58 and one trial did not report full data on the proton pump inhibitor used .", "label": "", "metadata": {}, "score": "112.5349"}
{"text": "53 - 58 , 2011 .View at Google Scholar \u00b7 View at Scopus .377 , no .9769 , pp .905 - 913 , 2011 .", "label": "", "metadata": {}, "score": "112.93396"}
{"text": "227 - 238 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .32 , no .12 , pp .", "label": "", "metadata": {}, "score": "113.18208"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. K. Chuah , F. W. Tsay , P. I. Hsu , and D. C. Wu , \" A new look at anti-", "label": "", "metadata": {}, "score": "115.97072"}
{"text": "Department of Medicine , Aga Khan University Hospital , Nairobi , Kenya II MB ChB , MMed .Department of Medicine , Aga Khan University Hospital , Nairobi , Kenya III MB ChB , MRCP .", "label": "", "metadata": {}, "score": "116.00397"}
{"text": "HP expresses high levels of urease enzyme , producing NH3 and CO 2 from the urea being present in the gastric juice [ 1 ] .", "label": "", "metadata": {}, "score": "116.27085"}
{"text": "1709 - 1715 , 2013 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .63 , no . 9 , pp .", "label": "", "metadata": {}, "score": "117.0483"}
{"text": "94 - 100 , 2006 .View at Google Scholar \u00b7 View at Scopus .30 , no . 3 , pp .528 - 534 , 2008 .", "label": "", "metadata": {}, "score": "117.94314"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "118.05228"}
{"text": "Received 23 April 2012 ; Accepted 19 June 2012 .Academic Editors : J.-P. Buts and H. Shimoda .Copyright \u00a9 2012 M. Gasparetto et al .", "label": "", "metadata": {}, "score": "119.35875"}
{"text": "317 - 322 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . 13 , no . 3 , pp . 311 - 315 , 1999 .", "label": "", "metadata": {}, "score": "120.081184"}
{"text": "Received 31 March 2012 ; Accepted 14 June 2012 .Academic Editor : Deng - Chyang Wu .Copyright \u00a9 2012 Sung - Shuo Kao et al .", "label": "", "metadata": {}, "score": "120.349686"}
{"text": "49 - 53 , 2012 .View at Google Scholar 4 Department of Medical and Surgical Sciences , University of Bologna , Italy .Accepted 10 July 2013 .", "label": "", "metadata": {}, "score": "120.99791"}
{"text": "1582 - 1589 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus", "label": "", "metadata": {}, "score": "122.27354"}
{"text": "Academic Editor : Deng - Chyang Wu .Copyright \u00a9 2014 Seng - Kee Chuah et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "127.61448"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .4 , no . 2 , pp .201 - 206 , 2010 .", "label": "", "metadata": {}, "score": "129.82527"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .377 , no .9769 , pp .905 - 913 , 2011 .", "label": "", "metadata": {}, "score": "130.95653"}
{"text": "Copyright \u00a9 2012 Ying - Qun Zhou et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "132.33783"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .16 , no . 2 , pp .139 - 145 , 2011 .", "label": "", "metadata": {}, "score": "132.73477"}
{"text": "Copyright \u00a9 2013 Ping - I Hsu and Nan - Jing Peng .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "136.55022"}
{"text": "The mean age was in the fourth decade with no statistically significant difference between the two groups , and men and women were equally represented .", "label": "", "metadata": {}, "score": "141.88715"}
{"text": "The mean age was in the fourth decade with no statistically significant difference between the two groups , and men and women were equally represented .", "label": "", "metadata": {}, "score": "141.88715"}
